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Figure	  7.	  Graph	  shows	  the	  intensity	  profile	  of	  region	  indicated	  by	  the	  red	  arrow.	  Green	  line	  
represents	  EdU	  stained	  nucleus,	  red	  line	  indicates	  GFAP	  profile	  and	  blue	  line	  indicates	  
Hoechst.	  Likewise,	  on	  the	  right	  the	  labelled	  astrocyte	  cytoskeleton	  (red)	  and	  EdU	  
positive	  nucleus	  (green)	  show	  the	  morphological	  star-­‐shape	  of	  glial	  cells.	  This	  pattern	  
of	  the	  cytoskeletal	  GFAP	  stain	  cupping	  the	  nuclear	  EdU	  is	  a	  positive	  indication	  that	  the	  
labelled	  cell	  is	  a	  glial	  cell.	  ......................................................................................................................	  26	  
Figure	  8.	  	  	  Displaying	  each	  treatment	  group	  	  (MS+R,	  MS+NR,	  NMS+R,	  NMS+NR).	  The	  rat	  
pups	  were	  treated	  with	  MS	  or	  NMS.	  	  These	  rats	  were	  then	  permitted	  to	  reach	  
adulthood	  and	  housed	  with	  running	  wheels	  on	  PND	  54.	  	  Wheels	  were	  locked	  or	  left	  
unlocked	  allowing	  some	  rats	  voluntary	  exercise	  and	  others	  not.	  EdU	  injections	  were	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administered	  on	  PND	  60	  to	  measure	  mitotic	  activity	  in	  the	  dentate	  gyri	  of	  runners	  and	  
non-­‐runners.	  	  Rats	  were	  immediately	  returned	  to	  their	  home	  cages	  with	  running	  
wheels	  until	  PND	  74.	  They	  were	  then	  perfused	  and	  brains	  collected	  for	  
immunohistochemistry.	  ........................................................................................................................	  28	  
Figure	  9.	  A	  representation	  of	  the	  processing	  of	  each	  rat	  brain	  collected.	  	  After	  the	  perfusion	  
adult	  rat	  brains	  were	  collected	  and	  the	  ventral	  and	  dorsal	  hippocampi	  were	  sectioned	  
separately.	  Five	  sections	  of	  each	  region	  of	  the	  hippocampus	  were	  kept	  for	  each	  
molecular	  label	  combination.	  Three	  molecular	  label	  combinations	  were	  used	  to	  study	  
neurogenesis	  in	  the	  dentate	  gyrus:	  EdU/NeuN/GFAP,	  EdU/DCX	  and	  Ki-­‐67/DCX.	  EdU	  was	  
used	  to	  quantify	  neuronal	  or	  astrocytic	  survival	  while	  Ki-­‐67	  Label	  was	  used	  as	  a	  pulse.
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Figure	  10.	  Cell-­‐type	  specific	  marker.	  Combination	  1	  shows	  GFAP	  (red),	  EdU	  (green),	  NeuN	  
(magenta)	  and	  Hoechst	  (blue)	  and	  a	  composite	  image	  allowing	  identification	  of	  the	  EdU	  
labelled	  cell.	  ...............................................................................................................................................	  33	  
Figure	  11.	  Cell-­‐type	  specific	  marker	  combination	  2	  shows	  DCX	  (red),	  EdU	  (green)	  and	  
Hoechst	  (blue)	  and	  a	  composite	  image.	  ..........................................................................................	  33	  
Figure	  12.	  Cell-­‐type	  specific	  marker	  combination	  3	  displays	  DCX	  (red),	  Hoechst	  (blue)	  and	  
KI-­‐67	  (yellow)	  and	  composite	  image.	  ...............................................................................................	  34	  
Figure	  13.	  Total	  number	  of	  cells	  co-­‐labelled	  with	  EdU/GFAP,	  EdU/NeuN	  or	  EdU/DCX	  in	  the	  
dentate	  gyrus	  of	  the	  dorsal	  hippocampus	  of	  Sprague	  Dawley	  rats	  injected	  with	  EdU	  at	  
(a)	  PND	  60	  or	  (b)	  PND	  94/95	  and	  perfused	  on	  PND	  74	  or	  94/95.	  Please	  note	  that	  this	  
study’s	  “total”	  refers	  to	  the	  total	  cells	  counted	  and	  summed	  per	  rat.	  The	  above	  data	  
were	  tested	  using	  the	  Shapiro-­‐Wilk	  normality	  test	  and	  found	  to	  be	  non-­‐parametrically	  
distributed.	  	  The	  data	  were	  therefore	  analyzed	  using	  the	  Kruskal-­‐Wallis	  test.	  	  Data	  
points	  represent	  the	  number	  of	  counted	  cells	  labelled	  with	  EdU/GFAP,	  EdU/NeuN	  or	  
EdU/DCX	  in	  the	  dentate	  gyrus	  summed	  per	  section	  (40	  μm)	  of	  the	  rat	  brain	  (2-­‐6	  
sections	  per	  rat).	  Results	  are	  expressed	  as	  individual	  data	  points	  with	  bars	  representing	  
median	  and	  inter-­‐quartile	  range.	  There	  were	  no	  significant	  differences	  in	  the	  number	  
of	  EdU	  co-­‐labelled	  cells	  between	  the	  different	  cell	  types.	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  37	  
Figure	  14.	  Columns	  represent	  the	  median	  and	  bars	  the	  upper-­‐quartile	  range	  of	  the	  average	  
number	  of	  EdU-­‐labelled	  cells	  found	  in	  each	  exercised	  rat	  per	  injection	  group	  (n=5).	  
Injections	  administered	  on	  PND	  60	  had	  a	  significantly	  higher	  median	  (6.16	  cells)	  than	  
PND	  96	  injections	  (1.1	  cells).	  ...............................................................................................................	  38	  
Figure	  15.	  Average	  number	  of	  cells	  per	  rat	  co-­‐labelled	  with	  EdU/GFAP,	  EdU/NeuN	  or	  
EdU/DCX	  in	  the	  dorsal	  hippocampus	  of	  Sprague	  Dawley	  rats	  injected	  with	  EdU	  at	  (a)	  
PND	  60	  or	  (b)	  PND	  96.	  The	  above	  data	  were	  tested	  using	  the	  Shapiro-­‐Wilk	  test	  and	  
found	  to	  be	  parametrically	  distributed	  (15a)	  and	  non-­‐parametrically	  distributed	  (15b).	  
The	  data	  were	  therefore	  tested	  for	  differences	  between	  rats	  injected	  with	  EdU	  at	  (a)	  
PND	  60	  using	  a	  one-­‐way	  analysis	  of	  variance	  and	  (b)	  PND	  96	  using	  the	  Kruskal-­‐Wallis	  
test.	  Data	  points	  represent	  the	  average	  number	  of	  cells	  labelled	  with	  EdU/GFAP,	  
EdU/NeuN	  or	  EdU/DCX	  in	  the	  dentate	  gyrus	  summed	  (per	  40	  μm	  section	  of	  the	  rat	  
brain	  2-­‐6	  sections	  were	  averaged	  per	  rat).	  Results	  are	  expressed	  as	  individual	  data	  
points	  with	  bars	  representing	  median	  and	  inter-­‐quartile	  range.	  There	  were	  no	  
significant	  differences	  in	  the	  number	  of	  EdU	  co-­‐labelled	  cells	  between	  the	  different	  cell	  
type	  markers.	  The	  data	  were	  also	  tested	  for	  differences	  between	  rats	  injected	  with	  EdU	  
at	  (a)	  PND	  60	  and	  (b)	  PND	  96	  using	  the	  Mann-­‐Whitney	  U	  test.	  There	  were	  no	  significant	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differences	  in	  the	  number	  of	  EdU	  co-­‐labelled	  cells	  between	  PND	  60	  and	  PND	  96	  for	  the	  
different	  cell	  type	  markers.	  ..................................................................................................................	  39	  
Figure	  16.	  Total	  (a)	  and	  average	  (b)	  number	  of	  EdU/NeuN	  plus	  EdU/DCX	  co-­‐labelled	  cells	  in	  
the	  dentate	  gyrus	  of	  rats	  injected	  with	  EdU	  at	  PND	  60	  and	  those	  injected	  on	  PND	  96.	  
Data	  points	  (a)	  represent	  the	  number	  of	  cells	  labelled	  with	  EdU/Neun	  and	  EdU/DCX	  in	  
the	  dentate	  gyrus	  summed	  per	  40-­‐μm	  section	  of	  the	  rat	  brain	  (2-­‐6	  sections	  per	  rat).	  	  
Data	  points	  (b)	  represent	  the	  average	  number	  of	  EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  
cells	  in	  2-­‐6	  x	  40-­‐μm	  sections	  of	  the	  dentate	  gyrus	  of	  the	  dorsal	  hippocampus	  of	  PND	  60	  
and	  PND	  96	  EdU-­‐injected	  rats.	  The	  data	  were	  tested	  using	  the	  Shapiro-­‐Wilk	  test	  and	  
found	  to	  be	  non-­‐parametrically	  distributed.	  The	  Mann-­‐Whitney	  U	  test	  revealed	  that	  
the	  dentate	  gyrus	  of	  the	  dorsal	  hippocampus	  of	  the	  PND	  60	  EdU-­‐injected	  rats	  had	  a	  
greater	  number	  of	  EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  cells	  than	  PND	  96	  EdU-­‐injected	  
rats	  (a,b).	  Results	  are	  expressed	  as	  median	  and	  interquartile	  range.	  *Significant	  
difference	  between	  NeuN	  +	  DCX	  60	  and	  NeuN	  +	  DCX	  96	  median	  values.	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  40	  
Figure	  17.	  Total	  number	  of	  EdU/GFAP,	  EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  cells	  in	  4-­‐6	  
sections	  of	  dentate	  gyrus	  in	  the	  dorsal	  hippocampus	  of	  rats	  that	  were	  housed	  in	  cages	  
with	  attached	  running	  wheels	  that	  were	  freely	  moving	  (a)	  or	  immobilized	  (b)	  for	  a	  
period	  of	  20	  days	  and	  then	  injected	  with	  EdU	  at	  PND74,	  4	  hours	  prior	  to	  perfusion	  and	  
collection	  of	  brains	  for	  immunohistochemistry.	  Data	  points	  represent	  the	  summed	  
number	  of	  EdU-­‐co-­‐labelled	  cells	  in	  2-­‐6	  x	  40-­‐μm	  sections	  of	  the	  dentate	  gyrus	  of	  3	  
exercised	  rats	  permitted	  to	  run	  for	  20	  days	  (a)	  and	  3	  non-­‐exercised	  rats	  (b).	  The	  bars	  
represent	  the	  median	  and	  interquartile	  range.	  ............................................................................	  41	  
Figure	  18.	  Average	  number	  of	  EdU/GFAP,	  EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  cells	  in	  2-­‐6	  
sections	  of	  dentate	  gyrus	  in	  dorsal	  hippocampus	  of	  rats	  that	  were	  housed	  in	  cages	  with	  
attached	  running	  wheels	  that	  were	  freely	  moving	  (a)	  or	  immobilized	  (b)	  for	  a	  period	  of	  
20	  days	  and	  then	  injected	  with	  EdU	  at	  PND74,	  4	  hours	  prior	  to	  perfusion	  and	  collection	  
of	  brains	  for	  immunohistochemistry.	  Data	  points	  represent	  the	  average	  number	  of	  
EdU-­‐co-­‐labelled	  cells	  in	  40-­‐μm	  sections	  of	  the	  dentate	  gyrus	  (4-­‐6	  x	  40-­‐μm	  sections	  of	  
the	  brain)	  of	  3	  exercised	  rats	  permitted	  to	  run	  for	  20	  days	  (a)	  and	  3	  non-­‐exercised	  rats	  
(b).	  The	  bars	  represent	  the	  median	  and	  interquartile	  range.	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  42	  
Figure	  19.	  Ki67	  and	  a	  pulse	  of	  EdU	  labelled	  the	  same	  cells	  in	  the	  dentate	  gyrus	  of	  the	  
hippocampus	  of	  a	  rat	  injected	  with	  EdU	  on	  PND	  60	  (A)	  Ki-­‐67	  labelled	  cells,	  (B)	  EdU	  
labelled	  cells,	  (C)	  Hoechst	  nuclear	  label,	  and	  (D)	  merged	  image	  (20x).	  ...............................	  43	  
Figure	  20.	  Graph	  showing	  the	  weights	  of	  maternally	  separated	  runners	  (MS+R),	  maternally	  
separated	  non-­‐runners	  (MS+NR),	  non-­‐separated	  runners	  (NMS+R)	  and	  non-­‐separated	  
non-­‐runners.	  A	  Kruskal-­‐	  Wallis	  test	  followed	  by	  Dunn’s	  multiple	  comparison	  Test	  
showed	  that	  MS+NR	  rats	  had	  a	  higher	  median	  then	  NMS+R	  rats.	  ........................................	  44	  
Figure	  21.Distance	  run	  from	  PND	  54-­‐74.	  The	  data	  were	  found	  to	  be	  non-­‐parametric.	  The	  
line	  graph	  showing	  the	  median	  and	  interquartile	  range	  of	  the	  distances	  run	  by	  MS	  and	  
NMS	  rats	  over	  20	  days	  of	  voluntary	  wheel	  running.	  A	  Wilcoxon	  matched-­‐pairs	  signed	  
rank	  test	  revealed	  that	  NMS+R	  had	  a	  significantly	  higher	  median	  than	  MS+R	  (W=	  128.0;	  
p=	  0.0153).	  .................................................................................................................................................	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Figure	  22.	  The	  number	  of	  co-­‐labelled	  EdU/NeuN	  cells	  (ai,	  aii)	  and	  EdU/GFAP	  cells	  (bi,	  bii)	  in	  
the	  dentate	  gyrus	  of	  the	  dorsal	  hippocampus	  (5	  x	  40-­‐μm	  sections)	  (ai,	  bi)	  and	  the	  
ventral	  hippocampus	  (5	  x	  50-­‐μm	  sections)	  (aii,	  bii)	  of	  maternally	  separated	  runners	  
(MS+R,	  n	  =	  4),	  maternally	  separated	  non-­‐runners	  (MS+NR,	  n	  =	  5),	  non-­‐separated	  
runners	  (NMS+R,	  n	  =	  5)	  and	  non-­‐separated	  non-­‐runners	  (NMS+NR,	  n	  =	  5).	  The	  data	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were	  tested	  using	  the	  Shapiro-­‐Wilk	  test	  and	  found	  to	  be	  non-­‐parametrically	  
distributed.	  The	  Kruskal-­‐Wallis	  test	  revealed	  no	  significant	  differences	  between	  groups.	  
Bars	  represent	  the	  median	  and	  inter-­‐quartile	  range.	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Figure	  23.	  The	  number	  of	  neurons	  relative	  to	  astrocytes	  in	  the	  a)	  dorsal	  and	  b)	  ventral	  
hippocampus.	  The	  data	  were	  tested	  using	  the	  Shapiro-­‐Wilk	  test	  and	  found	  to	  be	  non-­‐
parametrically	  distributed.	  The	  Mann-­‐Whitney	  U	  test	  revealed	  no	  significant	  difference	  
between	  the	  number	  of	  EdU/NeuN	  and	  EdU/GFAP	  co-­‐labelled	  cells	  in	  the	  dentate	  gyrus	  
of	  the	  dorsal	  and	  ventral	  hippocampus.	  Data	  points	  represent	  the	  summed	  number	  of	  
NeuN	  and	  EdU	  co-­‐labelled	  cells	  and	  GFAP	  and	  EdU	  co-­‐labelled	  cells	  counted	  in	  5	  
sections	  of	  dentate	  gyrus	  in	  the	  dorsal	  (40-­‐μm	  sections)	  (a)	  and	  ventral	  (50-­‐μm	  
sections)	  (b)	  dentate	  gyrus	  of	  the	  hippocampus	  of	  each	  rat	  (n=	  18).	  Bars	  show	  median	  
and	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Figure	  24.	  Correlation	  analysis	  of	  the	  number	  of	  neurons	  relative	  to	  astrocytes	  in	  the	  a)	  
dorsal	  and	  b)	  ventral	  hippocampus.	  There	  was	  no	  significant	  correlation	  between	  
EdU/GFAP	  co-­‐labelled	  astrocytes	  and	  EdU/NeuN	  co-­‐labelled	  neurons	  in	  the	  dentate	  
gyrus	  of	  the	  dorsal	  hippocampus	  of	  all	  rat	  groups	  (a).	  There	  was	  a	  significant	  positive	  
correlation	  between	  EdU/GFAP	  co-­‐labelled	  astrocytes	  and	  EdU/NeuN	  co-­‐labelled	  
neurons	  in	  the	  dentate	  gyrus	  of	  the	  ventral	  hippocampus	  of	  rats	  allowed	  to	  exercise	  for	  
20	  days	  as	  well	  as	  rats	  that	  were	  housed	  in	  cages	  with	  immobilized	  running	  wheels,	  14	  
days	  after	  injection	  of	  EdU	  (Spearman	  r	  correlation	  0.9006;	  n=	  18).	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  48	  
Figure	  25.	  Effect	  of	  maternal	  separation	  and	  exercise	  on	  the	  number	  of	  surviving	  immature	  
EdU-­‐labelled	  neurons	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus.	  The	  data	  points	  
represent	  the	  number	  of	  co-­‐labelled	  EdU/DCX	  cells	  in	  the	  dorsal	  (40-­‐μm	  sections)	  a)	  
and	  the	  ventral	  (50-­‐μm	  sections)	  b)	  dentate	  gyrus	  (total	  number	  of	  EdU/DCX	  co-­‐
labelled	  cells	  in	  5	  sections	  of	  the	  left	  and	  right	  hippocampus	  of	  rats	  in	  the	  four	  
treatment	  groups).	  The	  data	  were	  tested	  using	  the	  Shapiro-­‐Wilk	  test	  and	  found	  to	  be	  
non-­‐parametrically	  distributed.	  The	  Kruskal-­‐Wallis	  test	  revealed	  that	  there	  were	  no	  
significant	  differences	  between	  the	  treatment	  groups.	  	  Bars	  represent	  the	  median	  and	  
inter-­‐quartile	  range	  of	  each	  data	  set.	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Figure	  26.	  Confocal	  tile	  scan	  (10	  X)	  showing	  the	  dentate	  gyrus	  of	  the	  hippocampus	  of	  a	  
NMS+R	  rat	  (A)	  and	  a	  MS+R	  rat	  (B).	  The	  arrows	  indicate	  yellow	  fluorescence	  
representing	  Ki-­‐67	  labelled	  cells.	  There	  are	  more	  Ki-­‐67	  labelled	  cells	  in	  the	  NMS	  rat	  
than	  MS	  rats	  that	  underwent	  the	  same	  exercise	  regime.	  Scan	  C	  (20	  X)	  red	  (II)	  
representing	  the	  dorsal	  hippocampus	  shows	  DCX-­‐labelled	  immature	  neurons,	  blue	  
represents	  a	  Hoechst	  (I)	  and	  yellow	  (III)	  is	  Ki-­‐67	  marker	  while	  D	  (40	  x)	  displays	  the	  
yellow	  nuclear	  stain	  surrounded	  by	  cytoplasmic	  DCX	  stain	  giving	  an	  example	  of	  the	  
typical	  unipolar	  neuronal	  structure.	  	  The	  above	  data	  were	  tested	  using	  the	  Shapiro-­‐Wilk	  
test	  and	  a)	  was	  found	  to	  be	  parametric.	  The	  data	  were	  tested	  using	  a	  one-­‐way	  ANOVA	  
and	  a	  Tukey	  post-­‐hoc	  test	  to	  identify	  group	  differences.	  The	  data	  from	  b)	  were	  found	  to	  
be	  non-­‐parametrically	  distributed	  and	  were	  tested	  for	  differences	  using	  the	  Kruskal-­‐
Wallis	  test.	  Data	  points	  in	  (a)	  and	  (b)	  represent	  the	  summed	  number	  of	  Ki-­‐67/DCX	  
labelled	  cells	  in	  5	  sections	  of	  the	  dorsal	  (40-­‐μm	  sections)	  (a)	  and	  ventral	  (50-­‐μm	  
sections)	  (b)	  dentate	  gyrus.	  The	  bars	  in	  (a)	  represent	  the	  mean	  and	  standard	  deviations	  
of	  each	  group	  and	  (b)	  medians	  and	  interquartile	  ranges.	  A	  one-­‐way	  ANOVA	  	  (a)	  
revealed	  a	  significant	  difference	  between	  groups,	  and	  a	  Tukey	  post-­‐hoc	  test	  showed	  
that	  proliferating	  immature	  neurons	  in	  the	  dorsal	  hippocampus	  are	  significantly	  
decreased	  in	  four	  MS+R	  rats	  compared	  to	  five	  NMS+R	  rats.	  The	  same	  difference	  was	  
	   xi	  
found	  in	  the	  ventral	  hippocampus	  (by	  using	  the	  Kruskal-­‐Wallis	  test	  and	  Dunn’s	  multiple	  
comparison	  Test.	  The	  NMS+R	  group	  in	  (a)	  had	  significantly	  higher	  number	  of	  
proliferating	  neurons	  relative	  to	  the	  NMS+NR	  group	  	  (MS+R	  n=4,	  MS+NR	  n=4,	  NMS+R	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Abstract	  
THE	  EFFECT	  OF	  VOLUNTARY	  EXERCISE	  ON	  ADULT	  HIPPOCAMPAL	  NEUROGENESIS	  IN	  MATERNALLY	  SEPARATED	  RATS	  
	  
Maternal	  separation	  (MS)	  has	  been	  shown	  to	  produce	  depression-­‐like	  symptoms	  in	  male	  Sprague	  Dawley	  
rats.	  The	  underlying	  mechanisms	  responsible	  for	  the	  development	  of	  these	  depression-­‐like	  behaviors	  are	  
unknown.	  However,	  a	  growing	  body	  of	  evidence	  suggests	  that	  a	  reduction	  in	  neurogenesis	  may	  be	  a	  key-­‐
mediating	  factor.	  
	  
Voluntary	  wheel	  running	  is	  a	  form	  of	  exercise	  that	  increases	  neurogenesis	  and	  decreases	  depression-­‐like	  
behaviour	  in	  rats.	  However,	  the	  exact	  molecular	  role	  of	  neurogenesis	  in	  exercise-­‐induced	  antidepressant	  
effects	  still	  remains	  unanswered.	  This	  requires	  new	  tools	  to	  explore	  the	  interaction	  between	  exercise	  and	  
neurogenesis	  in	  vivo.	  To	  this	  end,	  the	  novel	  mitotic-­‐marker,	  5-­‐ethynyl-­‐2’-­‐deoxyuridine	  (EdU),	  and	  Ki-­‐67,	  an	  
endogenous	  marker	  of	  cell	  proliferation,	  was	  characterised	   in	  order	   to	  study	  neurogenesis	   in	  an	  MS	  rat	  
model	   of	   depression.	   Furthermore,	   this	   study	   aimed	   to	   provide	   insight	   into	   the	   effect	   of	   voluntary	  
exercise	  on	  cell	  genesis	  and	  survival.	  	  
	  
To	  characterise	  EdU	  labelling	  of	  cells	  in	  vivo,	  male	  Sprague	  Dawley	  rats	  (Characterisation	  rats	  n	  =13)	  were	  
injected	  with	  50	  mg/kg	  EdU	  as	  noted	  in	  the	   literature.	  The	  optimal	  time	  point	  to	   inject	  the	  EdU	  label	  to	  
measure	  mitotic	  activity	  was	  found	  to	  be	  post-­‐natal	  day	  (PND)	  60.	  MS	  or	  non-­‐maternal	  separation	  (NMS)	  
was	  conducted	   from	  PND	  2	   -­‐	  14	  on	  experimental	   rats	   (n=39).	  From	  PND	  54–74,	  experimental	   rats	  were	  
housed	   in	   cages	  with	  attached	   running	  wheels	   (R)	  or	   locked	   running	  wheels	   (NR).	  All	   experimental	   rats	  
were	   injected	  with	   50	  mg/kg	   EdU	   on	   PND	   60	   and	   transcardially	   perfused	   on	   PND	   74	   using	   Phosphate	  
Buffered	  Saline	  (PBS)	  followed	  by	  fresh	  4%	  paraformaldehyde.	  Whole	  brains	  were	  then	  removed	  from	  the	  
skull	  and	  placed	  in	  4%	  paraformaldehyde	  for	  three	  hours.	  The	  brains	  were	  transferred	  to	  a	  30%	  sucrose	  
solution,	   stored	   in	  sucrose	   for	  3	   -­‐	  5	  days	  and	  thereafter	  mounted	   in	  optimal	  cutting	  medium	  (OCT)	  and	  
sectioned	  using	  a	  cryostat.	  Brain	  sections	  of	  40	  μm	  from	  6.96	  to	  5.52	  mm	  anterior	  to	  the	  inter-­‐aural	  line	  
were	  taken	  as	  dorsal	  and	  50	  μm	  sections	  from	  3.84	  to	  2.76	  mm	  were	  analyzed	  as	  ventral.	   	  The	  marker,	  
EdU	   was	   detected	   in	   rat	   brains	   using	   the	   Click-­‐iT	   EdU	   Alexa	   Fluor	   488	   detection	   kit.	   Three	   molecular	  
marker	   combinations	  were	  used	   to	  detect	  different	   factors	   for	  both	  dorsal	   and	  ventral	   hippocampi:	   (1)	  
EdU/GFAP/NeuN,	  to	  establish	  how	  many	  EdU	  labelled	  cells	  survive	  to	  become	  neurons	  or	  astrocytes	  (2)	  
EdU/DCX	  to	  determine	  how	  many	  EdU	  labelled	  cells	  that	  have	  survived	  for	  14	  days	  are	  immature	  neurons	  
and	  (3)	  Ki-­‐67/DCX	  to	   indicate	  how	  many	  mitotically	  active	  cells	  are	   immature	  neurons	  on	  PND	  74.	  Brain	  
sections	   were	   then	   scanned	   using	   a	   confocal	   microscope	   whereby	   EdU	   stained	   nuclei	   were	   manually	  
counted	  and	  cell	  phenotypes	  identified.	  
	  
The	  molecular	  marker	  combination	  one	  and	  two	  revealed	  no	  differences	  between	  treatment	  groups	  in	  the	  
number	  of	  EdU-­‐labelled	  cells	  in	  the	  dorsal	  and	  ventral	  hippocampi.	  However,	  a	  significant	  correlation	  was	  
found	  between	  EdU/GFAP	  positive	  cells	  and	  EdU/NeuN	  positive	  cells	  in	  the	  ventral	  hippocampus	  when	  all	  
treatment	   groups	   were	   pooled	   (r	   =	   0.82,	   n=18,	   p	   <	   0.0001).	   The	   third	   molecular	   marker	   combination	  
revealed	   significant	   differences	   in	   neurogenesis	   between	   groups.	   The	   MS+R	   group	   had	   fewer	   dorsal	  
hippocampal	  Ki-­‐67/DCX	  cells	  relative	  to	  NMS+R	  and	  NMS+R	  had	  significantly	  higher	  Ki-­‐67/DCX	  cell	  count	  
relative	  to	  NMS+NR	  rats.	   In	  the	  ventral	  hippocampus	  MS+R	  rats	  had	  fewer	  Ki-­‐67/DCX	  cells	  compared	  to	  
NMS+R	  rats.	  
	  
The	   link	   between	   neurons	   and	   astrocytes	   in	   the	   ventral	   hippocampi	   corresponds	   with	   reports	   that	   an	  
increase	   in	  neurons	   is	   linked	  to	  the	  presence	  of	  astrocytes.	  However	   it	  may	  also	  be	  due	  to	  unavoidable	  
variation	   in	  the	   intensity	  of	   the	  stain.	  The	  third	  molecular	  marker	  combination	  (Ki-­‐67/DCX)	  revealed	  the	  
most	  significant	  finding	  of	  this	  study.	   It	  showed	  that	  voluntary	  wheel	  running	  significantly	   increased	  the	  
number	  of	  Ki-­‐67/DCX	  co-­‐labelled	  neurons	  in	  the	  dorsal	  hippocampus	  of	  NMS+R	  rats	  relative	  to	  NMS+NR	  
which	   is	   in	   agreement	  with	   the	   literature	   that	   suggests	   exercise	   increases	   neurogenesis.	   The	   literature	  
also	  reports	  that	  stress	  decreases	  neurogenesis	  and	   interestingly	  MS+R	  rats	  had	  a	   lower	  cell	  count	  than	  
NMS+R	  rats.	  This	  may	  indicate	  an	  interaction	  between	  early	  life	  stress	  and	  exercise-­‐induced	  neurogenesis.	  
This	  finding	  further	  suggests	  that	  MS	  alters	  neurogenesis	  in	  adult	  life	  and	  attenuates	  the	  effect	  of	  exercise	  
on	  the	  ventral	  hippocampus.	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Depression	  is	  a	  psychiatric	  condition	  d	  by	  a	  depressed	  mood,	  difficulties	  at	  work,	  loss	  of	  
interest	  in	  hobbies,	  agitation	  and	  in	  some	  cases	  suicide	  (Hamilton	  et	  al.,	  1960).	  It	  is	  the	  
international	  leading	  cause	  of	  disability	  (Marcus	  et	  al.,	  2012)	  and	  contributes	  largely	  to	  
world	  economic	  burden	  affecting	  up	  to	  350	  million	  individuals	  worldwide	  (Marcus	  et	  al.,	  
2012).	  Depression	  claims	  the	  ranking	  of	  10th	  leading	  cause	  of	  disability	  in	  Southern	  Sub-­‐
Saharan	  Africa	   (Murray	  et	  al.,	   2012)	  with	  a	  9.7%	  prevalence	   rate	  of	  depression	   in	   the	  
absence	   of	   any	   other	   diseases	   in	   South	   Africa	   (Tomlison	   et	   al.,	   2009).	   This	   has	   been	  
shown	   to	   manifest	   at	   a	   societal	   level	   in	   an	   association	   between	   unemployment,	  
disability	  and	  major	  depressive	  disorder	  (Rizvi	  et	  al.,	  2015).	  In	  South	  Africa	  the	  alarming	  
30%	  unemployment	  rate	  presents	  a	  particularly	  significant	  problem	  (Klasen	  &	  Woodlark,	  
2009).	  Therefore	  understanding	   the	  etiology	  of	  depression	   is	  paramount	   to	  effectively	  
treating	   it	   in	   order	   to	   reduce	   the	   negative	   impact	   it	   has	   at	   an	   individual	   and	   societal	  
level.	  	  	  
	  
Adverse	  childhood	  experiences	  have	  been	  directly	  linked	  to	  an	  increased	  predisposition	  
to	  development	  of	  depression	  throughout	  one’s	  life	  (Chapman	  et	  al.,	  2004).	  	  The	  role	  of	  
the	  mother	  and	  the	  maternal	  hypothalamic–pituitary–adrenal	  (HPA)	  axis	  on	  offspring	  is	  
important	   in	   childhood	   development	   (Goodman,	   2014;	   Shea	   et	   al.,	   2007).	   Early	   life	  
trauma	  reportedly	  increases	  long	  term	  HPA	  axis	  activity,	  decreases	  the	  volume	  of	  limbic	  
regions	  involved	  in	  emotional	  regulation	  such	  as	  the	  amygdala	  (Dannlowski	  et	  al.,	  2012)	  
and	   the	   hippocampus	   (Duman	   et	   al.,	   2002; Pruessner	   et	   al.,	   2015),	   decreases	  
connectivity	   to	  cognitive	  areas	  of	   the	  brain	  such	  as	   the	  prefrontal	  cortex	   (Grant	  et	  al.,	  
2014)	  and	  subsequently	  increases	  an	  individual’s	  predisposition	  to	  depression	  (Pariante	  
&	   Lightman,	  2008).	   It	  was	  also	   found	   that	  exposure	   to	  high	   levels	  of	   stress	  hormones	  
called	   glucocorticoids	   in	   early	   childhood	   increases	   the	   HPA	   axis	   activity	   in	   adulthood.	  
This	   increases	   the	   stress	   response	   as	   indicated	   by	   higher	   saliva	   cortisol	   and	  
adrenocorticotropic	  hormone	  (ACTH)	  present	  in	  response	  to	  a	  psycho-­‐social	  stressor	  in	  
humans	  (Hohne	  et	  al.,	  2014).	  Contrastingly,	  a	  decrease	  in	  HPA	  activity	  was	  reported	  in	  
females.	  Nevertheless,	  early	  life	  trauma	  clearly	  resulting	  in	  dysregulation	  of	  the	  HPA	  axis	  
is	  noted	   (Kempke	  et	  al.,	  2014).	   It	  has	   recently	  been	  suggested	   that	  gene	  expression	   is	  
altered	   by	   exposure	   to	   early	   life	   stress	   and	   that	   epigenetics	   may	   play	   a	   role	   in	   the	  
receptor	   density	   (Romens	   et	   al.,	   2015).	   Reduced	   receptor	   density	   results	   in	   a	   less	  
efficient	   regulation	   of	   the	   HPA	   axis	   stress	   response.	  While	   not	   every	   individual	   faced	  
with	  a	  stressor	  will	  develop	  depression	  (Nasca	  et	  al.,	  2015)	  early	  life	  trauma	  influences	  
the	  function	  of	  the	  HPA	  axis.	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The	   stress	   response	   is	   regulated	  by	   the	  HPA	   axis	   (Figure	   1)	   that	   is	   comprised	  of	   the	  
hypothalamus,	   anterior	   pituitary	   gland	   and	   adrenal	   cortex	   and	   the	   interactions	  
between	   them.	   Functionally	   the	   axis	   encapsulates	   a	   mergence	   of	   endocrine	   and	  
neuronal	   structures.	   The	   hypothalamus	   releases	   corticotropin	   releasing	   hormone	  
(CRH)	   and	   arginine	   vasopressin	   (AVP).	   These	   trigger	   the	   release	   of	   ACTH	   from	   the	  
pituitary	   gland	   which	   in	   turn	   stimulates	   the	   production	   of	   glucocorticoids	   from	   the	  
adrenal	   cortex	   in	   addition	   to	   the	   catecholamines	   such	   as	   adrenaline	   and	   nor-­‐
adrenaline.	   The	   ability	   to	   regulate	   this	   system	   relies	   heavily	   on	   the	   ability	   of	   the	  
glucocorticoids	   to	   bind	   to	   mineral	   corticoid	   receptors	   	   (MR)	   and	   glucocorticoid	  
receptors	   (GR)	   located	   in	   the	   frontal	  cortex,	  hippocampus	  and	  hypothalamus	  (Lupien	  
et	  al.,	  2009)	  (Figure	  1).	  The	  HPA	  axis	   is	   largely	  regulated	  by	  the	  hippocampus	  since	   it	  
expresses	  a	  very	  high	  density	  of	  GR	  that	  respond	  to	  the	  release	  of	  the	  glucocorticoid	  
hormone	   corticosterone	   (in	   rodents)	   and	   cortisol	   (in	   humans).	   These	   hormones	   are	  
released	  in	  response	  to	  stress	  and	  play	  a	  crucial	  role	  in	  the	  negative	  feedback	  loop	  that	  
acts	  at	  many	  levels,	   including	  the	  hippocampus,	  to	  arrest	  the	  stress	  response	  when	  a	  
stressor	   is	   no	   longer	   present.	   The	   development	   of	   this	   system	   is	   the	   foundation	   of	  
one’s	   ability	   to	   cope	  with	   chronic	   stress	   in	   later	   adult	   life	   (Lupien	   et	   al.,	   2009).	   The	  
interaction	  between	  the	  HPA	  axis	  and	  hippocampus	  is	  suggested	  to	  contribute	  to	  the	  
development	  of	  an	  increased	  susceptibility	  to	  depression.	  
	  
Figure	   1.	   This	  Diagram	  shows	  the	  hierarchical	  control	  of	  the	  stress	  response	  in	  the	  HPA	  axis	  (image	  adapted	  
from	   Lupien	   et	   al.,	   2009).	   	   When	   a	   stressor	   is	   present	   the	   brain	   processes	   the	   stress	   signals	   and	   the	  
hypothalamus	   releases	  CRH	  and	  AVP.	  These	   trigger	   the	   release	  ACTH	   from	  the	  pituitary	  gland	  stimulating	  
the	   production	   of	   glucocorticoids	   from	   the	   adrenal	   cortex	   in	   addition	   to	   the	   catecholamines	   such	   as	  
adrenaline	   and	   nor-­‐adrenaline.	   The	   response	   is	   arrested	   by	   glucocorticoids	   that	   bind	   to	   GR	   and	   MR	  
receptors	   on	   the	   hippocampus,	   hypothalamus,	   anterior	   pituitary	   and	   frontal	   cortex	   and	   arrest	   the	   stress	  
response.	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The	  hippocampus	  matures	  post-­‐natally	   and	  early	   life	   stress	   has	  been	   shown	   to	   alter	  
HPA	  activity	  and	  reduce	  GR	  and	  MR	  density	  on	  the	  hippocampus	  (Lupien	  et	  al.,	  2009)	  
and	  predispose	   individuals	   to	  depression.	   	   As	  mentioned	  previously,	   these	   receptors	  
are	   important	   as	   they	   mediate	   a	   feedback	   loop	   that	   regulates	   the	   stress	   response	  
(Figure	   1)	   and	   early	   life	   stress	   is	   thought	   to	   impair	   the	   glucocorticoid-­‐mediated	  
feedback	   loop	   (Pariante	   &	   Lightman,	   2008).	   This	   may	   pre-­‐dispose	   an	   individual	   to	  
developing	  depression	  later	  in	  life	  and	  requires	  effective	  treatment.	  
	  
Up	  to	  20%	  of	  sufferers	  of	  depression	  do	  not	  respond	  to	  currently	  available	  treatments	  
(Mayberg	   et	   al.,	   2005)	   that	   target	   the	   monoamine	   system.	   	   Most	   pharmacological	  
treatments	  are	  aimed	  at	  increasing	  monoamine	  transmission	  using	  selective	  serotonin	  
(5-­‐HT)	  reuptake	  inhibitors	  (SSRIs),	  norepinephrine	  (NE)	  reuptake	  inhibitors	  (SNRI)	  and	  
monoamine	   oxidase	   (MAO)	   inhibitors	   (Dale	   et	   al.,	   2015).	   SSRIs	   are	   the	   first	   line	   of	  
defense	   and	   block	   serotonin	   transporters	   to	   increase	   serotonin	   neurotransmission	  
(Codplan	  et	  al.,	   2014)	  but	   reportedly,	   less	   than	  half	   of	   all	   patients	   respond	   to	   them.	  
Long	  term	  less	  than	  half	  of	  all	  the	  major	  depressive	  disorder	  (MDD)	  sufferers	  achieve	  
remission	  with	  currently	  available	  treatments	  (Bennabi	  et	  al.,	  2015;	  Kemp	  et	  al.,	  2008	  ;	  
Rush	   et	   al.,	   2006).	   In	   addition,	   patients	   can	   become	   unresponsive	   to	   two	   or	   more	  
treatments	   termed	   treatment	   resistant.	   Targeting	   points	   of	   intervention	   to	   treat	  
resistant	  patients	   is	   essential	   to	   finding	  novel,	  homogenous	  and	  effective	   treatment.	  
There	   are	   many	   postulated	   causes	   of	   depression	   however,	   this	   study	   primarily	  
discusses	   maternal	   separation	   (MS)	   stress	   and	   the	   HPA	   axis	   and	   explores	   exercise-­‐
induced	  neurogenesis	  as	  the	  targeted	  point	  of	  intervention.	  	  
	  
Novel	  treatments	  for	  depression	  using	  exercise	  have	  been	  explored.	  Exercise	  has	  been	  
used	  in	  combination	  with	  antidepressant	  drugs	  to	  treat	  human	  depression	  (Blumenthal	  
et	   al.,	   1999).	   	   Twelve	  weeks	   of	   aerobic	   exercise	   in	   adults	   suffering	   from	   depression	  
who	  participated	  in	  treadmill	  running	  five	  days	  weekly	  displayed	  decreased	  depressive	  
symptoms	   as	   measured	   by	   the	   Hamilton	   Rating	   Scale	   for	   depression	   (Dunn	   et	   al.,	  
2005).	  Voluntary	  exercise	  has	  also	  been	  shown	  to	  result	   in	  an	  array	  of	  holistic	  health	  
benefits	   including	   reduced	   risk	   of	   heart	   disease,	   hypertension,	   diabetes	   and	   certain	  
cancers	   (Strohle	   et	   al.,	   2008).	   Additionally	   exercise	   results	   in	   a	   series	   of	   cognitive	  
improvements	   including	   improved	  memory	   and	   learning	   	   (Weuve	   et	   al.,	   2004).	   The	  
mechanisms	  behind	  these	  benefits	  are	  unclear	  as	  in	  vivo	  studies	  in	  human	  subjects	  are	  
limited	   by	   the	   available	   technology.	   	   A	   factor	   that	   is	   up	   regulated	   by	   exercise	   and	  
stimulates	  neurogenesis	   is	  brain	  derived	  neurotrophic	  factor	  (BDNF).	  This	   is	  a	  growth	  
factor	   found	   in	   the	  brain	   involved	   in	   the	  stress	   response	   that	   is	  decreased	   in	  plasma	  
serum	   of	   humans	   suffering	   from	   depression	   and	   in	   cortical	   serum	   of	   post-­‐mortem	  
studies	   (Schuch	  et	   al.,	   2013;	   Sen	  et	   al.,	   2008;	   Shimizu	  et	   al.,	   2003).	   It	   also	   regulates	  
neurogenesis,	   neurite	   outgrowth	   and	   synaptogenesis,	   synaptic	   function	   and	   cell	  
survival	   (Mattson	   et	   al.,	   2004).	   Directly	   studying	   exercise-­‐induced	   neurogenesis	   and	  
depression	  is	  difficult	  in	  humans	  due	  to	  the	  limited	  imaging	  technology	  and	  since	  most	  
neurogenic	   information	   is	   correlative	   or	   in	   vitro	   rather	   than	   a	   direct	   observation	   of	  
neurogenesis	  in	  vivo.	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Adult	  neurogenesis	  occurs	  in	  humans	  (Eriksson	  et	  al.,	  1998)	  with	  an	  estimated	  cell	  turn	  
over	  of	  700	  new	  hippocampal	  neurons	  per	  day	  (Borsini	  et	  al.,	  2015).	  A	  clinical	  imaging	  
study	  found	  that	  individuals	  suffering	  from	  major	  depressive	  disorder	  had	  significantly	  
smaller	  posterior	  hippocampal	  volumes	  compared	  to	  healthy	  controls	  using	  magnetic	  
resonance	  imaging	  (Neumeister	  et	  al.,	  2005).	  Depressive	  behavior	  has	  been	  linked	  to	  a	  
decrease	   in	   hippocampal	   volume	   (Krogh	  et	   al.,	   2014)	  with	   cellular	   studies	   indicating	  
that	   cortisol	   release	   and	   MR/GR	   receptors	   causal	   to	   the	   link	   (Nasca	   et	   al.,	   2015;	  
Anacker	  et	  al.,	   2013).	  Changes	   in	   receptor	  density	   influence	   the	  HPA	  axis’s	   ability	   to	  
control	  negative	  feedback	  (David	  et	  al.,	  2009)	  affecting	  neurogenesis.	  Although	  not	  all	  
studies	  agree	  that	  depression	   is	   linked	  to	  neurogenesis,	  a	  study	  by	  Reif	  et	  al.,	   (2006)	  
found	  no	   link	   between	  human	   cell	   proliferation	   and	  depression.	  On	   the	  other	   hand,	  
immortalized	   human	   hippocampal	   cell	   cultures	   have	   shown	   that	   GR	   are	   essential	   in	  
stimulating	  neurogenesis	  and	  increased	  cortisol	  levels	  arrest	  neurogenesis	  (Anacker	  et	  
al.,	   2013).	   There	   is	   likely	  more	   than	  one	   system	  and	  multiple	   factors	   interacting	  and	  
culminating	   in	   a	   depressive	   phenotype,	  with	   neurogenesis	   featuring	   as	   a	   paramount	  
factor	   (David	  et	  al.,	  2009)	   (Figure	  2).	  Neurogenesis	  has	  been	  suggested	  as	  a	  possible	  
factor	   that	   may	   contribute	   to	   the	   anti-­‐depressant	   action	   of	   exercise	   and	   cognitive	  
improvements	  seen	   in	  humans.	   It	  has	  been	  more	  extensively	  studied	   in	  animals	  than	  
humans	   and	   furthermore,	   while	   these	   processes	   are	   considered	   homologous,	  
variability	  between	  species	  must	  be	  noted	  
	  
Figure	  2.	  Overview	  of	  factors	  that	  influence	  depression	  and	  treatment	  plans.	  Early	  life	  trauma	  can	  lead	  to	  HPA	  
dysfunction	  and	  influence	  neurogenesis.	  These	  changes	  can	  lead	  to	  the	  development	  of	  depression.	  This	  is	  
then	   initially	   treated	   using	   SSRIs	   and	   resulting	   in	   either	   the	   amelioration	   of	   depression	   or	   treatment	  
resistance.	  Exercise	  has	  been	  proposed	  as	  an	  additional	  method	  to	  ameliorate	  depressive-­‐like	  symptoms	  as	  
it	  has	  been	  shown	  to	  influence	  HPA	  axis	  function	  and	  neurogenesis.	  However,	  this	  interaction	  merits	  further	  
exploration	  as	  little	  is	  known	  about	  cell	  survival	  or	  genesis	  in	  models	  for	  depression.	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1.2)	  Neurogenesis	  in	  Rodents	  	  
	  
The	  process	  of	  adult	  neurogenesis	  was	  discovered	  in	  rats	  during	  the	  twentieth	  century	  
(Altman	  &	  Das,	  1965).	  It	  can	  be	  defined	  as	  the	  generation	  and	  maturation	  of	  functional	  
neurons	   from	   Neural	   Stem	   Cells	   (NSC)/	   neural	   progenitor	   cells	   (NPC)	   (Ming	   &	   Song,	  
2011).	  Reportedly,	  there	  are	  populations	  of	  cells	  that	  divide	  symmetrically	  to	  give	  rise	  to	  
NPC	  (Ge	  et	  al.,	  2007;	  Carpenter	  et	  al.,	  1999).	  These	  are	  thought	  to	  self	  renew,	  migrate	  
and	  differentiate	  and	  integrate	  into	  the	  neuronal	  circuitry	  (Seirra	  et	  al.,	  2015;	  Ge	  et	  al.,	  
2007;	  Fricker	  et	  al.,	  1999).	  The	  migration	  of	  neurons	  is	  regulated	  by	  guidance	  cues	  and	  
growth	   factors	   (Imayoshi	   et	   al.,	   2010;	   Carpenter	   et	   al.,	   1999;	   Fricker	   et	   al.,	   1999).	  
Neurogenesis	  occurs	  in	  the	  adult	  mammalian	  brain	  in	  a	  number	  of	  regions	  including	  the	  
prefrontal,	  posterior,	  parietal,	  and	  inferior	  temporal	  cortex	  (Ohira	  et	  al.,	  2013;	  Gould	  et	  
al.,	   1999).	   Cell	   turnover	   in	   the	   brain	   is	   very	   tightly	   controlled	   to	   prevent	   tumour	  
formation	   with	   the	   production	   of	   stem	   cells	   modulated	   via	   microglia-­‐mediated	  
apoptosis	   (Tremblay	   et	   al.,	   2011;	   Das	   &	   Basu,	   2008).	   There	   is	   a	   continuous	   and	  
modulated	  turnover	  of	  new	  neurons	  and	   in	   rats	   there	   is	  an	  estimated	  cell	   turnover	  of	  
5000	  daily	  (Kent,	  2015).	  The	  modulation	  in	  the	  basal	  turnover	  of	  cells	  has	  been	  linked	  to	  
stimuli	  such	  as	  stress,	  exercise	  and	  enrichment.	  Inhibiting	  neurogenesis	  has	  behavioural	  
and	   molecular	   implications	   that	   have	   been	   linked	   to	   depression	   in	   mouse	   and	   rat	  
models.	  Only	  a	  few	  specific	  neurogenic	  niches	  that	  have	  been	  thoroughly	  explored	  by	  a	  
variety	   of	   studies,	  more	   specifically	   the	   sub-­‐ventricular	   zone	   (SVZ),	   olfactory	   bulb	   and	  
hippocampus	  (Ming	  &	  Song	  2011).	  
	  
Neurogenesis	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus	  is	  of	  particular	  interest	  as	  it	  has	  
been	   linked	   to	   cognitive	   and	   behavioral	   changes	   (Snyder	   et	   al.,	   2011;	   Levone	   et	   al.,	  
2015).	   The	   mechanism	   behind	   this	   is	   poorly	   understood	   but	   a	   growing	   number	   of	  
studies	   are	   slowly	   piecing	   together	   this	   process	   (Kirby	  et	   al.,	   2015;	   Pavlovicova	  et	   al.,	  
2015;	   Schloesser	  et	  al.,	  2009).	  The	  sub-­‐granular	  zone	   	   (SGZ)	  of	  the	  dentate	  gyrus	   is	  an	  
active	   site	   of	   neurogenesis	   which	   arises	   between	   the	   hilus	   and	   the	   granule	   cell	   layer	  
(consisting	  of	  no	  more	  than	  three	  rows	  of	  nuclei).	  It	  is	  lined	  with	  radial-­‐like	  glial	  cells	  or	  
stem	   cells/neural	   progenitor	   cells	   that	   become	   activated	   and	   proliferate	   into	   the	  
granular	   cell	   layer	   (Nicola	   et	   al.,	   2015).	   These	   cells	   potentially	   become	   neuroblasts	  
differentiating	   into	   immature	   doublecortin	   (DCX)	   expressing	   neurons	   and	   thereafter	  
generate	   dendritic	   extensions	   to	   the	   mossy	   fiber	   tracts	   in	   the	   CA3	   region	   of	   the	  
hippocampus	  (Ming	  and	  Song.	  2011)	  (Figure	  3).	  	  The	  mossy	  fibers	  project	  from	  the	  CA3	  
region	  to	  pyramidal	  cells	  of	  the	  CA1	  region	  that	  send	  projections	  to	  the	  subiculum	  of	  the	  
hippocampus	  (Figure	  2)	  and	  thereafter	  the	  target	  region	  specific	  to	  either	  the	  ventral	  or	  
dorsal	   hippocampus	   (Kumazawa-­‐Manita	   et	   al.,	   2013).	   The	   hippocampus	   processes	  
stimuli	   in	  a	  number	  of	  ways,	  one	  being	  when	   information	  enters	   the	  hippocampus	  via	  
the	   entorhinal	   cortex	   which	   receives	   the	   stimuli,	   stimulates	   the	   dentate	   gyrus	   which	  
then	   links	   to	  CA3	  region	  which	   relays	   to	  CA1	  region	  which	  eventually	   links	   to	   the	  pre-­‐
fontal	   cortex	   (Vivar	   &	   van	   Praag,	   2013).	   Newly	   generated	   neurons	   reportedly	   have	   a	  
lower	   threshold	   for	   stimulation	   and	   require	   less	   stimulation	   to	   induce	   long	   term	  
potentiation	   (LTP)	   from	   between	   1	   -­‐	   1.5	   months	   in	   mice	   (Ge,	   et	   al.,	   2007).	   The	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properties,	  function	  and	  survival	  of	  newly	  generated	  neurons	  are	  not	  well	  understood	  as	  
structural	   changes	   have	   been	   the	   primary	   line	   of	   investigation	   (Nicola	   et	   al.,	   2015)	  
specifically	  in	  the	  dentate	  gyrus	  as	  this	  influences	  both	  ventral	  and	  dorsal	  hippocampus	  






Figure	  3.Maturation	  of	  a	  young	  neuron	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus.	  Section	  a)	  represents	  the	  
stage	  of	  neurogenesis	  the	  section	  b)	  indicates	  cell-­‐type	  markers	  used	  to	  identify	  the	  stage	  of	  development.	  
Information	  adapted	  from	  Ming	  	  &	  Song.	  2002.	  
Neurogenesis	  has	  different	  effects	  on	  varying	  regions	  of	  the	  hippocampus.	  The	  dorsal	  
dentate	  gyrus	  and	  ventral	  hippocampus	  dentate	  gyrus	   (DG)	  are	   functionally	  different	  
and	   their	   connectivity	   is	   also	   distinctive	   (Fanselow	   &	   Dong,	   2010).	   The	   dorsal	  
hippocampus	   sends	   projections	   to	   the	   cortical	   regions	   involved	   in	   visuo-­‐spatial	  
information	  and	  memory	  processing	  and	  ventral	  hippocampus	  sends	  projections	  to	  the	  
prefrontal	  cortex,	  amygdala	  and	  hypothalamus	  and	  areas	  linked	  to	  affective	  behaviors	  
(Fanselow	   &	   Dong,	   2010).	   The	   dorsal	   hippocampus	   controls	   spatial	   memory	   and	  
pattern	   recognition	  and	   the	   ventral	  hippocampus	   controls	  emotional	   responses	   such	  
as	  anxiety	  and	  depression-­‐like	  behavior	   (Kheirbek	  et	  al.,	  2013;	  Spalding	  et	  al.,	  2013).	  
Together	  the	  dorsal	  and	  ventral	  hippocampi	  are	  both	  proposed	  to	  play	  an	   integrated	  
role	   in	   contextual	   memory	   and	   learning	   (Komorowoski	   et	   al.,	   2013).	   	   Ablation	   of	  
neurogenesis	  or	  enhancing	  neurogenesis	  (pharmacologically)	  renders	  alteration	  to	  the	  
respective	  behavioural	  or	  cognitive	  functions	  mentioned	  above	  (Kheirbek	  et	  al.,	  2013).	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There	   have	   been	   some	   deviations	   to	   the	   proposed	   division	   of	   functionalitites.	   The	  
dorsal	   and	   ventral	   hippocampi	   have	   been	   linked	   to	   the	   stress	   response.	   Arresting	  
neurogenesis	   in	  the	  ventral	  hippocampus	  did	  not	  alter	  anxiogenic	  responses	  to	  acute	  
restraint	  stress (Scopinho	  et	  al.,	  2013).	  These	  results	  could	  be	  due	  to	  the	  model	  used	  
for	  depression	  which	  was	  newly	  modified	  and	  the	  stress	  employed	  was	  acute.	  It	  could	  
also	   be	   indicative	   of	   neurogenesis	   having	   a	   variable	   role	   in	   amelioration	   of	   anxiety.	  
However	  reduced	  neurogenesis	  in	  the	  ventral	  hippocampus	  is	  thought	  to	  mediate	  the	  
depressive-­‐like	   behaviour	   in	   maternally	   separated	   rats	   (Hulshof	   et	   al.,	   2011)	   and	   in	  
addition	   to	   this,	   certain	   antidepressant	   drugs	   have	   been	   observed	   to	   selectively	  
increase	  cellular	  proliferation	  in	  the	  ventral	  hippocampus	  of	  rats	  (Banasir	  et	  al.,	  2006)	  
despite	  the	  tight	  regulation	  of	  cell	  turnover	  in	  the	  brain.	  
	  
1.3)	  The	  importance	  of	  Glia	  in	  Neurogenesis	  
	  
Neuroglia	  once	  only	  considered	  supportive	  cells	  in	  the	  brain,	  also	  act	  to	  release	  signaling	  
molecules	   such	   as	   cytokines.	   They	  do	  not	   express	   the	   same	  markers	   as	   neurons	   (DCX	  
and	  GFAP	  are	  not	   expressed	  on	   the	   same	   cell).	   Radial-­‐like	   glial	   cells	   and	  parenchymal	  
astrocytes	  are	  separate	  cell	  lineages,	  however	  neurons	  may	  in	  fact	  arise	  from	  radial-­‐like	  
glial	  progenitor	  cells	  expressing	  GFAP	  (Steiner	  et	  al.,	  2004;	  Ming	  &	  Song,	  2005).	  
	  
The	  role	  of	  astrocytes	  in	  physiological	  conditions	  and	  their	  modulation	  and	  relationship	  
to	  adult	  neurogenesis	   in	  the	  hippocampus	  is	  poorly	  explored	  and	  not	  well	  understood.	  
However,	  several	  studies	  have	  linked	  them	  to	  an	  increase	  in	  neurogenesis	  (Shigemoto-­‐
Mogami	  et	  al.,	  2014;	  Quesseveur	  et	  al.,	  2013;	  Lim	  et	  al.,	  1999).	  Physical	   insult	  such	  as	  
lesions	   have	   induced	   an	   increase	   in	   the	   production	   of	   neurons	   in	   the	   striatum	   via	  
astrocytes	   and	   astrocyte-­‐derived-­‐	   neuroblasts	   in	   mice	   (Magnusson	   et	   al.,	   2014)	  
suggesting	   a	   latent	   neuronal	   programming.	   The	   mechanism	   behind	   this	   increase	   is	  
unclear.	  	  
	  
In	   microglia	   it	   has	   been	   suggested	   that	   post-­‐natal	   stimulation	   causes	   the	   release	   of	  
cytokines	   to	   stimulate	   neurogenesis	   (at	   peak	   days	   4	   -­‐	   10).	   Cytokines	   released	   by	   glia	  
such	   as	   interleukin-­‐6,	   interleukin-­‐1-­‐beta,	   tumor	   necrosis	   factor	   and	   interferon	   gamma	  
were	   shown	   (at	   certain	   concentrations)	   to	   stimulate	   neurogenesis	   in	   neurosphere	  
cultures.	  However,	   the	   complexity	  of	   the	   interactions	  of	   cytokines	   in	   vivo	  may	  not	  be	  
accurately	   reflected	   in	   culture	   and	   neurons	   were	   cultivated	   from	   the	   subventricular	  
zone	  and	  thus	  the	  results	  may	  not	  hold	  true	  for	  the	  hippocampus	  (Shigemoto-­‐Mogami	  
et	  al.,	  2014).	  In	  contrast,	  another	  study	  of	  the	  influence	  of	  astroglia	  on	  neural	  stem	  cell	  
proliferation	   in	  the	  rat	  hippocampus	  found	  that	  neuronal	  counts	   increased	  by	  ten-­‐fold	  
when	  cultured	  with	  astrocytes.	  This	  study	  also	  found	  that	  the	  rate	  of	  proliferation	  and	  
neuronal	   commitment	   were	   increased	   significantly	   in	   cultures	   where	   astrocytes	   were	  
present	  (Song	  et	  al.,	  2002).	  A	  more	  recent	  finding	  is	  that	  a	  reduction	  in	  Notch1	  protein	  
(a	  transmembrane	  ligand-­‐activated	  receptor	  involved	  in	  cell	  fate)	  activity	  in	  the	  brains	  of	  
mice	  resulted	  in	  an	  increased	  neuronal	  phenotype	  in	  mice	  suggesting	  another	  molecular	  
mechanisms	  for	  a	  shift	  towards	  neurogenesis	  (Magnusson	  et	  al.,	  2014).	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It	   would	   appear	   that	   an	   increase	   in	   gliogenesis	   would	   be	   ideal	   to	   in	   turn	   increase	  
neurogenesis.	  In	  support	  of	  this,	  wheel	  running	  has	  been	  shown	  to	  increase	  the	  number	  
of	   astrocytes	   in	   the	   hippocampus	   (Steiner	   et	   al.,	   2004).	   Genetic	   manipulation	   to	   up-­‐
regulate	   the	   expression	   of	   BDNF	   (that	   is	   naturally	   up-­‐regulated	   via	   exercise)	   in	  
astrocytes	  resulted	  in	  an	  anxiolytic/anti-­‐depressant	  effect	  in	  mice.	  This	  provides	   in	  vivo	  
evidence	   that	   cell	   types	   other	   than	   neurons	   may	   play	   a	   role	   in	   the	   modulation	   of	  
neurogenesis	   and	   facilitate	   anxiolytic	   effects	   of	   fluoxetine	   	   (Quesseveur	   et	   al.,	   2013).	  
Although	   no	   functional	   link	   has	   been	   made	   to	   clearly	   explain	   this	   process	   at	   the	  
molecular	  level	  in	  the	  hippocampus.	  It	  does	  highlight	  the	  relevance	  of	  astro-­‐gliogenesis	  
in	   neurogenesis	   and	   possibly	   their	   unexplored	   role	   in	   the	   treatment	   of	   depression.	  
Improved	   quality	   imaging	   is	   therefore	   essential	   in	   preserving	   tissues	   sufficiently	   to	  




1.4)	  Animal	  Models	  for	  Depression	  and	  Behavioral	  Tests	  	  
	  
Animal	  models	  for	  depression	  are	  widely	  used	  and	  of	  great	  importance	  in	  understanding	  
the	   pathophysiology	   of	   diseases	   and	   have	   been	   validated	   by	   their	   use	   in	   testing	   anti-­‐
depressants	  (Sanchez	  &	  Meier,	  1996).	  An	  animal	  model	  must	  encapsulate	  face-­‐validity,	  
construct	   validity	   and	   predictive	   validity	   (Wilner,	   1984)	   in	   order	   to	   be	   of	   use	   in	   the	  
development	  of	  novel	  drug	  targets	  intended	  for	  humans.	  Although	  more	  recently	  their	  
use	  in	  the	  commercial	  development	  of	  novel	  drugs	  has	  reportedly	  stagnated	  due	  to	  the	  
complexity	   of	   depression	   (Hyman	   et	   al.,	   2014;	   Belzung,	   2014).	   It	   has	   been	   suggested	  
that	  models	  be	  viewed	  critically	  and	  a	  broad	  spectrum	  of	  behavioural	  tests	  be	  used	  with	  
varying	   sensitivity	   (Stewart	   &	   Kalueff,	   2015).	   The	   predisposition	   to	   developing	  
depression	  is	  often	  not	  addressed	  by	  animal	  models	  (Wilner	  &	  Belzung,	  2014)	  as	  issues	  
such	   as	   spontaneity	   and	   re-­‐occurrence	   are	   difficult	   to	   reproduce	   (Kato	   et	   al.,	   2015).	  
However,	   this	   does	   not	   diminish	   the	   role	   they	   played	   in	   developing	   SSRI	   such	   as	  
Citalopram,	   Paroxetine,	   Sertraline,	   Fluvoxamine	   and	   Fluoxetine	   are	   used	   to	   clinically	  
treat	  depression	  (Sanchez	  &	  Meier,	  1996)	  which	  have	  been	  validated	  by	  improving	  the	  
reduction	  of	  depressive	  symptomology.	  	  
	  
There	   are	   a	   handful	   of	   frequently	   used	   rodent	   models	   for	   depression	   namely,	   MS	  
(Plotsky	  &	  Meany	  1993),	  Chronic	  unpredictable	  mild	  stress	  (CUMS)	  (Wilner	  et	  al.	  1987),	  
Immune	  activation	  (Yirmiya,	  1996),	  Prenatal	  stress	  (Mueller	  &	  Bale,	  2008),	  Social	  defeat	  
stress	   (Henry	  et	  al.,	  1967),	  Dorsal	   raphe-­‐specific	  HTT	  knockout	  mice	   (Lira	  et	  al.,	  2003),	  
Flinders	  sensitive	   line	  rats	   (Overstreet,	  1986),	  Olfactory	  bulbectomized	  rats	   (Cairncross	  
et	   al.,	   1977),	   and	   Neonatal	   clomipramine	   administration	   (Mirmiram	   et	   al.,	   1980).	  
Interestingly	  MS,	  prenatal	  stress	  and	  Neonatal	  clomipramine	  administration	  are	  aimed	  
at	   emulating	   a	   predisposition	   to	   depression	   developed	   via	   early	   life	   stress	   that	   is	   not	  
addressed	  by	  the	  chronic	  stress	  paradigms.	  The	  MS	  model	  specifically	  has	  been	  widely	  
used	   to	   explore	   depression	   and	   novel-­‐treatments	   for	   depression	   in	   animal	   models	  
(Marais	  et	  al.,	  2009;	  Daniels	  et	  al.,	  2004;	  Ladd	  et	  al.,	  2004;	  Aisa	  et	  al.,	  2007).	  The	  model	  
has	  been	  critically	  assessed	  in	  terms	  of	  its	  validity	  (Milstein	  &	  Holmes,	  1997).	  The	  quality	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and	  duration	  of	  maternal	  care	  have	  been	  linked	  to	  the	  healthy	  development	  of	  the	  HPA	  
axis	  and	  stress	  regulation	  in	  adulthood	  (Ricon-­‐cortes	  &	  Sulivan,	  2015).	  
	  
MS	   uses	   behavioural	   tests	   to	   measure	   depressive-­‐like	   behaviors	   in	   rodents	   that	   are	  
thought	   to	   indicate	   depressive-­‐like	   behaviours	   homologous	   in	   humans	   (Cenci	   et	   al.,	  
2002).	   The	   depressive-­‐like	   behaviors	   measured	   include:	   time	   spent	   immobile	   in	   a	  
cylinder	  of	  water	  called	  the	  Porsolt	  Forced	  Swim	  Test	  (FST)	  (Porsolt	  et	  al.,	  1997)	  which	  
measures	   the	   motivation	   of	   the	   rodent	   to	   escape	   and	   an	   increase	   in	   time	   spent	  
immobile	   is	   thought	   to	   infer	   depressive-­‐like	   behavior.	   However,	   hypothermia	   and	   the	  
stress	   of	   swimming	   are	   weaknesses	   of	   this	   test.	   The	   tail	   suspension	   test	   is	   another	  
measure	  used	  which	  requires	   rodents	   to	  be	  suspended	  by	  the	  tail	  using	  tape	   in	  which	  
“escape-­‐like”	  behaviours	  and	  immobility	  are	  measured	  (Dalvi	  &	  Lucki,	  1999).	  This	  test	  is	  
very	  popular	  as	  they	  are	  thought	  to	  measure	  “behavioural	  despair”	  but	  it	  has	  also	  been	  
challenged	  as	  an	  energy	  saving	  mechanism	  as	   remaining	  stationary	  possibly	  conserves	  
energy	  required	  for	  later	  escape	  (West	  et	  al.,	  1990).	  	  The	  sucrose	  preference	  test	  is	  used	  
to	   measure	   anhedonia	   (loss	   of	   ability	   to	   experience	   pleasure),	   which	   is	   lost	   in	   both	  
humans	   and	   rodents	   experiencing	   depressive-­‐like	   behaviour	   (Wilner,	   1997).	   The	  
locomotor	  activity	  in	  the	  Open	  Field	  Test	  (OFT)	  can	  also	  be	  measured	  and	  analyzed	  as	  a	  
measure	  of	  depressive-­‐like	  behavior.	  This	  monitors	  the	  behavioor	  of	  a	  rat	  in	  an	  enclosed	  
but	  open	  environment.	  The	   time	   in	   the	  closed	  arm	  of	  an	  elevated	  plus	  maze	   (EPM)	   is	  
another	   indicator	  of	  depressive-­‐like	  behaviour	   (Daniels	  et	  al.,	   2004;	  Huot	  et	  al.,	   2001;	  
Grace	  et	  al.,	  2009).	  Even	  the	  frequency	  of	  ultrasonic	  vocalizations	  emitted	  can	  be	  used	  
as	   a	   behavioural	   measure	   indicative	   of	   depressive-­‐like	   behaviours.	   In	   rats	   22	   kHz	  
indicates	  a	  negative	  emotional	  state	  and	  50	  kHz	  a	  positive	  state	  (Knutson	  et	  al.,	  2002).	  	  
	  
There	   is	  a	  body	  of	   literature	  on	  the	  MS	  model	   that	  has	   found	  MS	  to	  effectively	  mimic	  
depressive-­‐like	  symptoms.	  It	  emulates	  depressive-­‐like	  behaviours	  such	  as	  increased	  time	  
spent	  in	  the	  closed	  arms	  of	  the	  EPM	  (Daniels	  et	  al.,	  2004;	  Huot	  et	  al.,	  2001;	  Grace	  et	  al.,	  
2009),	   decreased	   sucrose	   consumption	   (Huot	   et	   al.,	   2001;	   Asia	   et	   al.,	   2007; Ru	  ̈edi-­‐
Bettschen	  et	  al.,	  2005),	  decreased	  time	  in	  the	  center	  of	  the	  OFT	  (Rana	  et	  al.,	  2015;	  Shu	  
et	  al.,	  2015;	  Asia	  et	  al.,	  2007),	  decreased	  mobility	  in	  the	  Porsolt	  FST	  (Marais	  et	  al.,	  2009;	  
Maniam	   &	   Morris,	   2010;	   Asia	   et	   al.,	   2007;	   Rana	   et	   al.,	   2015),	   novelty	   suppression	  
feeding	  test	  (Chee	  &	  Manard,	  2011)	  among	  others.	  The	  effects	  of	  MS	  are	   indicative	  of	  
increased	  anxiety	  and	  depression-­‐like	  behaviors	  in	  rodents	  (Daniels	  et	  al.,	  2004;	  Marais	  
et	   al.,	   2009;	   Grace	   et	   al.,	   2009;	   Maniam	   &	  Morris,	   2010;	   Aisa	   et	   al.,	   2007).	   MS	   rats	  
display	   increased	   susceptibility	   to	   developing	   depressive-­‐like	   symptoms	   after	   a	  
subsequent	   trauma	   in	   adult	   life.	   MS	   rats	   exposed	   to	   5	   days	   of	   restraint	   stress	   in	  
adulthood	  exhibited	  increased	  immobility	  in	  the	  FST	  (Marais	  et	  al.,	  2009)	  an	  inference	  of	  
depressive-­‐like	  behaviour.	  	  	  
	  
The	   physiological	   changes	   caused	   by	   MS	   to	   the	   HPA	   axis	   include	   decreased	  
responsiveness	  to	  long-­‐term	  stress	  and	  an	  exaggerated	  response	  to	  acute	  stressors	  (e.g.	  
Air-­‐puff	  startle)	  (Ladd	  et	  al.,	  2004)	  and	  physiological	  changes	  such	  as	  an	  increased	  ACTH	  
response	  to	  air-­‐puff	  startle	  (Huot	  et	  al.,	  2001).	  Daniels	  et	  al.,	  2004	  reported	  an	  increase	  
in	  basal	  ACTH	   in	  MS	  rats	   relative	   to	  NMS	  control	   rats,	  and	  significantly	   lower	   levels	  of	  
ACTH	  15	  minutes	  after	  acute	  restraint	  stress	  proposing	  a	  blunted	  stress	  response	  in	  MS	  
animals.	  Higher	  maximal	  corticosterone	  levels	  after	  restraint	  stress	  have	  been	  reported	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in	  mice	  although	  the	  rate	  at	  which	  corticosterone	  returned	  to	  base-­‐line	  was	  not	  found	  
to	   be	   significantly	   different	   to	   NMS	   mice	   (van	   Heerden	   et	   al.,	   2010).	   The	   proposed	  
reasons	  for	  this	  are	  changes	  at	  the	  level	  of	  the	  HPA	  axis	  and	  in	  neuronal	  turnover.	  
	  
Despite	   this,	  MS	  has	  been	  criticized	   for	   its	  ability	   to	   reproduce	  homogenous	   results	   in	  
mice	  within	  a	  study	  (Milstein	  &	  Holmes,	  1997).	  The	  depressive-­‐behavioural	  phenotype	  is	  
not	  consistent	  and	  eight	  strains	  of	  MS	  mice	  were	  tested	  and	  none	  displayed	  a	  consistent	  
depressive-­‐like	  phenotype	  as	  measured	  by	  the	  forced	  swim	  test,	  elevated	  plus	  maze	  and	  
open	  field	  test	  which	  do	  not	  always	  agree	  within	  a	  specific	  treatment	  group	  (Milstein	  &	  
Holmes,	  1997).	  MS	  also	  affects	  mice	  in	  a	  sex	  dependent	  manner	  as	  MS	  male	  mice	  were	  
seen	  to	  be	  more	  susceptible	   to	  corticosterone	  and	  alcohol	  administration	  than	   female	  
mice.	   Females	  displayed	  a	   significantly	   higher	   scoring	  of	   locomotor	   activity	   relative	   to	  
male	  mice	  in	  a	  novelty	  test	  (Kawakami	  et	  al.,	  2013).	  Therefore,	  only	  male	  rats	  are	  used	  
in	   this	   study	   to	   avoid	   the	   variability	   introduced	   by	   sex.	   Another	   consideration	   to	   be	  
noted	  is	  individual	  variability	  existing	  in	  both	  animals	  and	  humans.	  Thus,	  the	  model	  has	  
not	   been	   homogenously	   reproduced	   in	   mice,	   while	   rat	   studies	   indicate	   a	   more	  
reproducible	  phenotype	  although	  results	  also	  vary.	  	  
	  
A	   study	   by	   Hulshof	   et	   al.,	   2011	   using	   Wistar	   rats	   found	   no	   increase	   in	   anxiety-­‐like	  
behaviour	   as	   measured	   by	   difference	   in	   social	   interaction	   scores	   and	   exploratory	  
behaviour	   in	  a	  novel	  environment	  that	   is	   thought	  to	  be	   indicative	  of	  Wistar	  rats	  being	  
more	  resistant	  to	  MS	  stress.	  This	   finding	  disagrees	  with	  Rana	  et	  al.,	  2015	  that	  showed	  
MS	  Wistar	  rats	  displayed	  a	  depressive	  phenotype	  while	  MS	  WKY	  rats	  did	  not	  (Grace	  et	  
al.,	  2009).	  No	  increase	  was	  also	  shown	  in	  anxiety-­‐like	  and	  depressive-­‐like	  behaviours	  in	  
male	   Sprague	   Dawley	   rats	   as	   measured	   by	   the	   OFT	   and	   EPM.	   Thus	   inconsistencies	  
remain	   in	   the	  model’s	   effectiveness	   to	   induce	   a	   consistent	   behavioural	   phenotype	   in	  
both	  rats	  and	  mice,	  despite	  this	  there	  are	  numerous	  studies	  that	  report	  its	  effectiveness	  
in	  producing	  a	  depressive-­‐phenotype.	  
	  
Discrepancies	   in	   the	  model	  may	  also	  be	  attributed	   to	   the	   loose	  use	  of	   the	   term	  “MS”	  
which	   encapsulates	   a	   variety	   of	   separation	   parameters.	   The	   model	   varies	   in	   time	  
windows	   of	   separation	   days	   ranging	   between	   PND	   1	   -­‐	   21	   and	   times	   of	   separation	  
ranging	   from	  15min	  -­‐	  24h	  (Schmidt	  et	  al.,	  2004;	  Aisa	  et	  al.,	  2007;	  Marais	  et	  al.,	  2009),	  
however	   the	   most	   commonly	   used	   method	   is	   removing	   dam	   (mother)	   from	   pups	  
(infants)	   from	   PND	   2	   -­‐	   14	   for	   3	   hours	   daily	   (Grace	   et	   al.,	   2009;	   Daniels	   et	   al.,	   2004;	  
Marais	  et	  al.,	  2009;	  Rana	  et	  al.,	  2015;	  Shu	  et	  al.,	  2015).	  The	  duration	  of	  separation	  and	  
time	  at	  which	  chronic/acute	  separation	  is	  conducted	  remains	  variable	  between	  studies	  
(Carrera	   et	   al.,	   2009).	   It	   would	   appear	   that	   longer	   periods	   of	   separation	   are	   more	  
effective	  at	  inducing	  a	  depressive	  phenotype	  (Ladd	  et	  al.,	  2004;	  Aisia	  et	  al.,	  2007).	  
	  
The	  PND	  2	  -­‐	  14	  for	  3	  hours	  daily	  MS	  model	  is	  thought	  to	  activate	  the	  HPA	  axis	  and	  alter	  
the	  development	  of	  the	  hippocampus	  as	  the	  hippocampus	  develops	  post-­‐natally	  and	  is	  
rich	   in	   GR	   in	   the	   granule	   cell	   layer	   of	   the	   hippocampus	   (Hulshof	   et	   al.,	   2011).	   The	  
changes	   to	   the	   neurons	   and	   regulatory	   alterations	   that	   occur	   post-­‐natally	   increase	  
susceptibility	  to	  alternations	  in	  neuronal	  functioning	  and	  caused	  enhanced	  susceptibility	  
of	   neurons	   to	   oxidative	   stress	   (Daniels	   et	   al.,	   2011).	   A	  more	   recent	   study	   in	   Sprague	  
Dawley	   rats	   showed	   that	   MS	   reduces	   the	   capacity	   for	   proliferation	   neuronal	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differentiation	   in	   the	  denate	  gyrus	  of	   the	  hippocampus	   (Boku	  et	  al.,	  2015).	   It	  has	  also	  
been	  shown	  to	  decrease	  Reelin	  protein	  expression	   (Zhang	  et	  al.,	  2013)	   that	   influences	  
migration	  of	  radial-­‐like	  neurons	  during	  embryonic	  development	  and	  plays	  a	  role	  in	  post-­‐
natal	   synaptic	   strengthening	   and	   plasticity	   in	   newly	   generated	   neurons	   (Zhang	   et	   al.,	  
2013).	  Additionally	  MS	  decreases	  hippocampal	  proteins	  bdnf	   and	   creb	   involved	   in	   the	  
process	  of	  neurogenesis	  (Shu	  et	  al.,	  2015).	  These	  are	  just	  a	  few	  of	  the	  molecular	  changes	  
that	   occur	   as	   a	   result	   of	  MS,	   other	   changes	   include	   decreased	  MSis	   c-­‐fos	   (marker	   of	  
activated	   neurons)	   (Horii-­‐Hayashi	   et	   al.,	   2013)	   and	   changes	   in	   receptors	   for	  
glucocorticoids	   and	   serotonin	   (GR	   and	   5HT1A)	   (Maniam	   &	   Morris,	   2010;	   Aisa	   et	   al.,	  
2007;	  Ladd	  et	  al.,	  2004).	   	  These	  molecular	  changes	  caused	  by	  MS	  to	   the	  HPA-­‐axis	  and	  
hippocampus	   has	   also	   been	   shown	   to	   have	   behavioral	   implications.	   Reduced	  
neurogenesis	  has	  been	  suggested	  to	  underpin	  the	  anxiogenic	  behaviours.	  
	  
	  
1.5)	  Rodent	  Studies	  linking	  depression	  and	  neurogenesis	  
	  
Neurogenesis	   in	   the	   rodent	   hippocampus	   is	   increased	   by	   chronic	   anti-­‐depressants	  
(Nibuya	   et	   al.,	   1995,	   Nibuya	   et	   al.,	   1996;	   Duman	   et	   al.,	   2000).	   Findings	   like	   these	  
encouraged	   further	   exploration	   of	   the	   link	   between	   hippocampal-­‐neurogenesis	   and	  
depressive-­‐like	  symptoms	  (Manij	  et	  al.,	  2003).	  	  
	  
In	   mice	   inhibiting	   neurogenesis	   in	   the	   hippocampus	   through	   irradiation	   or	  
administration	   of	   exogenous	   corticosterone	   (Kong	   et	   al.,	   2014)	   resulted	   in	   a	   delayed	  
recovery	  time	  to	  normalize	  corticosterone	  levels	  and	  mice	  showed	  an	  increase	  in	  anxiety	  
and	   depressive-­‐like	   symptoms	   (Snyder	   et	   al.,	   2011).	   The	   prolonged	   imbalance	   in	  
corticosterone	   release	   reduces	   activity	   of	   pathways	   such	   as	   TGFb-­‐SMAD2/3	   that	  
function	   to	   stimulate	  neurogenesis	   and	  hedgehog	   signaling	  which	   stimulates	  neuronal	  
differentiation.	   These	  pathways	  have	  been	   linked	   to	  glucocorticoid-­‐based	   reduction	   in	  
neurogenesis	   (Anacker	   et	   al.,	   2013).	   	   Contrastingly,	   Jedynak	   et	   al.,	   2014	   found	  
neurogenesis	   in	  mutant	  mice	   is	   not	   linked	   to	   depressive-­‐like	   behavior	   and	   refute	   the	  
notion	   that	   there	   is	   a	  meaningful	   link	   between	   them.	   The	   earlier	   literature	   suggested	  
that	   the	   antidepressant	   fluoxetine	   acts	   independently	   or	   partly	   dependent	   of	  
neurogenesis	   (David	  et	  al.,	   2007;	  Santarelli	  et	  al.,	   2003).	  Another	   suggestion	  has	  been	  
that	   there	   is	   a	  modulatory	   and	   rather	   than	   causal	   relationship	   between	   neurogenesis	  
and	  depressive-­‐like	  behavior	  in	  animals	  (Vollmayr	  et	  al.,	  2007).	  Despite	  the	  variation	  in	  
results	   in	   mice	   there	   has	   been	   a	   body	   of	   data	   in	   rats	   supporting	   a	   link	   between	  
neurogenesis	  and	  depressive-­‐like	  behavior	  and	  molecular/cellular	  changes.	  
	  
Depressive-­‐like	   behavioural	   changes	   were	   observed	   when	   neurogenesis	   was	  
pharmacologically	   arrested	   in	   Long	  Evans	   rats	  with	  methylazoxymethanol.	  Depressive-­‐
like	   behaviour	   increased	   as	   measured	   by	   an	   array	   of	   behavioral	   tests	   including	   the	  
forced	   swim	   test	   	   (Mateus-­‐Pinheiro	   et	   al.,	   2013).	   Pharmacologically	   up-­‐regulating	  
neurogenesis	   reversed	   these	   behavioral	   effects.	   Adult	   hippocampal	   neurogenesis	   has	  
also	   been	   observed	   in	   male	   Sprague	   Dawley	   rats.	   When	   treated	   with	   exogenous	  
corticosterone	   a	   reduction	   in	   neurogenesis	  was	   coupled	  with	   an	   increased	   immobility	  
time	  in	  the	  Porsolt	  forced	  swim	  test	  that	  measures	  depressive-­‐like	  behaviour	  (Yau	  et	  al.,	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2014;	   Hulshof	   et	   al.,	   2011).	   Similarly	   a	   study	   using	   Gravid	   Sprague	   Dawley	  model	   for	  
depression	   reported	   decreased	   neurogenesis	   as	   measured	   by	   cell	   counts	   in	   the	  
hippocampus	   (Lin	   and	   Wang,	   2014).	   A	   link	   between	   neurogenesis	   and	   depression	   is	  
further	  supported	  by	  a	  study	  by	  Hushlof	  et	  al.,	  (2011)	  that	  proposed	  neurogenesis	  in	  the	  
ventral	   hippocampus	   mediated	   the	   depressive-­‐like	   behavior	   in	   maternally	   separated	  
rats	  (Hulshof	  et	  al.,	  2011).	  	  
	  
Studies	  observing	   cellular	   changes	   in	   rat	  models	   for	   stress	   and	  depression	  also	   report	  
links	  between	  neurogenesis	  and	  depression.	  	  A	  model	  for	  depression	  using	  exposure	  to	  
corticosterones	  has	  also	  been	   linked	  to	  a	  reduction	   in	  the	  protein	  reelin	   in	  Long	  Evans	  
rats.	   Reelin	   reportedly	   plays	   a	   role	   in	  maturation	   and	  migration	   of	   newly	   developing	  
neurons	   and	   depressive	   symptoms	  were	   coupled	  with	   a	   decrease	   in	   this	   protein	   and	  
neurogenesis	  (Fenton	  et	  al.,	  2015).	  Excessive	  activation	  of	  the	  HPA	  axis	  (which	  has	  been	  
linked	  to	  depression)	  via	  GR	  causes	  atrophy	  and	  decrease	  in	  the	  size	  of	  the	  hippocampus	  
and	   decrease	   in	   synaptic	   connectivity	   with	   chronic	   stress	   decreasing	   GR	   density	   and	  
receptor	   function	   in	   the	   hippocampus	   (Isgor	   et	   al.,	   2004).	   In	   rats	   these	   changes	  
influences	  neuronal	  density	  and	  morphology	  (Mateus-­‐Pinheiro	  et	  al.,	  2013).	  	  Thus	  stress	  
has	   been	   shown	   to	   decrease	   neurogenesis.	   Stress	   has	   also	   been	   linked	   to	   levels	   of	  
synaptophysin	  that	  promotes	  neurogenesis,	  furthermore	  depressive-­‐like	  behaviour	  was	  
reversed	   by	   two	   weeks	   of	   voluntary	   running	   via	   increased	   levels	   of	   synaptophysin	  
promoting	  hippocampal	  neurogenesis	  (Yau	  et	  al.,	  2014).	  	  
	  
The	   suppression	   of	   neurogenesis	   causes	   molecular	   changes	   and	   reportedly	   causes	   a	  
reduction	   in	   dendritic	   spine	   density	   (Mateus-­‐Pinheiro	   et	   al.,	   2013).	   	   This	   reduction	   in	  
dendritic	  branching	  was	  also	  reported	  in	  immature	  DCX	  labelled	  neurons	  in	  the	  granular	  
layer	   of	   rats	   (Fenton	   et	   al.,	   2015)	   in	   addition	   to	   the	   decrease	   in	   number	   of	   neurons	  
present	   after	   chronic	   exposure	   to	   corticosterone.	   This	   also	   caused	   changes	   in	   the	  
hippocampal	  neurogenic	  niche	  and	  decreased	  the	  negative	  feedback	  receptors	  required	  
to	   regulate	   stress	   (Mateus-­‐Pinheiro	   et	   al.,	   2013).	   Thus	   neurogenesis	   is	   thought	   to	   be	  
impaired	  at	  the	  molecular	  and	  cellular	   level	   in	  rodent	  models	  for	  stress.	  Targeting	  and	  
reversing	  these	  changes	  may	  play	  a	  role	  in	  decreasing	  depressive-­‐like	  behavior	  in	  animal	  
models.	  
	  
1.6)	  Rodent	  Studies	  linking	  exercise	  and	  neurogenesis	  
	  
Exercise	  has	  been	   studied	   in	  a	  number	  of	   rodent	  models	   for	  depression	  and	   found	   to	  
have	   systemic	   effects,	   which	   alter	   brain	   morphology	   (Stranahan	   et	   al.,	   2007)	   and	  
metabolism	   (Speisman	   et	   al.,	   2013;	  Marais	   et	   al.,	   2010).	   Exercise	   has	   been	   shown	   to	  
suppress	   apoptosis	   and	   mitigate	   autophagy	   and	   consequently	   increase	   adult	  
hippocampal	   neurogenesis	   and	   improve	   memory	   and	   synaptic	   plasticity	   (Kim	   et	   al.,	  
2010;	  Zhang	  et	  al.,	  2013;	  Bechara	  &	  Kelly,	  2013).	  
	  
The	   question	   of	   which	   type	   of	   exercise	   is	   optimal	   and	   what	   duration	   is	   best	   for	  
increasing	  neurogenesis	  and	  ameliorating	  depressive-­‐like	   symptoms	   is	  disputed.	  Three	  
weeks	   of	   forced	   wheel	   running	   of	   adult	   Sprague	   Dawley	   rats	   was	   effective	   in	   up-­‐
regulating	   the	   BDNF-­‐pCREB	   pathway	   increasing	   neurogenesis	   (Jian-­‐feng	   et	   al.,	   2014),	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forced	   swimming	   (Rodriguez	   et	   al.,	   2015)	   has	   also	   shown	   to	   improve	   neurogenesis,	  
although	   intense	   exercise	   has	   been	   suggested	   to	   negate	   the	   beneficial	   effects	   of	  
exercise	  (Inou	  et	  al.,	  2015).	  There	  is	  earlier	  dated	  literature	  that	  suggests	  that	  the	  stress	  
of	  forced	  exercise	  abrogates	  the	  positive	  effect	  of	  physical	  activity	  by	  increasing	  anxiety	  
in	  mice	  although	  both	  forms	  of	  exercise	  increase	  neurogenesis	  (Leasure	  &	  Jones,	  2008).	  
However,	   voluntary	   wheel	   running	   has	   been	   shown	   to	   have	   beneficial	   effects	   on	   rat	  
memory	  (Nobel	  et	  al.,	  2014).	  
	  
Voluntary	   Wheel	   running	   in	   mice	   has	   been	   shown	   to	   increase	   BDNF	   levels	   and	  
neurogenesis	   including	   the	   generation	   of	   new	   cells,	   normalizing	   dendritic	   outgrowths	  
and	  increasing	  survival	  of	  neurons	   (Myoung-­‐Hwa	  et	  al.,	  2013).	  Voluntary	  wheel	  running	  
up-­‐regulates	   neurotrophic	   growth	   factors	   such	   as	   vascular	   endothelial	   growth	   factor	  
(VEGF),	   brain	   derived	   neurotrophic	   factor	   (BDNF)	   factors	   and	   gene	   expression	   of	  
proteins	   such	   as	   Wnt,	   which	   have	   all	   been	   implicated	   in	   enhanced	   neuroplasticity	  
(Speisman	  et	  al.,	  2013,	  Bayod	  et	  al.,	  2014;	  Gregoire	  et	  al.,	  2014).	  Running	  increases	  the	  
dendritic	   complexity	   and	   density	   of	   new	   neurons	   generated	   in	   the	   SGZ	   of	   the	   rat	  
dentate	   gyrus	   (Stranahan	   et	   al.,	   2007).	   This	   increase	   in	   neurogenesis	   improves	  
hippocampal	  dependent	  behaviours,	  improving	  the	  ability	  of	  rodents	  to	  better	  recognize	  
stressors	   and	   subsequently	   avoid	   them	   (Hamilton	  et	   al.,	   2014).	   	   Voluntary	   exercise	   in	  
rats	  has	  been	  shown	  to	  reverse	  the	  effects	  of	  restraint	  stress	  and	  increase	  the	  number	  
of	   immature	   neurons	   and	   mature	   functioning	   neurons	   present	   relative	   to	   stressed	  
controls	  (Castilla-­‐Ortega	  et	  al.,	  2014).	  As	  such	  the	  benefits	  of	  this	  exercise	   induced	  up-­‐
regulation	  of	  neurogenesis	  is	  a	  key	  area	  of	  exploration.	  	  
	  
Exercise	   in	   the	   form	   of	   voluntary	   wheel	   running	   has	   been	   shown	   to	   reverse	   the	  
depressive	  and	  anxiety-­‐like	  behaviour	  caused	  by	  MS	   (Marais	  et	  al.,	  2009;	  Grace	  et	  al.,	  
2009).	   It	   has	   also	   has	   been	   shown	   to	   reverse	   the	   molecular	   changes	   caused	   by	   MS	  
including	  decreasing	  the	  vulnerability	  of	  neurons	  to	  oxidative	  stress	  (Daniels	  et	  al.,	  2011)	  
in	   addition	   to	   reversing	   the	   aberrations	   in	   molecular	   expression	   caused	   by	   maternal	  
separation	   (Maniam	   &	   Morris,	   2010).	   This	   is	   because	   exercise	   is	   thought	   to	   have	   a	  
compensatory	   effect	   and	   targets	   the	   same	   proteins	   affected	   by	  MS	   (Dimatelis	   et	   al.,	  
2012).	   Thus	   this	   MS	   model	   was	   selected	   to	   explore	   the	   impact	   of	   voluntary	   wheel	  






1.7)	  Tools	  to	  study	  neurogenesis	  
	  
The	  gold	  standard	  for	  measuring	  neurogenesis	  in	  vivo	  and	  in	  vitro	  (Ming	  &	  Song,	  2005)	  
is	   the	   use	   5’-­‐bromo-­‐2’-­‐deoxyuridine	   (BrdU)	   (Figure	   4	   A)	   as	   an	   assay.	   This	   is	   a	  
halopyrimidine	   thymidine	   analogue	   that	   is	   incorporated	   into	   the	   DNA	   of	   cells	  
undergoing	  mitosis	  during	  the	  S-­‐phase	  of	  mitosis.	  It	  can	  be	  detected	  using	  monoclonal	  
antibodies	   but	   only	   after	   the	   tissue	   has	   been	   severely	   denatured	   in	   order	   to	   permit	  
binding	   of	   fluorophores	   (Gratzner,	   1982).	   This	   marker	   gives	   no	   indication	   of	   the	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phenotype	  of	  cells	  undergoing	  mitosis	  and	  subsequently	  must	  be	  used	  in	  conjunction	  
with	   cell-­‐type	   specific	   markers	   in	   order	   to	   identify	   neurogenesis.	   There	   are	   several	  
commonly	   used	   cell	   type	  markers	   including	  NeuN	   and	   calbindin,	   these	   label	  mature	  
neurons.	   There	   are	   also	   cell-­‐type	   markers	   for	   immature	   neurons	   such	   as	   DCX	   or	  
polysialic-­‐acid	  neural	  cell	  adhesion	  molecule.	  The	  use	  of	  these	  markers	  in	  conjunction	  








	  1.8)	  Challenges	  with	  BrdU	  
	  
BrdU	  has	  been	  used	  to	  study	  neurogenesis	  in	  multiple	  recent	  rodent	  studies	  (He	  et	  al.,	  
2014;	   Gi-­‐Mohapel,	   2013;	   Lehmann	   et	   al.,	   2013).	   	   It	   has	   also	   been	   used	   to	   study	  
modulation	  of	  neurogenesis	  in	  rodents	  that	  have	  been	  exercised	  using	  forced	  treadmill	  
exercise	   (Kim	   et	   al.,	   2014),	   voluntary	   wheel	   running	   (Liu	   et	   al.,	   2013;	   Rhodes	   et	   al.,	  
2003).	  Despite	  its	  prominence	  and	  consistent	  use	  in	  many	  recent	  studies	  there	  has	  been	  
a	  body	  of	  criticism	  of	  the	  label.	  
	  
One	   such	   issue	   is	   that	   BrdU	   labelling	   requires	   that	   tissue	   be	   exposed	   to	   acid	   and	  
denatured	   at	   high	   temperatures	   in	   order	   for	   the	   large	   fluorophore	   to	   bind	   to	   the	  
thymidine	  when	  it	   is	   incorporated	  into	  the	  double	  helix	  of	  the	  DNA	  (Wojtowicz	  &	  Kee,	  
2006).	  This	   results	   in	   the	   loss	  of	  many	  epitopes	   that	  would	  hinder	   the	  use	  of	  multiple	  
cell-­‐type	  labelling	  as	  sites	  for	  label	  to	  bind	  would	  be	  diminished	  via	  tissue	  damage	  and	  
consequently	  data	   could	  not	  be	  used	   for	  quantitative	  analysis	   (Tang	  et	  al.,	   2008).	   The	  
process	  is	  labor	  intensive	  and	  not	  compatible	  with	  multiple	  markers.	  Despite	  this,	  many	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papers	  readily	  use	  BrdU	  as	  a	   label	   to	  study	  neurogenesis	  quantitatively	   (Rhodes	  et	  al.,	  
2003;	  Speisman	  et	  al.,	  2013).	  
	  
BrdU	  dosage	  has	  also	  been	  called	  into	  question.	  The	  optimal	  dosage	  for	  labelling	  all	  cells	  
undergoing	  neurogenesis	  at	  a	  single	  time	  point	  has	  been	  examined.	  It	  was	  found	  to	  be	  
300	  mg/kg	  in	  rats	  (Cameron	  &	  McKay,	  2001),	  although	  most	  studies	  consistently	  use	  the	  
sub-­‐optimal	  50mg/kg	  dose	  (Ponti	  et	  al.,	  2012;	  Shruster	  et	  al.,	  2012;	  Chehrehasa	  et	  al.,	  
2009)	  despite	  this	  being	  shown	  to	  label	  only	  a	  fraction	  of	  all	  mitotically	  active	  cells.	  This	  
is	   possibly	   because	   of	   the	   perceived	   toxicity	   coupled	   with	   higher	   dosages.	   The	   most	  
common	   dosage	   used	   is	   50	   mg/kg	   (usually	   in	   mice)	   with	   more	   than	   one	   injection	  
administered	  over	   the	  course	  of	   treatment	   (Lehmann	  et	  al.,	   2013;	  Gil-­‐Mohapel,	  2013;	  
Rhodes	   et	   al.,	   2003).	   Multiple	   injections	   have	   also	   been	   used	   in	   labelling	   rat	   cells	  
undergoing	  mitosis	  (Monje	  et	  al.,	  2003;	  He	  et	  al.,	  2014;	  Speisman	  et	  al.,	  2013).	  Problems	  
arise	  when	  trying	  to	  quantitatively	  analyze	  the	  total	  number	  of	  cells	  undergoing	  mitosis	  
at	   a	   single	   time	   point	   that	   is	   not	   possible	   with	   sub-­‐optimal	   labelling	   or	   multiple	  
injections	   which	   gives	   an	   average	   over	   longer	   time	   periods.	   Another	   factor	   to	   be	  
considered	  is	  the	  build	  up	  of	  toxicity	  with	  a	  large	  number	  of	  injections.	  
	  
High	   levels	  of	  BrdU	  have	  been	  found	  to	  be	  toxic	  specifically	  when	  administered	  during	  
the	   prenatal	   stages	   of	   development	   where	   formation	   of	   the	   cerebellum	   was	   altered	  
(Nagoa	  et	  al.,	  1998).	  However	  in	  the	  context	  of	  adult	  neurogenesis	  there	  have	  been	  no	  
studies	  that	  report	  any	  cases	  of	  toxicity	  with	  high	  levels	  of	  BrdU	  administration	  such	  as	  
200	   mg/kg	   x	   6	   injections.	   No	   adverse	   effects	   were	   noted	   after	   42	   days	   in	   mice	   (Gil-­‐
Mohapel	  et	  al.,	  2013).	  The	  label	  was	  seen	  to	  last	  in	  the	  aforementioned	  study	  over	  the	  
period	  of	  42	  days	  however	  the	  label	  (when	  administered	  at	  lower	  levels)	  has	  been	  found	  
to	  decay	  over	  time	  (Sauerzweig	  et	  al.,	  2009).	  An	  experiment	  using	  male	  Sprague	  Dawley	  
rats	  found	  that	  BrdU	  leaks	  into	  the	  cytosol	  after	  2-­‐3	  weeks	  and	  resulted	  in	  a	  punctuated	  
and	   segmented	   label	   in	   the	   nucleus	   of	   labelled-­‐cells	   (Sauerzweig	   et	   al.,	   2009).	   These	  
observations	  have	  lead	  to	  the	  development	  of	  novel	  markers	  for	  neurogenesis.	  
	  
	  
1.9)	  Novel	  Marker	  EdU	  
	  
One	  such	  novel	  marker	  is	  5-­‐ethynyl-­‐2’-­‐deoxyuridine	  (EdU)	  a	  thymidine	  analogue	  	  (Figure	  
4B)	  that	  is	  detected	  using	  a	  copper	  catalyzed	  reaction	  with	  a	  fluorescent	  azide	  (Salic	  &	  
Mitchison,	  2008).	  This	  reagent	  is	  small	  and	  does	  not	  require	  denaturation	  for	  exposure	  
of	  EdU	  binding	  site	  and	  the	  detection	  is	  more	  sensitive	  than	  that	  of	  BrdU.	  It	  is	  thought	  
for	  these	  reasons	  it	  would	  result	  in	  improved	  in	  vivo	  detection	  of	  neurogenesis.	  EdU	  was	  
reported	  to	  be	  sensitive	  to	  low	  levels	  of	  neurogenesis	  and	  labels	  regions	  of	  low	  level	  of	  
neurogenic	   turn	   over	   such	   as	   the	   mouse	   brain	   	   (96	   hours	   after	   injection)	   and	   small	  
intestines	  (Salic	  &	  Mitchison,	  2008).	  Thus	  EdU	  was	  considered	  an	  improvement	  on	  BrdU	  
and	  several	   studies	  have	  undertaken	  to	  compare	  the	  two	   labels	   to	   illustrate	   this	   in	  an	  
attempt	  to	  optimize	  the	  assay	  for	  neurogenesis	  (Zeng	  et	  al.,	  2010).	  
	  
Studies	  were	  undertaken	  to	  compare	  quantitative	  measurement	  of	  neurogenesis	  by	  EdU	  
and	  BrdU.	  A	  study	  by	  Zeng	  et	  al.,	  (2010)	  sought	  to	  directly	  compare	  the	  use	  of	  EdU	  and	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BrdU	   in	   mice	   having	   undergone	   voluntary	   exercise	   and	   restraint	   stress.	   Mice	   were	  
injected	  with	  200	  mg/kg	  EdU	  once	  off	  and	  an	  equivalent	  amount	  of	  BrdU	  and	  perfused	  4	  
hours	   later.	  Counts	  of	   the	  cells	   in	   the	  dentate	  gyrus	   revealed	  no	   significant	  difference	  
between	   BrdU	   labelled	   cells	   and	   EdU	   labelled	   cell	   numbers	   although	   both	   labels	  
revealed	   that	   mice	   that	   exercised	   had	   significantly	   higher	   number	   of	   labelled	   cells	  
relative	   to	   control	   mice.	   Thus	   the	   study	   highlights	   the	   novel	   marker	   EdU	   as	   a	   useful	  
replacement	   for	  BrdU	   in	  quantitative	  studies	  where	  preserving	  antigenicity	  of	   tissue	   is	  
preferable.	  The	  study	  also	  showed	  that	  there	  was	  no	  interaction	  between	  BrdU	  and	  EdU	  
labels	  allowing	  for	  the	  use	  of	  both	  labels	  in	  the	  same	  animal.	  
	  
1.10)	  EdU	  as	  compared	  to	  BrdU	  
	  
EdU	   has	   been	   used	   in	   conjunction	   with	   BrdU	   in	   a	   number	   of	   studies	   exploring	   the	  
mechanisms	  of	  neurogenesis	  (Bonaguidi	  et	  al.,	  2008;	  Guo	  et	  al.,	  2009;	  Nagashima	  et	  al.,	  
2013;	  Worlitzer	  et	  al.,	  2013;	  Vadodaria	  et	  al.,	  2013).	  It	  has	  been	  used	  largely	  as	  a	  short-­‐
term	  label	  with	  BrdU	  being	  used	  as	  a	  long-­‐term	  label	  (Shuster	  et	  al.,	  2012).	  This	  is	  in	  line	  
with	   the	  discovery	   that	  at	  high	   levels	  EdU	   is	   toxic	   in	  mice	  and	  alters	  nuclear	   structure	  
(Ponti	  et	  al.,	  2012).	  This	  was	  found	  in	  mice	  that	  were	  administered	  16	   injections	  of	  50	  
mg/kg	  (one	  every	  2	  hours)	  so	  it	  requires	  a	  high	  dosage	  before	  any	  side	  effects	  are	  noted	  
in	   vivo.	   Another	   criticism	   of	   EdU	   in	   vivo	   was	   that	   it	   altered	   metabolic	   activity	   and	  
decreased	   cell	   proliferation	   in	   vivo	   and	   alternative	   improved	  marker	   (2ʹ′S)-­‐2ʹ′-­‐deoxy-­‐2ʹ′-­‐
fluoro-­‐	   5-­‐ethynyluridine	   (F-­‐ara-­‐EdU)	   was	   considered	   a	   superior	   label	   in	   terms	   of	  
sensitivity	   and	  minimally	   interfering	   with	   genomic	   expression	   (Neef	   &Luedtke,	   2011).	  
This	   study	  did	  not	  compare	   tissues	   from	   in	  vivo	   rodent	  models	  and	  subsequently	  may	  
not	  accurately	  represent	  metabolism	  in	  a	  living	  rodent	  model.	  
	  
However,	  EdU	  has	  been	  shown	  to	  be	  a	  superior	  marker	  relative	  to	  BrdU	  that	  has	  been	  
shown	  to	  render	  inconclusive	  results	  due	  to	  poor	  tissue	  quality	  (Worlitzer	  et	  al.,	  2013).	  
Qualitative	   analysis	   has	   shown	   that	   EdU	   preserved	   tissue	   quality	   and	   improved	   the	  
epitope	  binding	  of	  multiple	  labels	  such	  as	  NeuN	  (Chehrehasa	  et	  al.,	  2009).	  This	  has	  led	  
to	  EdU	  being	  used	  instead	  of	  its	  counterpart	  BrdU	  in	  several	  studies	  (Culley	  et	  al.,	  2011;	  
Becker	  et	  al.,	  2012;	  Vadodaria	  et	  al.,	  2013;	  Bhansali	  et	  al.,	  2014;	  Azzarelli	  et	  al.,	  2014).	  It	  
should	  be	  noted	  that	  many	  studies	  still	  use	  BrdU	  as	  the	  first	  option	  for	  labelling.	  
	  
Another	  marker	  to	  take	  note	  of	  which	  is	  frequently	  used	  as	  a	  tool	  to	  study	  neurogenesis	  
is	   Ki-­‐67.	   This	   is	   a	   large	   nuclear	   protein	   with	   a	   molecular	   mass	   of	   395	   kDa,	   which	   is	  
endogenous	  and	  variably	  expressed	  during	  the	  different	  stages	  of	  mitosis.	  The	  obvious	  
benefit	   is	   that	   it	   is	   already	   present	   in	   the	   cells	   and	   thus	   no	   stressful	   injections	   are	  
required	   (Wojtowicz	   &	   Kee,	   2006;	   Shingemoto-­‐Mogami	   et	   al.,	   2014;	   Gregoire	   et	   al.,	  
2014).	   Surprisingly	   little	   is	   known	   about	   the	   function	   of	   this	  molecule	   considering	   its	  
popularity	  but	  it	  would	  appear	  to	  have	  a	  primary	  role	  in	  cell	  proliferation	  and	  is	  widely	  
used	   as	   a	  medical	   diagnostic	   tool	   to	   diagnose	   proliferation	   of	  malignant	   cells	   such	   as	  
cancer	  cells	  (Brown	  &	  Gatter,	  2002).	  
	  
Thus	  using	   the	  above	  mentioned	  novel	  marker	  EdU	  and	  Ki-­‐67	   this	   study	  attempted	   to	  
explore	   the	   physiological	   process	   of	   adult	   neurogenesis	   in	   the	   hippocampus	   of	   rats	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subjected	  to	  MS	  and	  then	  later	  exercised	  using	  voluntary-­‐wheel	  running	   in	  an	  attempt	  
to	  further	  elucidate	  the	  relationship	  between	  depression	  and	  neurogenesis,	  and	  explore	  
the	  hypothesis	  that	  neurogenesis	  is	  increased	  in	  MS	  rats	  as	  is	  cellular	  proliferation	  and	  
neuronal	  survival.	  These	  markers	  would	   improve	  the	  quality	  of	  data	  attained	  from	  the	  




Purpose	  of	  the	  Study	  
	  
We	  hypothesized	  that	  neurogenesis	  in	  MS	  rats	  would	  be	  decreased	  and	  then	  increased	  
by	  voluntary	  exercise	  as	  it	  would	  be	  in	  NMS	  rats,	  as	  would	  cellular	  proliferation	  and	  cell	  
survival.	  	  Exercise	  has	  been	  reported	  to	  ameliorate	  the	  behavioral	  and	  molecular	  effects	  
of	  MS.	   This	   study	   aimed	   to	   study	   exercise-­‐induced	   hippocampal	   neurogenesis.	   It	   also	  
attempted	  to	  accurately	  capture	  this	  quantitatively	  using	   imagining	  tools	  based	  on	  the	  





1. To	  characterise	  the	  use	  of	  thymidine	  analogue	  EdU	  in	  conjunction	  with	  co-­‐labels.	  
In	  order	  to	  accurately	  identify,	  count	  and	  quantify	  cell-­‐types	  undergoing	  neurogenesis.	  	  
2. Determine	   whether	   MS	   blocks	   the	   effect	   of	   exercise	   on	   cell	   genesis	   and/or	  
survival	   in	   the	   hippocampus	   and/or	   prevents	   these	   proliferating	   cells	   from	   becoming	  
mature	  neurons	  or	  glia.	  
3. Explore	  whether	  or	  not	  voluntary	  exercise	  affects	  cell	  genesis	  and	  survival	  in	  the	  




o Characterise	  EdU	  and	  co-­‐labels	  GFAP,	  NeuN,	  DCX	  and	  Ki-­‐67	  optimally,	  specifically	  
focusing	  in	  the	  adult	  rat	  hippocampus.	  
• Using	  stain	  combinations	  EdU/GFAP/NeuN,	  EdU/DCX	  and	  KI67/DCX	  to	  compare	  cell	  
genesis	  and	  survival	  in	  the	  hippocampi	  MS	  rats.	  	  	  

































































The	  first	  aim	  of	  the	  pilot	  study	  was	  to	  characterise	  EdU	  labelling	  of	  hippocampal	  cells.	  
The	  optimal	  volume	  and	  concentration	  for	  EdU	  labelling	  of	  cells	  would	  then	  be	  used	  to	  
study	   neurogenesis	   in	   the	   dentate	   gyrus	   of	   MS	   rats	   and	   NMS	   rats	   that	   had	   been	  
housed	   in	   cages	  with	   locked	  or	  unlocked	   running	  wheels.	   EdU	  was	  used	   to	   compare	  
the	   survival	   of	   cells	   that	   underwent	   cell	   genesis	   after	   EdU	   injections	   were	  
administered,	   additionally	   the	  marker	   Ki-­‐67	  was	   used	   as	   a	   pulse	   to	  measure	  mitotic	  
activity	  at	  the	  time	  of	  perfusion.	  The	  optimization	  of	  these	  labels	  was	  necessary	  to	  use	  
them	  to	  identify	  group	  differences	  in	  the	  experimental	  rats.	  	  
	  
	  2.1.2)	  Animals	  
	  
Ten	  male	  Sprague-­‐Dawley	  rats	  were	  obtained	  from	  the	  Animal	  Facility	  of	  the	  University	  
of	   Cape	   Town.	   An	   additional	   five	   Sprague-­‐Dawley	   rats	   were	   purchased	   from	   The	  
University	  of	  Stellenbosch.	  Rats	  were	  obtained	  at	  PND	  30	  whereby,	  two	  rats	  were	  used	  
to	  optimize	  EdU-­‐label	  and	  the	  remaining	  thirteen	  rats	  were	  used	  for	  the	  pilot	  study.	  	  
	  
Rats	  were	  housed	  in	  the	  Satellite	  Animal	  Facility	  in	  the	  Department	  of	  Human	  Biology	  under	  
standard	  conditions	  12	  h:	  12	  h	  light/dark	  cycle	  with	  lights	  on	  at	  6:00.	  The	  temperature	  was	  
set	  at	  22	  ±	  2°C.	  Rats	  had	  access	  to	  food	  and	  water	  ad	  libitum.	  	  Rats	  were	  fed	  Nutroscience	  
rat	  chow	  (See	  Addendum).	  	  All	  procedures	  were	  authorised	  by	  the	  Health	  Sciences	  Faculty	  
Animal	  Ethics	  Committee	  of	  the	  University	  of	  Cape	  Town	  (protocol	  no.	  012/061).	  The	  Study	  
was	  carried	  out	  in	  accordance	  with	  the	  South	  African	  National	  Standard:	  The	  care	  and	  use	  of	  
animals	  for	  scientific	  purposes	  10386:2008.	  
	  
2.1.3)	  Exercise	  and	  ethynyl-­‐2'-­‐deoxyuridine	  (EdU)	  Injection	  
	  
Rat	   treatment	   included	  voluntary	  exercise	   (in	  order	   to	   stimulate	  neurogenesis	   in	   the	  
brain)	   in	   the	   form	   of	   voluntary	   wheel	   running.	   Distance	   travelled	   was	   measured	  
manually	  using	  daily	  wheel	  rotations	  (one	  rotation	  was	  equivalent	  to	  one	  meter).	  On	  
postnatal	  day	  (PND)	  54/55	  rats	  were	  placed	  in	  cages	  with	  adjoined	  running	  wheels	  in	  a	  
separate	   wheel	   running	   room	   in	   the	   satellite	   animal	   facility	   in	   the	   Human	   Biology	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Department.	   Rats	   had	   free	   access	   to	   Nutroscience	   rat	   chow	   and	   water	   and	   had	   an	  
additional	  option	  of	  powdered	  food.	  
	  
All	   rats	   were	   intraperitoneally	   (IP)	   injected	  with	   the	  mitotic	  marker	   EdU	   (50	  mg/kg,	  
6.66	  mg/ml)	  on	  either	  PND	  60/61	  or	  PND	  74/75	  or	  PND	  94/95.	  This	  was	  done	  to	  label	  
and	  monitor	  cells	  undergoing	  mitosis.	  	  
	  
Rats	   were	   divided	   into	   three	   groups.	   Group	   one	   consisted	   of	   five	   rats	   that	   were	  
allowed	  to	  run	  from	  PND	  54	  -­‐	  96	  with	  EdU	  injections	  administered	  to	  rats	  on	  PND	  96	  
four	   hours	   prior	   to	   perfusion.	   	  Group	   two	   consisted	   of	   five	   rats	   that	  were	   exercised	  
from	  PND	  54	  -­‐	  74	  and	  a	  third	  group	  of	  three	  rats	  was	  housed	  in	  locked	  wheels,	  which	  
acted	  as	  a	  control	  group.	  EdU	  injections	  were	  administered	  on	  PND	  74	  four	  hours	  prior	  
to	  perfusion	  (Figure	  5).	  	  
	  
Figure	   5.	  Diagram	  of	  treatments	  each	  rat	  group	  underwent.	   	  Adult	  rats	  were	  housed	  in	  cages	  with	  running	  
wheels	  that	  were	  either	  locked	  (NR)	  or	  not	  (R)	  as	  indicated	  by	  the	  diagrammatic	  wheels.	  The	  locked	  wheels	  
are	   indicated	  by	  a	   	  red	  cross.	  EdU	  injections	  were	  administered	  at	  one	  of	  three	  time	  points	  (PND	  60,	  96	  or	  
74).	  Rats	  were	  returned	  to	  home	  cages	  and	  perfused	  either	  four	  hours	   later	  (Group	  1	  and	  3)	  or	  two	  weeks	  
after	  injection	  (Group	  2)	  in	  order	  to	  establish	  the	  optimal	  window	  of	  time	  to	  study	  neurogenesis	  in	  vivo.	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  2.1.4)	  Transcardial	  Perfusions	  
	  
Paraformaldehyde	  (PFA,	  4%)	  was	  prepared	  in	  the	  morning	  of	  perfusion	  using	  fresh	  0.01	  
M	   phosphate	   buffered	   saline	   (PBS)	   (see	   addendum	   for	   full	   composition).	  
Paraformaldehyde	  powder	  (Sigma-­‐Aldridge)	  was	  weighed	  out	  and	  stirred	  on	  a	  hot	  plate	  
until	   the	   solution	   reached	   66	   °C.	   	   At	   this	   temperature,	   a	   saturated	   Sodium	  Hydroxide	  
solution	  was	  added	  in	  a	  drop-­‐wise	  fashion	  until	  the	  precipitate	  cleared	  to	  adjust	  the	  pH	  
to	   approximately	   6.9.	   Thereafter	   the	   solution	   was	   permitted	   to	   cool	   to	   room	  
temperature.	  This	  solution	  was	  prepared	  in	  a	  fume	  hood	  	  
	  
A	  Gilson	  mini-­‐pulse	  2	  pump	  was	  used	  to	  emulate	  the	  pumping	  motion	  of	  the	  heart	  and	  
to	  pump	  solution	  through	  the	  vascular	  system.	  The	  perfusion	  tubes	  were	   flushed	  with	  
ethanol	  to	  sterilize	  tubes	  and	  then	  PBS	  to	  ensure	  no	  ethanol	  or	  contaminants	  remained.	  
These	   tubes	   consisted	   of	   a	   valve	   that	   allowed	   one	   to	   switch	   from	   PBS	   flow	   to	   PFA	  
without	  losing	  pressure.	  
	  
Rats	  were	  habituated	   (in	  perspex	  cages	   containing	  wood	  shavings	  and	  had	  access	   to	  
food	   and	   water	   ad	   libitum)	   for	   one	   hour	   prior	   to	   procedure.	   Animals	   were	   deeply	  
anesthetized	  using	  halothane	  (Safeline	  Pharmaceuticals).	  	  
	  
The	   deeply	   anaesthetized	   rats	   were	   secured	   to	   the	   operating	   surface	   and	   a	   lateral	  
incision	  was	  made	  through	  the	  integument	  and	  abdominal	  wall	  below	  the	  ribcage.	  An	  
incision	  was	  made	  along	  the	  length	  of	  the	  ribcage	  to	  expose	  the	  pleural	  cavity	  and	  the	  
sternum	  was	  lifted	  away	  to	  expose	  the	  heart.	  The	  connective	  tissue	  around	  the	  heart	  
was	  carefully	  trimmed	  away	  and	  the	  perfusion	  tube	  needle	  was	  inserted	  into	  the	  left	  
ventricle	  and	  a	  small	  incision	  was	  made	  in	  the	  posterior	  of	  the	  right	  atrium	  to	  release	  
pressure.	   	  The	   rat	  was	   then	  exsanguinated	  with	  50	  ml	   -­‐	  100	  ml	  0.01	  M	  PBS	   (pH	  7.4)	  
solution.	  The	  valve	  was	  then	  switched	  from	  buffer	  to	  4	  %	  PFA	  300	  -­‐	  400	  ml.	  Then	  PFA	  
was	   pumped	   through	   the	   body	   of	   the	   rats	   taking	   note	   of	   whole	   body	   fasciculation	  
(which	  indicated	  cross-­‐linking	  of	  proteins	   in	  muscles).	   	  The	  perfusion	  process	  took	  on	  
average	  1	  hour	  per	  rat.	  	  It	  was	  noted	  that	  100	  ml	  0.01	  M	  PBS	  and	  400	  ml	  4	  %	  PFA	  were	  
optimal	  for	  rats	  ranging	  between	  350-­‐400g.	  
	  
Thereafter,	   the	   rats	   were	   decapitated	   using	   a	   guillotine	   and	   the	   brain	   removed	  
immediately	  and	  placed	  in	  4	  %	  PFA	  for	  three	  hours.	  The	  brain	  was	  transferred	  to	  30	  %	  
sucrose	  solution	  and	  stored	  in	  sucrose	  at	  4°C	  until	  it	  sank	  (3	  -­‐	  5	  days).	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2.1.4)	  Brain	  Sectioning	  
	  
Brains	  were	  extracted	  and	  stored	  using	  three	  methods.	  Six	  brains	  were	  stored	  in	  
30	  %	  sucrose	  and	  processed	  immediately	  upon	  sinking,	  two	  brains	  were	  frozen	  in	  
OCT	  medium	  and	  kept	  in	  the	  -­‐20	  °C	  freezer	  for	  4/5	  days	  after	  sinking	  before	  being	  
sectioned.	  Two	  brains	  were	  frozen	  in	  30	  %	  sucrose	  and	  stored	  for	  four	  days	  prior	  
to	  sectioning.	  The	  tissue	  quality	  varied.	  Processing	  brains	   immediately	  rendered	  
optimal	   tissue	   quality.	   The	   final	   three	   rats	   were	   sectioned	   immediately	   upon	  
sinking	  in	  30%	  sucrose	  with	  no	  more	  than	  1	  day	  between	  sinking	  and	  sectioning.	  
Whole	  brains	  were	   frozen	   in	  OCT	  medium	  and	  cryo-­‐sectioned	  coronally	  using	  a	  
cryostat	   (Leica	   cryostat	   CM1850)	   at	   a	   thickness	   of	   40	   μm.	   Every	   3rd	   section	   of	  
dorsal	  hippocampus	  was	  collected	  (total	  6	  sections	  per	  rat	  per	  stain	  combination)	  
in	  3	  %	  Triton	  X-­‐100	  (Merck)	  in	  PBS.	  	  
	  
	  	  2.1.6)	  Staining	  Wells	  
	  
Sections	   were	   stored	   in	   Greiner	   well	   plates	   (6	   x	   4)	   containing	   either	   the	  
appropriate	  wash	  or	  antibody	  incubation	  medium.	  A	  fresh	  well	  plate	  was	  used	  for	  
each	   immunohistochemistry	   step	   (e.g.	   blocking,	   washing	   and	   antibody	  





	  	  2.1.7)	  Immunohistochemistry	  	  
	  
Brain	  sections	  were	  collected	  using	  wells	  containing	  0.03	  %	  Triton-­‐X-­‐100	  in	  PBS.	  
These	  were	  incubated	  in	  the	  fridge	  for	  an	  hour	  to	  permeabilise	  cell	  membranes	  
to	   allow	   entry	   and	   binding	   of	   fluorescent	   antibodies	   to	   epitopes	   on	   brain	  
sections.	  EdU	  was	  the	  first	  molecular	  marker	  to	  be	  detected.	  
	  
The	   EdU	   detection	   was	   performed	   prior	   to	   incubation	   with	   additional	  
antibodies.	   The	   Invitrogen	   Imaging	   kit	   (C10337)	   Click-­‐iT	   reaction	   cocktail	   was	  
used.	  The	  method	  was	  modified	  for	  fixed	  free-­‐floating	  tissue	  with	  endogenous	  
EdU.	   The	   click-­‐iT	   reagent	   cocktail	   was	   prepared	   with	   volumes	   listed	   in	   the	  
Invitrogen	   product	   information	   sheet.	   The	   kit	   comprised	   of	   4	   components:	   a	  
click-­‐iT	  reaction	  buffer,	  CuSO4,	  Alexa-­‐Fluor	  and	  a	  reaction	  buffer	  additive.	  Brain	  
sections	  were	  incubated	  in	  1000	  μl	  click-­‐iT	  reagent;	  860	  μl	  1x	  click-­‐iT	  buffer,	  40	  
μl	   CuSo4,	   2.5	   μl	   Alexa	   Fluor-­‐Azide	   and	   100	   μl	   of	   reaction	   buffer.	   Adding	   the	  
reagents	   in	   this	   order	   ensured	   a	   specifically	   buffered	   environment	   for	   the	  
reaction	  to	  take	  place.	  The	  cocktail	  was	  prepared	  in	  the	  dark	  as	  the	  reaction	  is	  
light	  sensitive.	  The	  reaction	  is	  a	  copper-­‐catalyzed	  covalent	  reaction	  between	  an	  
azide	   (fluorophore)	   and	   an	   alkyne	   (EdU)	   and	   required	   30	   minutes	   for	   the	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reagents	   to	   react	   optimally	   binding	   the	   fluorophore	   to	   the	   EdU,	   which	   was	  
already	  integrated	  into	  the	  DNA	  of	  the	  fixed	  brain	  tissue.	  	  
	  
	  
Tissue	   was	   blocked	   in	   3	   %	   Bovine	   Serum	   Albumin	   (BSA)	   (Roche	   Diagnostics,	  
USA)	   for	  2	   x	  10	  min	   to	  prevent	  non-­‐specific	  binding	  of	   antibodies.	   Tissue	  was	  
thereafter	  incubated	  in	  primary	  antibody	  (prepared	  in	  a	  blocking	  solution;	  20	  ml	  
0.01M	  PBS,	  200	  mg	  BSA	  &	  0.1	  ml	  100	  %	  Triton-­‐X-­‐100)	  for	  16	  hours	  at	  ambient	  
room	  temperature.	  Brain	  sections	  were	  washed	  in	  3	  %	  Triton	  X-­‐100	  in	  PBS	  for	  3	  
x	  10	  min	  and	  then	  incubated	  in	  secondary	  antibody	  (which	  was	  made	  up	  in	  the	  
aforementioned	   blocking	   solution)	   for	   5	   h.	   The	   sections	   were	   manually	  
transferred	  into	  wells	  containing	  3	  %	  Triton	  X-­‐100	  in	  PBS	  for	  3	  x	  10	  min	  washes	  
prior	  to	  a	  15	  min	  Hoechst	  incubation	  followed	  by	  a	  10	  min	  PBS	  wash.	  Sections	  
were	  then	  free	   floated	   in	  PBS,	  placed	  on	  slides	   in	  anti-­‐fade	  and	  cover	  slipped.	  
Two	   staining	   combinations	  were	   used	   for	   characterisation.	   The	   first	   was	   EdU	  
and	  the	  immature	  neuronal	  marker	  Doublecortin	  (DCX),	  and	  the	  second,	  EdU	  in	  
conjunction	   with	   a	   cell-­‐type	   specific	   marker	   for	   mature	   neurons	   (NeuN)	   and	  





2.1.8)	  Quantification	  	  
	  
The	  confocal	  microscope	   (LSM	  510	  Zeiss)	  was	  used	   to	  scan	  brain	  sections	  and	  
Zen	   2009	   software	   was	   used	   to	   identify	   cell-­‐type	   specific	   markers	   using	   co-­‐
localisation	  and	  profiling	  (See	  Table	  1,	  2	  for	  parameters).	  
	  
	  
Table	  1.	  Tile-­‐scan	  Settings	  (20x)	  for	  overview	  scan	  of	  hippocampus	  
	  

























Table	  2.	  Detail	  Scan	  Settings	  (10x)	  for	  dentate	  gyrus	  
	  
Laser	   	  Excitation	  
Wavelength	  
(nm)	  
Power	  (%)	   	  Emission	  
Filters	  
Mai	  Tai	   750	   10	   390-­‐465	  
(blue)	  




solid	   state	  
(DPSS)	  
561	   10	   575-­‐630	  
(red)	  
HeNe633	   633	   10	   650-­‐710	  
(purple)	  
	  
Confocal	   Lasers	   scanned	   each	   pixel	   of	   the	   specimen	   gathering	   data	   about	   the	  
intensity	   of	   each	   marker’s	   fluorescence.	   The	   co-­‐localisation	   function	   was	   used	   to	  
identify	   areas	   of	   overlap	   between	   fluorescent	   markers.	   These	   fluorescent	   signal	  
intensities	   were	   used	   to	   estimate	   the	   correspondence	   between	   the	   two	   or	   more	  
markers	   that	   spatially	   overlapped.	   This	   confirmed	   whether	   two	   markers	   were	  
associated	  with	  the	  same	  structure	  (Figure	  6).	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Figure	   6.	   Co-­‐localisation	   scatterplots	   displaying	   the	   stain	   intensity	   of	   the	   pixels	  
selected	  in	  the	  green	  circle	  in	  A	  and	  B.	  Region	  1	  represents	  only	  pixels	  with	  EdU	  stain,	  
region	   2	   represents	   only	   pixels	   with	   stain	   for	   NeuN	   (A)	   and	   GFAP	   (B)	   and	   region	   3	  
represents	   the	   number	   of	   pixels	   which	   overlap	   in	   fluorescence	   intensity	   of	   the	  
respective	  stains.	  The	  majority	  of	  pixels	  overlap	  in	  region	  three	  indicating	  that	  the	  two	  
stains	   co-­‐localized	   in	   the	   same	   structure.	   The	   tile	   scans	  on	   the	   right	   show	   the	  NeuN	  
positive	   neurons	   (pink),	   GFAP	   positive	   Astrocytes	   (Red)	   and	   Hoechst	   stained	   nuclei	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Figure	  7.	  Graph	  shows	  the	  intensity	  profile	  of	  region	  indicated	  by	  the	  red	  arrow.	  Green	  
line	   represents	   EdU	   stained	   nucleus,	   red	   line	   indicates	   GFAP	   profile	   and	   blue	   line	  
indicates	  Hoechst.	  Likewise,	  on	  the	  right	  the	  labelled	  astrocyte	  cytoskeleton	  (red)	  and	  
EdU	   positive	   nucleus	   (green)	   show	   the	   morphological	   star-­‐shape	   of	   glial	   cells.	   This	  
pattern	  of	  the	  cytoskeletal	  GFAP	  stain	  cupping	  the	  nuclear	  EdU	  is	  a	  positive	  indication	  
that	  the	  labelled	  cell	  is	  a	  glial	  cell.	  
	  
	  
The	  Intensity	  profiling	  function	  was	  used	  in	  conjunction	  with	  the	  co-­‐localisation	  
function.	   This	   provided	   a	   visual	   representation	   of	   the	   pattern	   of	   florescence	  
intensities	  emitted	  by	  markers	  over	  a	  selected	  area	  of	  interest.	  Profile	  analysis	  
separated	  channels	  and	  represented	  each	  pixel’s	  various	  channels’	  florescence	  
intensities.	  This	  allowed	  for	  further	  identification	  of	  EdU	  co-­‐labelled	  cells.	  
	  
The	   co-­‐localisation	   (Figure	   6)	   and	   intensity	   profiling	   (Figure	   7)	   functions	  were	  
used	  to	  identify	  EdU	  co-­‐labelled	  cells	  expressing	  combinations	  of	  EdU	  and	  DCX,	  
EdU	  and	  NeuN	  	  (6	  A)	  or	  EdU	  with	  GFAP	  (6	  B).	  Using	  this	  method	  the	  study	  was	  
able	  to	   identify	  neurons	  due	  to	  overlap	   in	  pixel	   intensity	  (6	  A)	  and	  glia	  via	  the	  
cupped	  pattern	  in	  intensity	  profiling	  peaks	  and	  troughs	  (Figures	  6	  B	  and	  7).	  This	  
was	  supported	  by	  the	  co-­‐localisation	  function.	  
	  
	  
	  2.1.9)	  Statistics	  
	  
	  All	  statistics	  were	  carried	  out	  using	  Statistica	  V.12	  (StatSoft	  2012)	  and	  Prism	  V.5	  
(GraphPad	  Software	  2010).	  Characterisation	  data	  distribution	  was	  identified	  as	  
being	  normal	  or	  non-­‐parametric	  using	  the	  Shapiro-­‐Wilk	  test.	  Thereafter	  either	  a	  
One-­‐Way	  Analysis	  of	  Variance	  (ANOVA)	  with	  a	  Tukey	  post	  hoc	  test	  or	  a	  Kruskal-­‐
Wallis	   test	  coupled	  with	  Dunn’s	  multiple	  comparison	   tests	  were	  performed	  as	  
appropriate.	   These	   tests	   were	   used	   in	   order	   to	   identify	   differences	   between	  
groups	  and	  where	  specific	  differences	  occurred	  between	  mean/median	  values,	  
respectively.	   Data	   were	   reported	   as	  mean	   and	   standard	   deviation	   or	  median	  
and	  inter-­‐quartile	  range.	  
	  




	  2.2.1)	  Experimental	  Animals	  
	  
Once	  the	  mitotic	  marker	  (EdU)	  had	  been	  characterised,	  the	  effect	  of	  maternal	  
separation	   (MS)	  on	   the	  hippocampus	  was	   investigated.	  Additionally	   the	  effect	  
of	  voluntary	  wheel	  running	  on	  the	  hippocampus	  was	  studied	  in	  MS	  rats	  in	  order	  
to	   explore	   the	   influence	   of	   exercise	   on	   neurogenesis	   in	   the	  MS	   rat-­‐model	   of	  
depression.	  
	  
Thirty-­‐nine	   Sprague	   Dawley	   rats	   were	   obtained	   from	   the	   University	   of	   Cape	  
Town	  Animal	  Unit.	  Thirty-­‐nine	  animals	  were	  perfused	  and	  their	  brains	  sectioned	  
for	  immunohistochemistry.	  Eighteen	  animals	  were	  lost	  to	  the	  study	  because	  of	  
poor	   EdU	   staining.	   The	   remaining	   21	   brains	  were	   used	   to	   test	   for	   differences	  
between	  treatment	  groups.	  Animals	  were	  bred	  and	  housed	  in	  the	  University	  of	  
Cape	  Town	  Animal	  Unit	  under	   standard	   conditions	  12	  h:	  12	  h	   light/dark	   cycle	  
(lights	  on	  at	  6:00	  A.M.)	  with	  a	  temperature	  of	  23	  ±	  2°C.	  Rats	  had	  access	  to	  food	  
and	  water	  ad	  libitum.	  All	  procedures	  were	  authorized	  by	  the	  Faculty	  of	  Health	  
Sciences	   Animal	   Ethics	   Committee	   of	   the	  University	   of	   Cape	   Town	   (012/061).	  
The	   Study	   was	   carried	   out	   in	   accordance	   with	   the	   South	   African	   National	  
Standard:	  The	  care	  and	  use	  of	  animals	  for	  scientific	  purposes	  10386:2008.	  Rats	  
were	  fed	  Tekland	  Equifeed	  rat	  chow	  (see	  appendix	  for	  details	  of	  composition).	  
	  
2.2.2)	  Maternal	  Separation	  (MS)	  
	  
Rats	  were	  bred	  over	  three	  months	  and	  a	  maximum	  of	  four	  male	  rats	  were	  taken	  
from	  each	  litter.	  Studs	  and	  Dams	  were	  housed	  together	  until	   litters	  were	  born	  
at	  which	  time	  the	  stud	  was	  removed.	  On	  PND	  2,	  litters	  were	  culled	  to	  eight	  pups	  
(with	  a	  minimum	  of	  two	  females	  and	  two	  males	  per	  litter).	  	  
	  
Litters	  were	  randomly	  assigned	  to	  MS	  (n=19)	  or	  NMS	  (n=20)	  groups.	  Five	  dams	  
were	  used	  to	  breed	  MS	  litters	  with	  one	  female	  being	  re-­‐used	  and	  contributing	  
two	  litters	  to	  the	  study.	  Five	  dams	  were	  used	  to	  breed	  NMS	  litters.	  	  A	  different	  
stud	  was	  used	   for	  each	   litter.	  On	  PND	  2	   -­‐	  14	  pups	  were	  separated	   from	  dams	  
between	  9:00	  and	  12:00	  and	  transported	  to	  a	  different	  room	  in	  the	  animal	  unit	  
to	   prevent	   vocal	   communication	   between	   mother	   and	   pups.	   The	   dam	   was	  
removed	   from	   the	   home	   cage	   and	   kept	   in	   a	   single	   cage	  within	   the	   rat	   room.	  
Pups	  were	  placed	  under	  an	  infrared	  light	  (temperature	  =	  31	  ±	  1°C).	   	  This	   lamp	  
was	  attached	  to	  an	  adjustable	  stand	  and	  raised	  to	  26	  cm	  above	  the	  pups.	  NMS	  
litters	  were	  left	  undisturbed.	  
	  
Pups	   and	  dams	  were	  housed	   together	  until	   PND	  21	   at	  which	   time	  pups	  were	  
weaned	  and	  housed	  with	  3	  -­‐	  4	  littermates.	  Nineteen	  rats	  were	  MS	  and	  twenty	  
rats	  were	  NMS	  however,	  due	  to	  variability	  in	  the	  staining	  of	  brain	  sections	  only	  
10	  MS	  rats	  and	  11	  NMS	  rats	  were	  used	  for	  statistical	  analysis.	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  2.2.3)	  Voluntary	  Exercise	  
	  
Rats	  were	  housed	  in	  single	  cages	  with	  attached	  running	  wheels	  from	  PND	  54	  -­‐	  
74.	   Twenty	   rats	   were	   housed	   in	   cages	   with	   free	   running	   wheels	   (n=10)	   and	  
could	  exercise	  at	  will	  and	  twenty	  rats	  were	  housed	  in	  cages	  with	  locked	  wheels	  
(n=10).	   Of	   those	   rats	   only	   11	   were	   used	   in	   the	   statistical	   analysis	   due	   to	  
variability	   in	   early	   brain	   staining.	   The	   method	   was	   the	   same	   as	   described	   in	  
section	  2.1.2.	  The	  daily	  rotations	  (distance	  travelled)	  were	  manually	  recorded.	  
	  
	  
	  2.2.4)	  Injections	  
	  
All	   rats	   received	   a	   single	   IP	   EdU	   (50	   mg/kg)	   injection	   on	   PND	   60.	   Rats	   were	  
weighed	   on	   the	   day	   of	   injection	   and	   EdU	   (1	  mg/0.15	  ml	   or	   6.66	  mg/ml)	  was	  








Figure	  8.	  	  	  Displaying	  each	  treatment	  group	  	  (MS+R,	  MS+NR,	  NMS+R,	  NMS+NR).	  The	  
rat	  pups	  were	  treated	  with	  MS	  or	  NMS.	  	  These	  rats	  were	  then	  permitted	  to	  reach	  
adulthood	  and	  housed	  with	  running	  wheels	  on	  PND	  54.	  	  Wheels	  were	  locked	  or	  left	  
unlocked	   allowing	   some	   rats	   voluntary	   exercise	   and	   others	   not.	   EdU	   injections	  
were	   administered	   on	   PND	   60	   to	  measure	  mitotic	   activity	   in	   the	   dentate	   gyri	   of	  
runners	   and	   non-­‐runners.	   	   Rats	   were	   immediately	   returned	   to	   their	   home	   cages	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with	   running	  wheels	  until	   PND	  74.	  They	  were	   then	  perfused	  and	  brains	   collected	  
for	  immunohistochemistry.	  
	  
	  2.2.5)	  Transcardial	  Perfusions	  
	  
Thirty-­‐nine	   rats	   were	   perfused	   in	   the	   afternoon	   between	   13:00	   -­‐	   17:00.	  
Perfusions	  took	  place	  on	  PND	  74	  according	  to	  the	  method	  previously	  described	  
in	   chapter	   2.1.3.	   The	   whole	   brain	   of	   each	   rat	   was	   removed	   from	   the	   skull,	  
placed	  in	  4	  %	  PFA	  for	  three	  hours	  and	  then	  dehydrated	  in	  30	  %	  sucrose	  solution	  
or	   3	   -­‐	   5	   days	   until	   the	   brain	   sank.	   Thereafter	   brains	   were	   sectioned	   with	   no	  
more	  than	  two	  days	  between	  sinking	  and	  sectioning.	  
	  
	  
	  2.2.6)	  Sectioning	  
	  
Brain	   sections	  were	   frozen	   using	  OCT	   to	   prevent	   ice-­‐crystal	   formation	   (which	  
would	  damage	  the	   tissue).	  Brains	  were	  mounted	  upon	  a	  chuck	  using	  OCT	  and	  
sectioned	   using	   a	   cryostat	   microtome.	   The	   coronal	   sections	   containing	   the	  
dorsal	   hippocampus	   (40	   μm	   sections	   from	   6.96	   to	   5.52	   mm	   anterior	   to	   the	  
inter-­‐aural	  line)	  and	  the	  ventral	  hippocampus	  (50	  μm	  sections	  from	  3.84	  to	  2.76	  
mm	  anterior	   to	   the	   inter-­‐aural	   line)	  were	   collected.	   The	   ventral	   hippocampus	  
was	   larger	   in	   surface	   area	   and	   broke	   more	   easily	   and	   therefore	   50	   μm	   was	  
found	  to	  be	  the	  optimal	  sectioning	  thickness.	  Every	  5thsection	  was	  collected	  for	  
the	  dorsal	  and	  ventral	  hippocampus	  (Figure	  9).	  Sections	  were	  submerged	  in	  3	  %	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  Figure	  9.	  A	  representation	  of	  the	  processing	  of	  each	  rat	  brain	  collected.	  	  After	  the	  
perfusion	   adult	   rat	   brains	   were	   collected	   and	   the	   ventral	   and	   dorsal	   hippocampi	  
were	   sectioned	  separately.	   Five	   sections	  of	  each	   region	  of	   the	  hippocampus	  were	  
kept	   for	   each	   molecular	   label	   combination.	   Three	   molecular	   label	   combinations	  
were	  used	  to	  study	  neurogenesis	  in	  the	  dentate	  gyrus:	  EdU/NeuN/GFAP,	  EdU/DCX	  
and	  Ki-­‐67/DCX.	  EdU	  was	  used	  to	  quantify	  neuronal	  or	  astrocytic	  survival	  while	  Ki-­‐67	  
Label	  was	  used	  as	  a	  pulse.	  
	  
	  2.2.7)	  Staining	  Vials	  &	  Wells	  
	  
To	   increase	   the	   number	   of	   brain	   sections	   stained	   per	   session,	   individual	  
drainable	  staining-­‐vials	  were	  constructed.	  
	  
These	   plastic	   drainable	   vials	   were	   placed	   in	   separate	   Greiner	   24-­‐well	   plates	  
containing	  primary	  antibodies,	  secondary	  antibodies,	  washes	  and	  Hoechst	  stain.	  
The	  staining-­‐vials	  were	  allowed	   to	  drain	  and	  were	   transferred	  between	  plates	  
for	  each	  step	  of	  the	  immunohistochemistry	  procedure.	  
	  
	  
2.2.8)	  Immunohistochemistry	  	  
	  
Staining	   was	   performed	   according	   to	   the	   methods	   outlined	   in	   section	   2.1.6.	  
There	  were	  three	  staining	  combinations	  used	  per	  rat	  brain.	  The	  first	  used	  NeuN	  
and	  GFAP	  in	  conjunction	  with	  the	  EdU	  label	  to	  ascertain	  how	  many	  progenitor	  
cells	  survived	  cellular	   integration	  and	  the	  fate	  of	  the	  specific	  cell	   types	  (Figure	  
9).	  The	  second	  stain	  combination	  was	  DCX	  and	  EdU	  and	  this	  stain	  was	  used	  to	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determine	   how	  many	   EdU	   labelled	   immature	   Neurons	  were	   present	   after	   20	  
days	  of	  exercise	  (Figure	  9).	  The	  third	  stain	  comprised	  Ki-­‐67	  and	  DCX	  and	  was	  a	  
pulse	   label	  used	  to	  determine	  the	  number	  of	  mitotically	  active	  cells	   that	  were	  
destined	  to	  become	  neurons	  at	  the	  end	  of	  the	  exercise	  period	  (Figures	  10-­‐12).	  
The	   amount	   of	   EdU	   click-­‐iT	   reagent	   used	   for	   the	   first	   18	   brains	   stained	   sub-­‐
optimally	  and	  thus	  only	  21	  EdU	  labelled	  brains	  were	  processed	  for	  counting.	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Figure	   10.	   Cell-­‐type	  specific	  marker.	   Combination	  1	   shows	  GFAP	   (red),	   EdU	   (green),	  
NeuN	  (magenta)	  and	  Hoechst	  (blue)	  and	  a	  composite	  image	  allowing	  identification	  of	  




Figure	   11.	   Cell-­‐type	   specific	  marker	   combination	   2	   shows	   DCX	   (red),	   EdU	   (green)	   and	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Figure	  12.	  Cell-­‐type	  specific	  marker	  combination	  3	  displays	  DCX	  (red),	  Hoechst	  (blue)	  
and	  KI-­‐67	  (yellow)	  and	  composite	  image.	  
	  
	  2.2.9)	  Quantification	  
	  
The	  process	  of	  quantification	  was	  the	  same	  as	   that	  described	   in	  section	  2.1.7.	  	  
Thus	  EdU	  co-­‐labelling	  with	  NeuN	  and	  GFAP	  was	  established	  using	  co-­‐localisation	  
and	  profile	  analysis	  for	  stain	  1,	  co-­‐labelling	  of	  EdU	  and	  DCX	  was	  established	  for	  
stain	  2	  using	  the	  same	  methods	  and	  co-­‐localisation	  of	  Ki-­‐67	  and	  DCX	  for	  stain	  
combination	  3	  was	  also	  established.	  The	  specific	  cell-­‐type	  counts	  were	  averaged	  
separately	  for	  each	  rat	  brain	  area	  and	  analyzed	  according	  to	  treatment	  groups.	  
	  
	  2.2.10)	  Statistics	  
	  
The	  distance	   travelled	  by	  each	   rat	  was	  measured	   in	  meters	   travelled	  per	  day.	  
The	  Shapiro-­‐Wilk	  Test	  revealed	  that	  the	  data	  were	  not	  normally	  distributed.	  The	  
repeated	  measures	  Wilcoxon	   Test	   (Wilcoxon	   signed-­‐rank	   test)	  was	   applied	   to	  
the	  running	  data	  to	  determine	  whether	  there	  was	  any	  difference	  between	  MS	  
and	  NMS	  rats	  in	  terms	  of	  distance	  travelled.	  The	  weight	  data	  were	  found	  to	  be	  
non-­‐parametric	   and	   a	   Kruskal-­‐Wallis	   Test	   coupled	   with	   Dunn’s	   multiple	  
comparison	   Test	  was	   conducted.	   The	   Shapiro-­‐Wilk	   test	  was	   used	   to	   establish	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whether	   the	   data	   for	   each	   stain	   combination	   1,	   2	   and	   3	   were	   normally	  
distributed.	  Thereafter	  either	  a	  one-­‐way	  analysis	  of	  variance	  (ANOVA)	  followed	  
by	  a	  Tukey’s	  post	  hoc	  test	  or	  a	  Kruskal-­‐Wallis	  Test	  coupled	  with	  Dunn’s	  multiple	  
comparison	  test	  were	  performed	  as	  appropriate.	  	  	  
	  
A	  non-­‐parametric	   Spearman’s	   rank	   correlation	   coefficient	  was	  determined	   for	  










3.1)	  Characterisation	  Data	  
	  
The	  EdU	  label	  was	  characterised	  in	  an	  in	  vivo	  animal	  model	  using	  male	  Sprague	  Dawley	  
rats.	  EdU-­‐labelled	  cells	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus	  were	  counted	  in	  2	  -­‐	  6	  
x	   40	   μm	   sections	   of	   the	   rat	   brain.	   The	   data	   were	   found	   to	   be	   non-­‐parametrically	  
distributed.	   	  The	  Kruskal-­‐Wallis	   test	   revealed	   there	  were	  no	  significant	  differences	   in	  
the	  number	  of	  cell–type	  specific	  labelled	  cells	  of	  the	  5	  rats	  injected	  on	  PND	  60	  or	  the	  5	  












Figure	   13.	   Total	   number	  of	   cells	   co-­‐labelled	  with	   EdU/GFAP,	   EdU/NeuN	  or	  
EdU/DCX	  in	  the	  dentate	  gyrus	  of	  the	  dorsal	  hippocampus	  of	  Sprague	  Dawley	  
rats	  injected	  with	  EdU	  at	  (a)	  PND	  60	  or	  (b)	  PND	  94/95	  and	  perfused	  on	  PND	  
74	   or	   94/95.	   Please	   note	   that	   this	   study’s	   “total”	   refers	   to	   the	   total	   cells	  
counted	   and	   summed	   per	   rat.	   The	   above	   data	   were	   tested	   using	   the	  
Shapiro-­‐Wilk	  normality	  test	  and	  found	  to	  be	  non-­‐parametrically	  distributed.	  	  
The	  data	  were	  therefore	  analyzed	  using	  the	  Kruskal-­‐Wallis	  test.	  	  Data	  points	  
represent	  the	  number	  of	  counted	  cells	   labelled	  with	  EdU/GFAP,	  EdU/NeuN	  
or	   EdU/DCX	   in	   the	   dentate	   gyrus	   summed	   per	   section	   (40	   μm)	   of	   the	   rat	  
brain	   (2-­‐6	  sections	  per	  rat).	  Results	  are	  expressed	  as	   individual	  data	  points	  
with	   bars	   representing	   median	   and	   inter-­‐quartile	   range.	   There	   were	   no	  
significant	   differences	   in	   the	   number	   of	   EdU	   co-­‐labelled	   cells	   between	   the	  
different	  cell	  types.	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The	  average	  number	  of	  co-­‐labelled	  cells	  (averages	  of	  2	  -­‐	  6	  sections	  of	  dentate	  gyrus	  per	  
rat)	  was	  calculated.	  Examining	  only	  the	  EdU	   label	   the	  two	   injection	  time	  points	  were	  
compared	  using	  a	  Mann-­‐Whitney	  U	  test.	  The	  median	  of	  PND	  60	  injections	  was	  higher	  
than	  PND	  96	   injections.	   There	  was	  a	  difference	  between	  EdU-­‐labelled	   cell	   counts	  14	  
days	   after	   injection	   of	   EdU	   compared	   to	   4	   hours	   after	   injection	   (Figure	   14).	   This	  
suggested	  that	  injections	  of	  EdU	  given	  four	  hours	  prior	  to	  perfusion	  labelled	  fewer	  cells	  






Figure	   14.	   Columns	   represent	   the	   median	   and	   bars	   the	   upper-­‐quartile	  
range	  of	  the	  average	  number	  of	  EdU-­‐labelled	  cells	  found	  in	  each	  exercised	  
rat	   per	   injection	   group	   (n=5).	   Injections	   administered	   on	   PND	   60	   had	   a	  
significantly	  higher	  median	  (6.16	  cells)	  than	  PND	  96	  injections	  (1.1	  cells).	  	  
	  
The	  average	  number	  of	  counted	  co-­‐labelled	  cells	  (averages	  of	  2-­‐6	  sections	  of	  dentate	  
gyrus	   per	   rat)	   was	   used	   to	   compare	   cell	   phenotypes	   using	   a	   one-­‐way	   ANOVA	   and	  
Kruskal-­‐Wallis	   test.	   No	   significant	   differences	   were	   observed	   (Figure	   15).	   The	   two	  
injection	   time	   points	   were	   compared	   using	   this	   data.	   The	   average	   number	   of	   co-­‐
labelled	   cells	   per	   cell-­‐type	   specific	   marker	   was	   compared	   using	   a	   Mann-­‐Whitney	   U	  
test.	  The	  Medians	  per	  rat	  that	  received	  an	  injection	  on	  PND	  60	  were	  GFAP	  7;	  NeuN	  7;	  
DCX	  7	  and	  unknown	  cell	  types	  3	  (Figure	  3.1.3a).	  The	  Medians	  of	  rats	  injected	  on	  PND	  
96	  were	  GFAP	  0;	  NeuN	  0;	  DCX	  2	   and	  unknown	   cell	   types	   1.There	  was	  no	  difference	  
between	  EdU-­‐labelled	   cell	   types	  14	  days	  after	   injection	  of	  EdU	  compared	   to	  4	  hours	  
after	  injection	  (Figure	  15).	  	  
	  




Figure	   15.	   Average	   number	   of	   cells	   per	   rat	   co-­‐labelled	   with	   EdU/GFAP,	   EdU/NeuN	   or	  
EdU/DCX	  in	  the	  dorsal	  hippocampus	  of	  Sprague	  Dawley	  rats	  injected	  with	  EdU	  at	  (a)	  PND	  60	  
or	   (b)	   PND	   96.	   The	   above	   data	  were	   tested	   using	   the	   Shapiro-­‐Wilk	   test	   and	   found	   to	   be	  
parametrically	   distributed	   (15a)	   and	   non-­‐parametrically	   distributed	   (15b).	   The	   data	   were	  
therefore	  tested	  for	  differences	  between	  rats	  injected	  with	  EdU	  at	  (a)	  PND	  60	  using	  a	  one-­‐
way	  analysis	  of	  variance	  and	  (b)	  PND	  96	  using	  the	  Kruskal-­‐Wallis	  test.	  Data	  points	  represent	  
the	  average	  number	  of	  cells	  labelled	  with	  EdU/GFAP,	  EdU/NeuN	  or	  EdU/DCX	  in	  the	  dentate	  
gyrus	   summed	   (per	   40	   μm	   section	   of	   the	   rat	   brain	   2-­‐6	   sections	   were	   averaged	   per	   rat).	  
Results	   are	   expressed	   as	   individual	   data	   points	  with	   bars	   representing	  median	   and	   inter-­‐
quartile	  range.	  There	  were	  no	  significant	  differences	  in	  the	  number	  of	  EdU	  co-­‐labelled	  cells	  
between	  the	  different	  cell	  type	  markers.	  The	  data	  were	  also	  tested	  for	  differences	  between	  
rats	  injected	  with	  EdU	  at	  (a)	  PND	  60	  and	  (b)	  PND	  96	  using	  the	  Mann-­‐Whitney	  U	  test.	  There	  
were	  no	  significant	  differences	  in	  the	  number	  of	  EdU	  co-­‐labelled	  cells	  between	  PND	  60	  and	  
PND	  96	  for	  the	  different	  cell	  type	  markers.	  
	  
	  






The	   study	   sought	   to	   identify	   differences	   in	   neurogenesis	   thus	   NeuN	   and	   DCX	   co-­‐
labelled	   cells	  were	  pooled	   in	   rats	   injected	  on	  PND	  60	  and	   those	   injected	  on	  PND	  96	  
(Figure	   16).	   There	   was	   a	   marked	   difference	   in	   the	   total	   and	   average	   number	   of	  
EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  cells	  in	  the	  dentate	  gyrus	  of	  rats	  injected	  with	  EdU	  
at	  PND	  60	  and	  those	  injected	  on	  PND	  96	  (Mann-­‐Whitney	  U	  test).	  This	  suggested	  that	  
injections	  of	  EdU	  given	  four	  hours	  prior	  to	  perfusion	  labelled	  fewer	  neurons	  than	  those	  








Figure	   16.	   Total	   (a)	   and	   average	   (b)	   number	   of	   EdU/NeuN	   plus	   EdU/DCX	   co-­‐labelled	   cells	   in	   the	   dentate	  
gyrus	   of	   rats	   injected	  with	   EdU	   at	   PND	   60	   and	   those	   injected	   on	   PND	   96.	   Data	   points	   (a)	   represent	   the	  
number	  of	  cells	   labelled	  with	  EdU/NeuN	  and	  EdU/DCX	  in	  the	  dentate	  gyrus	  summed	  per	  40-­‐μm	  section	  of	  
the	   rat	   brain	   (2-­‐6	   sections	   per	   rat).	   	   Data	   points	   (b)	   represent	   the	   average	   number	   of	   EdU/NeuN	   and	  
EdU/DCX	  co-­‐labelled	  cells	  in	  2-­‐6	  x	  40-­‐μm	  sections	  of	  the	  dentate	  gyrus	  of	  the	  dorsal	  hippocampus	  of	  PND	  60	  
and	   PND	   96	   EdU-­‐injected	   rats.	   The	   data	   were	   tested	   using	   the	   Shapiro-­‐Wilk	   test	   and	   found	   to	   be	   non-­‐
parametrically	   distributed.	   The	   Mann-­‐Whitney	   U	   test	   revealed	   that	   the	   dentate	   gyrus	   of	   the	   dorsal	  
hippocampus	  of	  the	  PND	  60	  EdU-­‐injected	  rats	  had	  a	  greater	  number	  of	  EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  
cells	   than	   PND	   96	   EdU-­‐injected	   rats	   (a,b).	   Results	   are	   expressed	   as	   median	   and	   interquartile	   range.	  
*Significant	  difference	  between	  NeuN	  +	  DCX	  60	  and	  NeuN	  +	  DCX	  96	  median	  values.	  	  
	  
The	  results	  obtained	   from	  the	   rats	   injected	  with	  EdU	  on	  PND	  74,	   four	  hours	  prior	   to	  
transcardial	   perfusion	   showed	   no	   significant	   difference	   between	   exercised	   and	   non-­‐
exercised	  rats	  in	  any	  of	  the	  cell-­‐type	  specific	  markers	  (Mann-­‐Whitney	  U	  test,	  Figure	  a	  
low	   level	   of	   EdU	   labelling	  was	  observed	   in	   both	   exercised	   and	  non-­‐exercised	   groups	  
with	   no	   significant	   difference	   between	   the	   different	   cell	   types	   within	   each	   group	  
(Kruskal-­‐Wallis	  test,	  Figure	  17).	  Despite	  voluntary	  wheel	  running	  for	  20	  days	  the	  total	  
number	   of	   EdU/GFAP,	   EdU/NeuN	   and	   EdU/DCX	   co-­‐labelled	   cells	   in	   2	   -­‐	   6	   sections	   of	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dorsal	  hippocampus	  per	  exercised	  rat	  had	  a	  median	  value	  of	  0	  when	  injected	  with	  EdU	  









Figure	  17.	  Total	  number	  of	  EdU/GFAP,	  EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  cells	  in	  4-­‐6	  
sections	  of	  dentate	  gyrus	  in	  the	  dorsal	  hippocampus	  of	  rats	  that	  were	  housed	  in	  cages	  
with	   attached	   running	   wheels	   that	   were	   freely	   moving	   (a)	   or	   immobilized	   (b)	   for	   a	  
period	  of	  20	  days	  and	  then	  injected	  with	  EdU	  at	  PND74,	  4	  hours	  prior	  to	  perfusion	  and	  
collection	   of	   brains	   for	   immunohistochemistry.	   Data	   points	   represent	   the	   summed	  
number	   of	   EdU-­‐co-­‐labelled	   cells	   in	   2-­‐6	   x	   40-­‐μm	   sections	   of	   the	   dentate	   gyrus	   of	   3	  
exercised	  rats	  permitted	  to	  run	  for	  20	  days	  (a)	  and	  3	  non-­‐exercised	  rats	  (b).	  The	  bars	  
represent	  the	  median	  and	  interquartile	  range.	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Similarly,	   a	   Mann-­‐Whitney	   U	   test	   comparing	   the	   average	   number	   of	   EdU/GFAP,	  
EdU/NeuN	   and	   EdU/DCX	   co-­‐labelled	   cells	   in	   2-­‐6	   sections	   of	   dentate	   gyrus	   in	   dorsal	  
hippocampus	  revealed	  no	  significant	  difference	  between	  exercised	  and	  non-­‐exercised	  
rats	  in	  any	  of	  the	  cell-­‐type	  specific	  markers	  (Figure	  18).	  The	  Kruskal-­‐Wallis	  test	  revealed	  





Figure	  18.	  Average	  number	  of	  EdU/GFAP,	  EdU/NeuN	  and	  EdU/DCX	  co-­‐labelled	  
cells	  in	  2-­‐6	  sections	  of	  dentate	  gyrus	  in	  dorsal	  hippocampus	  of	  rats	  that	  were	  
housed	  in	  cages	  with	  attached	  running	  wheels	  that	  were	  freely	  moving	  (a)	  or	  
immobilized	  (b)	  for	  a	  period	  of	  20	  days	  and	  then	  injected	  with	  EdU	  at	  PND74,	  
4	  hours	  prior	  to	  perfusion	  and	  collection	  of	  brains	  for	  immunohistochemistry.	  
Data	  points	   represent	   the	  average	  number	  of	  EdU-­‐co-­‐labelled	  cells	   in	  40-­‐μm	  
sections	  of	  the	  dentate	  gyrus	  (4-­‐6	  x	  40-­‐μm	  sections	  of	  the	  brain)	  of	  3	  exercised	  
rats	   permitted	   to	   run	   for	   20	   days	   (a)	   and	   3	   non-­‐exercised	   rats	   (b).	   The	   bars	  
represent	  the	  median	  and	  interquartile	  range.	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Characterisation	  of	  EdU	  stain	  in	  conjunction	  with	  cell-­‐type	  specific	  markers	  
	  
Three	   sections	   taken	   from	   one	   experimental	   rat	   showed	   that	   Ki-­‐67	   labelled	   EdU	  
stained	  cells	  throughout	  the	  dentate	  gyrus	  (Figure	  19).	  	  These	  sections	  were	  also	  used	  
to	   determine	   concentrations	   of	   reagents	   required	   for	   optimal	   EdU,	   DCX,	   NeuN	   and	  
GFAP	   staining	   (See	   methods	   Table	   2,3	   for	   further	   details).	   It	   was	   shown	   that	   Ki-­‐67	  
labelled	   the	   same	  cells	   as	   an	  EdU	  pulse.	   It	  did	  not	  address	   the	  question	  of	  neuronal	  
survival,	   but	   could	   be	   used	   to	   effectively	   label	  mitotically	   active	   cells	   at	   the	   time	   of	  
perfusion.	  Thus	  EdU	  was	  used	  to	  measure	  neuronal	  survival	  after	  14	  days	  and	  Ki-­‐67	  at	  
the	  end	  point	  of	   the	  experiment	  at	   the	  time	  of	  perfusion.	  This	  would	  provide	   insight	  




Figure	  19.	  Ki67	  and	  a	  pulse	  of	  EdU	  labelled	  the	  same	  cells	  in	  the	  dentate	  gyrus	  of	  
the	  hippocampus	  of	  a	  rat	  injected	  with	  EdU	  on	  PND	  60	  (A)	  Ki-­‐67	  labelled	  cells,	  (B)	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3.2)	  Experimental	  Results	  
	  
Once	  the	  novel	  marker	  EdU	  was	  characterised	  with	  co-­‐labels	  the	  rats	  were	  separated	  
into	   four	   experimental	   groups.	   Two	   groups	   were	   used	   investigate	   the	   effect	   of	   MS	  
relative	  to	  NMS	  rats	  and	  the	  other	  two	  groups	  sought	  to	  explore	  the	  effect	  of	  exercise	  
in	  the	  hippocampus	  MS+R	  and	  NMS+R.	  
	  
	  
	  MS	  higher	  Weights	  at	  PND	  60	  relative	  to	  NMS	  
	  
	  Weights	  of	  each	  treatment	  group	  were	  measured	  and	  the	  data’s	  distribution	  was	  found	  
to	   be	   non-­‐parametric.	   A	   Kruskal-­‐Wallis	   test	   showed	   that	   the	   medians	   of	   the	   body	  
weights	  were	  different	  and	  a	  Dunn’s	  multiple	  comparison	  test	  showed	  MS+NR	  rats	  had	  a	  






Figure	   20.	   Graph	   showing	   the	   weights	   of	   maternally	   separated	   runners	   (MS+R),	  
maternally	  separated	  non-­‐runners	  (MS+NR),	  non-­‐separated	  runners	  (NMS+R)	  and	  non-­‐
separated	  non-­‐runners.	  A	  Kruskal-­‐	  Wallis	  test	  followed	  by	  Dunn’s	  multiple	  comparison	  
Test	  showed	  that	  MS+NR	  rats	  had	  a	  higher	  median	  then	  NMS+R	  rats.	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  A	  Wilcoxon	  matched-­‐pairs	   signed	   rank	   test	   showed	  a	   significant	  difference	  between	  
the	  medians	  of	  distances	   travelled	  by	  MS	  and	  NMS	   rat	   groups	  per	  day.	   The	  MS	   rats	  
showed	   a	   significantly	   lower	   median	   than	   NMS.	   The	   non-­‐runners	   data	   is	   not	  
represented	  on	  the	  graph	  as	  these	  rats	  did	  not	  exercise	  (Figure	  21).	  
	   	  
Figure	   21.Distance	  run	   from	  PND	  54-­‐74.	  The	  data	  were	   found	  to	  be	  non-­‐parametric.	  The	   line	  
graph	   showing	   the	  median	  and	   interquartile	   range	  of	   the	  distances	   run	  by	  MS	  and	  NMS	   rats	  
over	  20	  days	  of	  voluntary	  wheel	  running.	  A	  Wilcoxon	  matched-­‐pairs	  signed	  rank	  test	  revealed	  
that	  NMS+R	  had	  a	  significantly	  higher	  median	  than	  MS+R	  (W=	  128.0;	  p=	  0.0153).	  
	  
No	   Effect	   of	   maternal	   separation	   and	   exercise	   on	   the	   number	   of	   EdU-­‐labelled	  
mature	  neurons	  and	  astrocytes	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus.	  	  
	  
The	   number	   of	   co-­‐labelled	   EdU/NeuN	   and	   EdU/GFAP	   cells	   in	   the	   dentate	   gyrus	   of	  
MS+R,	  MS+NR,	  NMS+R	   and	  NMS+NR	  were	   compared	   (Figure	   22).	   The	   Kruskal-­‐Wallis	  
test	  revealed	  that	  there	  were	  no	  significant	  differences	  between	  treatment	  groups	  in	  








Figure	  22.	  The	  number	  of	  co-­‐labelled	  EdU/NeuN	  cells	  (ai,	  aii)	  and	  EdU/GFAP	  cells	  (bi,	  bii)	   in	  the	  
dentate	   gyrus	   of	   the	   dorsal	   hippocampus	   (5	   x	   40-­‐μm	   sections)	   (ai,	   bi)	   and	   the	   ventral	  
hippocampus	   (5	   x	   50-­‐μm	   sections)	   (aii,	   bii)	   of	   maternally	   separated	   runners	   (MS+R,	   n	   =	   4),	  
maternally	   separated	  non-­‐runners	   (MS+NR,	  n	  =	   5),	   non-­‐separated	   runners	   (NMS+R,	  n	  =	  5)	   and	  
non-­‐separated	  non-­‐runners	  (NMS+NR,	  n	  =	  5).	  The	  data	  were	  tested	  using	  the	  Shapiro-­‐Wilk	  test	  
and	   found	   to	  be	  non-­‐parametrically	  distributed.	  The	  Kruskal-­‐Wallis	   test	   revealed	  no	  significant	  







Number	   of	   Surviving	   EdU-­‐labelled	   Neurons	   compared	   to	   the	   number	   of	   EdU-­‐
labelled	  astrocytes.	  	  
	  
The	  data	  obtained	   from	  both	  exercised	  and	  non-­‐exercised	   rats	  were	  pooled	  and	   the	  
number	  of	  surviving	  astrocytes	  was	  compared	  to	  the	  number	  of	  neurons	  that	  survived	  
14	   days	   after	   injection	   of	   EdU,	   to	   establish	   if	   there	   was	   a	   dominant	   phenotype	  
expressed	  by	  newly	  generated	  cells.	  There	  was	  no	  significant	  difference	  between	  the	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number	  of	  neurons	  and	  astrocytes	  in	  the	  dorsal	  (a)	  or	  ventral	  (b)	  dentate	  gyrus	  of	  the	  
hippocampus	  as	  shown	  by	  the	  Mann-­‐Whitney	  U	  non-­‐parametric	  test	  (Figure	  23).	  
	  
	  
Figure	   23.	   The	   number	   of	   neurons	   relative	   to	   astrocytes	   in	   the	   a)	   dorsal	   and	   b)	   ventral	  
hippocampus.	   The	   data	   were	   tested	   using	   the	   Shapiro-­‐Wilk	   test	   and	   found	   to	   be	   non-­‐
parametrically	  distributed.	  The	  Mann-­‐Whitney	  U	  test	  revealed	  no	  significant	  difference	  between	  
the	  number	  of	  EdU/NeuN	  and	  EdU/GFAP	  co-­‐labelled	  cells	  in	  the	  dentate	  gyrus	  of	  the	  dorsal	  and	  
ventral	  hippocampus.	  Data	  points	  represent	  the	  summed	  number	  of	  NeuN	  and	  EdU	  co-­‐labelled	  
cells	  and	  GFAP	  and	  EdU	  co-­‐labelled	  cells	  counted	  in	  5	  sections	  of	  dentate	  gyrus	  in	  the	  dorsal	  (40-­‐
μm	  sections)	  (a)	  and	  ventral	  (50-­‐μm	  sections)	  (b)	  dentate	  gyrus	  of	  the	  hippocampus	  of	  each	  rat	  
(n=	  18).	  Bars	  show	  median	  and	  inter-­‐quartile	  range.	  	  
	  
The	  dorsal	  and	  ventral	  GFAP	  and	  NeuN	  data	  was	   found	   to	  be	  non-­‐parametric.	  There	  
was	   a	   significant	   correlation	   between	   the	   number	   of	   EdU/NeuN	   co-­‐labelled	   cells	  
(neurons)	   and	   EdU/GFAP	   co-­‐labelled	   cells	   (astrocytes)	   that	   survived	   14	   days	   after	  
injection	   of	   EdU	   (Spearman	   r	   correlation)	   in	   the	   ventral	   hippocampus	   but	   not	   the	  
dorsal	  hippocampus	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  Figure	  24.	  Correlation	  analysis	  of	  the	  number	  of	  neurons	  relative	  to	  
astrocytes	  in	  the	  a)	  dorsal	  and	  b)	  ventral	  hippocampus.	  There	  was	  no	  
significant	  correlation	  between	  EdU/GFAP	  co-­‐labelled	  astrocytes	  and	  
EdU/NeuN	   co-­‐labelled	   neurons	   in	   the	   dentate	   gyrus	   of	   the	   dorsal	  
hippocampus	   of	   all	   rat	   groups	   (a).	   There	   was	   a	   significant	   positive	  
correlation	  between	  EdU/GFAP	  co-­‐labelled	  astrocytes	  and	  EdU/NeuN	  
co-­‐labelled	  neurons	  in	  the	  dentate	  gyrus	  of	  the	  ventral	  hippocampus	  
of	   rats	   allowed	   to	   exercise	   for	   20	   days	   as	   well	   as	   rats	   that	   were	  
housed	   in	   cages	   with	   immobilized	   running	   wheels,	   14	   days	   after	  
injection	  of	  EdU	  (Spearman	  r	  correlation	  0.9006;	  n=	  18).	  	  
	  
	  
	  No	  Effect	  of	  maternal	  separation	  and	  exercise	  on	  the	  number	  of	  surviving	  immature	  EdU-­‐
labelled	  neurons	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus.	  
	  
There	  was	  no	  significant	  difference	  in	  the	  number	  of	  EdU/DCX	  co-­‐labelled	  (immature)	  
neurons	  between	  treatment	  groups	  (maternally	  separated	  and	  non-­‐separated	  rats	  that	  
were	  allowed	  to	  exercise	  or	  not).	  Data	  were	  analyzed	  using	  a	  Kruskal-­‐Wallis	   test	  and	  
no	  significant	  differences	  were	  found.	  There	  was	  a	  low	  level	  of	  labelling	  and	  many	  rat	  
brain	  sections	  displayed	  no	  EdU/DCX	  co-­‐labelled	  cells	  (Figure	  25).	  	  
	  
	  







Figure	   25.	  Effect	  of	  maternal	  separation	  and	  exercise	  on	  the	  number	  of	  surviving	   immature	  
EdU-­‐labelled	  neurons	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus.	  The	  data	  points	  represent	  the	  
number	  of	  co-­‐labelled	  EdU/DCX	  cells	  in	  the	  dorsal	  (40-­‐μm	  sections)	  a)	  and	  the	  ventral	  (50-­‐μm	  
sections)	  b)	  dentate	  gyrus	  (total	  number	  of	  EdU/DCX	  co-­‐labelled	  cells	  in	  5	  sections	  of	  the	  left	  
and	  right	  hippocampus	  of	  rats	  in	  the	  four	  treatment	  groups).	  The	  data	  were	  tested	  using	  the	  
Shapiro-­‐Wilk	   test	   and	   found	   to	   be	   non-­‐parametrically	   distributed.	   The	   Kruskal-­‐Wallis	   test	  
revealed	   that	   there	   were	   no	   significant	   differences	   between	   the	   treatment	   groups.	   	   Bars	  
represent	  the	  median	  and	  inter-­‐quartile	  range	  of	  each	  data	  set.	  
	  
	  
	  	  Neuronal	  proliferation	  reduced	  in	  maternally	  separated	  (MS)	  rats	  
	  
Confocal	  microscope	  tile	  scans	  (10	  X)	  of	  the	  dentate	  gyrus	  (Scan	  A)	  showed	  that	  there	  
were	  more	  proliferating	  neurons	   in	  NMS+R	   rats	   (Scan	  A)	   than	  MS+R	   rats	   (Scan	  B)	  as	  
indicated	  by	  the	  arrows	  indicating	  yellow	  fluorescence	  representing	  Ki-­‐67	  labelled	  cells	  
(Kruskal-­‐Wallis	  test,	  P	  <	  0.05,	  Figure	  26).	  The	  qualitative	  Scan	  C	  (20	  X)	  shows	  a	  sample	  
section	  of	  half	  the	  dentate	  gyrus.	  	  The	  red	  represents	  DCX-­‐labelled	  immature	  neurons,	  
blue	  represents	  Hoechst	  stained	  nuclei	  and	  yellow	  is	  the	  Ki-­‐67	  marker.	  These	  markers	  
were	  used	  to	  identify	  immature	  neurons	  and	  count	  them	  to	  quantify	  and	  compare	  rat	  
treatment	  group.	  The	  data	  were	  tested	  using	  the	  Shapiro-­‐Wilk	  test	  and	  was	  found	  to	  
be	  parametric	  (Figure	  26a)	  and	  data	  were	  tested	  using	  a	  one	  way	  ANOVA	  and	  a	  Tukey	  
post-­‐hoc	   test	   to	   identify	   group	   differences.	   The	   data	   from	   Figure	   26b	   were	   non-­‐
parametrically	  distributed	  and	  tested	  for	  differences	  using	  the	  Kruskal-­‐Wallis	  test	  and	  
Dunn’s	   post-­‐hoc	   test	   for	   group	   differences.	   The	   ANOVA	   revealed	   that	   there	   was	   a	  
significant	   difference	  between	   the	  number	  of	   non-­‐EdU	   labeled	   cells	   and	   counted	  Ki-­‐
67/DCX	   co-­‐labelled	   cells	   in	   the	   different	   treatment	   groups.	   The	   Tukey	   post-­‐hoc	   test	  
revealed	  that	  the	  number	  of	  Ki-­‐67/DCX	  co-­‐labelled	  cells	  was	  significantly	  decreased	  in	  
the	  MS+R	   rats	   compared	   to	   the	  NMS+R	   group	   of	   rats.	   The	  NMS+R	   group	   had	  more	  
proliferating	   neurons	   than	   the	  NMS+NR	   group	   of	   rats	   (Figure	   26a,	   26b).	   The	   ventral	  
hippocampus	   followed	   the	   same	   pattern	   with	   the	   MS+R	   group	   having	   significantly	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lower	  median	  number	  of	  Ki-­‐67/DCX	  co-­‐labelled	  cells	  than	  the	  NMS+R	  group	  (Kruskal-­‐
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Figure	  26.	  Confocal	  tile	  scan	  (10	  X)	  showing	  the	  dentate	  gyrus	  of	  the	  hippocampus	  of	  a	  NMS+R	  rat	  (A)	  and	  a	  
MS+R	  rat	  (B).	  The	  arrows	  indicate	  yellow	  fluorescence	  representing	  Ki-­‐67	  labelled	  cells.	  There	  are	  more	  Ki-­‐67	  
labelled	  cells	   in	  the	  NMS	  rat	  than	  MS	  rats	  that	  underwent	  the	  same	  exercise	  regime.	  Scan	  C	  (20	  X)	  red	  (II)	  
representing	  the	  dorsal	  hippocampus	  shows	  DCX-­‐labelled	  immature	  neurons,	  blue	  represents	  a	  Hoechst	  (I)	  
and	  yellow	  (III)	   is	  Ki-­‐67	  marker	  while	  D	  (40	  x)	  displays	  the	  yellow	  nuclear	  stain	  surrounded	  by	  cytoplasmic	  
DCX	  stain	  giving	  an	  example	  of	  the	  typical	  unipolar	  neuronal	  structure.	   	  The	  above	  data	  were	  tested	  using	  
the	  Shapiro-­‐Wilk	  test	  and	  a)	  was	  found	  to	  be	  parametric.	  The	  data	  were	  tested	  using	  a	  one-­‐way	  ANOVA	  and	  
a	  Tukey	  post-­‐hoc	  test	  to	  identify	  group	  differences.	  The	  data	  from	  b)	  were	  found	  to	  be	  non-­‐parametrically	  
distributed	  and	  were	  tested	  for	  differences	  using	  the	  Kruskal-­‐Wallis	  test.	  Data	  points	  in	  (a)	  and	  (b)	  represent	  
the	  summed	  number	  of	  Ki-­‐67/DCX	  labelled	  cells	  in	  5	  sections	  of	  the	  dorsal	  (40-­‐μm	  sections)	  (a)	  and	  ventral	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(50-­‐μm	   sections)	   (b)	   dentate	   gyrus.	   The	   bars	   in	   (a)	   represent	   the	  mean	   and	   standard	   deviations	   of	   each	  
group	   and	   (b)	  medians	   and	   interquartile	   ranges.	   A	   one-­‐way	   ANOVA	   	   (a)	   revealed	   a	   significant	   difference	  
between	   groups,	   and	   a	   Tukey	   post-­‐hoc	   test	   showed	   that	   proliferating	   immature	   neurons	   in	   the	   dorsal	  
hippocampus	   are	   significantly	   decreased	   in	   four	   MS+R	   rats	   compared	   to	   five	   NMS+R	   rats.	   The	   same	  
difference	   was	   found	   in	   the	   ventral	   hippocampus	   (by	   using	   the	   Kruskal-­‐Wallis	   test	   and	   Dunn’s	   multiple	  
comparison	  Test.	  The	  NMS+R	  group	  in	  (a)	  had	  significantly	  higher	  number	  of	  proliferating	  neurons	  relative	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4.1.)	  Pilot	  Study:	  Characterising	  the	  mitotic	  marker,	  EdU	  	  
	  	  
The	  purpose	  of	  the	  pilot	  study	  was	  to	  characterise	  the	  use	  of	  the	  thymidine	  analogue,	  
EdU	  to	  measure	  neurogenesis	  in	  Sprague	  Dawley	  rat	  brains.	  This	  novel	  mitotic	  marker	  
is	   reportedly	   superior	   to	   its	   counter-­‐part	   BrdU	   as	   it	   is	   a	  more	   sensitive	  marker	  with	  
lower	  toxicity	  in	  animals.	  This	  makes	  it	  the	  ideal	  marker	  to	  be	  used	  in	  vivo	  to	  quantify	  
neurogenesis	  in	  a	  rat	  model	  for	  depression.	  Therefore	  our	  study	  undertook	  to	  establish	  
the	  novel	  technique	  to	  measure	  neurogenesis	  in	  an	  MS	  model	  for	  depression	  primarily	  
by	   optimizing	   EdU	   immunohistochemistry	   and	   thereafter	   establishing	   a	   method	   to	  
quantify	   this	  with	   the	   co-­‐labels	   Ki-­‐67,	   NeuN,	   DCX	   and	  GFAP.	   It	   should	   be	   noted	   the	  
effect	   of	   exercise	  was	  not	   analyzed	   as	   a	   behavioural	   treatment	   in	   this	   aspect	   of	   the	  
pilot	   study.	   Exercise	  was	   used	   to	   up-­‐regulate	   neurogenesis	   and	   enhance	   the	   study’s	  
ability	  to	  identify	  mitotic	  activity.	  Therefore	  all	  rats	  in	  this	  objective	  of	  this	  study	  were	  
housed	  with	   running	  wheels	  excluding	   three	   rats	   involved	   in	  a	  validation	  experiment	  
comparing	  run	  and	  non-­‐run	  rats	  which	  were	  housed	  with	  locked	  wheels.	  
	  
No	  Discernable	  effect	  of	  exercise	  in	  PND	  74	  injected	  rat	  cohort	  
	  
A	  small	  study	  to	  compare	  the	  effect	  of	  exercise	  in	  PND	  74	  injected	  (and	  perfused)	  rats	  
was	   conducted	   (Chapter	   3	   Figure	   17	   and	   18).	   There	   was	   no	   discernable	   difference	  
between	   rats	   that	   were	   exercised	   and	   sedentary	   rats.	   All	   group	  medians	   were	   lower	  
than	   2	   cells	   per	   40µm	   section.	   Exercise	   is	   reported	   to	   up-­‐regulate	   mitotic	   activity	   in	  
neurons	   and	   glia	   in	   the	   dentate	   gyrus	   of	   rodents	   (van	   Praag	  et	   al.,	   2002;	   Pusic	  et	   al.,	  
2014)	  and	  thus	  our	  rats	  were	  housed	  in	  cages	  with	  running	  wheels	  for	  two	  weeks	  (PND	  
74)	  or	  in	  cages	  with	  locked	  wheels.	  	  	  
	  
The	   literature	  reports	  that	  mice	  housed	  with	  adjoined	  running	  wheels	  have	  a	  range	  of	  
mitotically	   active	   hippocampal	   cells	   between	   approximately	   600	   -­‐	   1600	   (as	  measured	  
with	  EdU)	  (Zeng	  et	  al.,	  2010).	  Castilla	  Ortega	  (2014)	  found	  that	  approximately	  220	  BrdU-­‐
positive	   cells	   were	   present	   in	   mice	   after	   24	   days	   of	   exercise.	   Gregorie	   et	   al.,	   (2014)	  
found	  approximately	  1600	  mitotically	  active	  cells	  present	   in	   the	  dentate	  gyrus	  of	  mice	  
after	  four	  weeks	  of	  wheel	  running.	  	  An	  older	  study	  by	  Steiner	  et	  al.	  (2004)	  showed	  that	  
wheel	   running	   increased	   neurogenesis	   significantly	   increasing	   both	   BrdU/NeuN	   (1000	  
vs.	  3000	  cells	   in	   the	  DG)	  and	  BrdU/GFAP	  cells	   (150	  vs.	  450	  cells	   in	   the	  DG).	  Our	  study	  
was	  conducted	  in	  rats,	  and	  the	  literature	  reports	  a	  similar	  effect	  of	  exercise	  as	  seen	  in	  
mice.	  Long	  Evans	  rats	  housed	  with	  running	  wheels	  for	  6	  -­‐	  11	  weeks	  had	  1600	  DCX	  cells	  
per	  DG	   in	   runners	  and	  1225	   in	  non-­‐runners	   (Winocur	  et	  al.,	  2014).	   In	  agreement	  with	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the	  above	  literature	  Speisman	  et	  al.,	  (2013)	  found	  that	  non-­‐runner	  rats	  had	  significantly	  
fewer	  BrdU	  labelled	  cells	  per	  dentate	  gyrus	  (1600)	  as	  compared	  to	  runners	  (2300	  BrdU	  
positive	  cells).	  Thus	  their	  finding	  was	  that	  voluntary	  exercise	  increased	  neurogenesis	  in	  
rats.	  	  We	  did	  not	  find	  this,	  possibly	  due	  to	  low	  levels	  of	  label	  detection.	  
	  
EdU-­‐labelled	  neuronal	   (EdU/DCX+EdU/NeuN)	  cell	   survival	  was	  higher	   in	  PND	  60	   injected	  	  	  	  
and	  exercised	  rats	  in	  the	  dentate	  gyrus	  	  
	  
After	   just	   under	   three	  weeks	  of	   exercise,	   there	  were	   significantly	  more	  EdU-­‐labelled	  
cells	  present	  in	  the	  dentate	  gyrus	  of	  rats	  when	  injected	  with	  EdU	  at	  PND	  60	  (Figure	  14)	  
compared	  to	  those	  cells	  present	  in	  the	  dentate	  gyrus	  of	  rats	  injected	  4	  hours	  prior	  to	  
perfusion	  on	  PND	  96.	  Studies	  have	  reported	  EdU-­‐labelled	  cell	  survival	  at	  separate	  time	  
points	  but	  few	  directly	  compared	  different	  injection	  time	  points	  in	  rat	  or	  mice	  models	  
(Zeng	  et	  al.,	  2010;	  Steiner	  et	  al.,	  2004).	  	  
	  
When	   to	   inject	   EdU	   for	   detection	   of	   EdU	   in	   exercised	   mice	   has	   been	   previously	  
explored	   and	   addressed	   by	   Zeng	  et	   al.	   (2010).	   Zeng	   and	   his	   colleagues	   found	   that	   a	  
delay	   of	   4	   hours	   rendered	   a	   significantly	   higher	   EdU	   labelling	   of	   dentate	   gyrus	   cells	  
(1600	   EdU	   labelled	   cells	   per	   mouse	   brain)	   compared	   to	   a	   100	   mg/kg	   injection	  
administered	  30	  days	  prior	   to	  perfusion	   (mean	  of	   632	  ±	  64	  EdU	   labelled	   cells	   in	   the	  
entire	  hippocampus).	  The	   reason	   for	  EdU-­‐labelled	  cell	   values	  being	   lower	   than	   those	  
seen	  in	  the	  literature	  can	  partly	  be	  attributed	  to	  the	  study	  being	  conducted	  in	  mice.	  A	  
similar	   study	   conducted	   in	  mice	   by	   Castella-­‐Ortega	   et	   al.	   (2014)	   showed	   that	   in	   the	  
entire	   hippocampus	   of	   an	   exercised	   mouse	   there	   were	   approximately	   200	   cells	  
labelled	   by	   BrdU	   (which	   is	   comparable	   to	   EdU).	   The	   higher	   values	   are	   further	  
supported	   by	   a	   study	   examining	   adult	   mice	   exercised	   in	   a	   wheel	   for	   4	   weeks	   that	  
estimated	  there	  were	  6000	   immature	  NeuroD	   labelled-­‐neuoblasts	  per	  dentate	  gyrus.	  
Mice	  are	  notably	  smaller	  than	  rats	  and	  subsequently	  may	  require	  less	  EdU	  to	  label	  all	  
mitotically	  active	  cells.	  In	  contrast	  when	  using	  the	  common	  BrdU	  injection	  at	  the	  same	  
dosage	   (50mg/kg)	   in	   mice,	   Steiner	   et	   al.	   (2004)	   showed	   that	   a	   lower	   number	   of	  
labelled	  cells	   (100	  BrdU	  positive	  cells	  per	  mouse	  dentate	  gyrus)	  were	  rendered	  upon	  
injection	  after	  4	  hours	  relative	  to	  an	   injection	  and	  subsequent	  brain	  harvesting	  three	  
days	  later	  (700	  BrdU	  positive	  per	  mouse	  DG).	  In	  mice	  it	  was	  found	  that	  utilizing	  as	  little	  
as	  one	  day	  between	   injection	  and	  perfusion	   is	   effective	   (Chehrehasa	  et	  al.,	   2009).	  A	  
more	  recent	  study	  investigated	  the	  injection	  of	  pregnant	  dams	  with	  EdU	  on	  the	  same	  
day	   as	   tissue	   collection	   and	   found	   this	   to	   be	   effective	   (Bhansali	   et	   al.,	   2014).	   	   This	  
demonstrates	  the	  potent	  labelling	  ability	  of	  EdU	  over	  shorter	  periods	  of	  time	  in	  mice.	  
This	   contrasts	  with	  our	   study’s	   findings	   that	  did	  not	   find	   four	  hours	   to	  be	  optimal	   in	  
rats.	  In	  our	  study,	  we	  found	  that	  an	  EdU	  injection	  4	  hours	  prior	  to	  perfusion	  rendered	  a	  
lower	   level	  of	   labelled	   cells	   than	  14	  days	  prior	   to	  perfusion	   (Figure	  14).	   This	   finding,	  
though	  supported	  by	  Zeng	  et	  al.,	  (2010),	  warrants	  further	  exploration	  since	  the	  survival	  
time	  of	  EdU	   in	  vivo	   is	  not	  currently	  well	  explored	  in	  the	   literature	   involving	  rats.	  This	  
would	  be	  an	  ideal	  future	  avenue	  to	  explore	  in	  terms	  of	  optimization.	  
	  
In	  the	  current	  study	  the	  reason	  for	  such	  low	  level	  labelling	  on	  PND	  96	  may	  be	  due	  to	  
the	  insufficiency	  of	  a	  single	  EdU	  pulse	  to	  detect	  surviving	  neurons	  optimally.	  This	  could	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also	  suggest	  that	  BrdU	  and	  EdU	  take	  longer	  to	  cross	  the	  blood	  brain	  barrier	  in	  rats	  than	  
in	   mice.	   It	   is	   also	   possible	   that	   the	   dosage	   of	   EdU	   was	   not	   optimal	   for	   immediate	  
detection,	   however,	   50	   mg/kg	   appeared	   to	   be	   a	   functional	   dosage	   to	   permit	   the	  
quantification	  of	  cells.	  This	  aspect	  requires	  further	  research	  in	  order	  to	  fully	  optimise	  
the	  methodology.	  
	  
Another	   suggested	  method	   for	   optimisation	   is	   to	   increase	   the	   number	   of	   injections.	  
This	  was	   also	   explored	   in	  mice	   given	   three	   injections	   of	   50	  mg/kg	   of	   EdU.	   This	  was	  
found	   to	   effectively	   label	  mitotically	   active	   cells	   (Bonaguidi	   et	   al.,	   2008).	   Zeng	   at	   al.	  
(2010)	  used	  one	  200mg/kg	  injection	  to	  quantify	  the	  number	  of	  mitotically	  active	  cells	  
in	   mice	   that	   underwent	   voluntary	   wheel	   running,	   despite	   their	   standard	   curve	  
indicating	   that	   50	   mg/kg	   was	   optimal	   for	   mice.	   The	   majority	   of	   studies	   using	   rat-­‐
models	  also	  used	  multiple	  injections	  or	  a	  higher	  dosage	  of	  mitotic	  marker	  with	  as	  many	  
as	   five	   rounds	   of	   50	  mg/kg	  BrdU	   (which	   is	   thought	   to	   be	   comparable	   to	   EdU)	   being	  
administered	  per	  rat	  (Speisman	  et	  al.,	  2013).	  In	  the	  brains	  of	  male	  Sprague	  Dawley	  rats	  
forced	  to	  run	  for	  approximately	  1	  hour	  daily	  for	  3	  weeks	  there	  were	  2225	  BrdU/NeuN	  
labelled	  cells	  in	  the	  dentate	  gyrus	  after	  four	  days	  of	  50mg/kg	  twice	  daily	  (Jian-­‐feng	  et	  
al.,	  2014).	   	  A	  study	  by	  Chehrehasa	  et	  al.	   (2009)	  used	  only	  one	  50	  -­‐mg/kg	   injection	  of	  
EdU	  in	  a	  rat-­‐model	  but	  did	  not	  quantify	  cells	  and	  analyzed	  sections	  qualitatively.	  Thus	  
in	   order	   to	   	   	   better	   quantify	   labelled	   neurons	  more	   injections	   would	   potentially	   be	  
beneficial	  in	  order	  to	  optimally	  quantify	  the	  various	  cell	  types	  identified.	  
	  
	  
Differences	   between	   cell	   counts	   for	   EdU/NeuN,	   EdU/DCX	   and	   EdU/GFAP	   undetected	   in	  
pilot	  study	  exercised	  rats	  	  
	  
The	  ability	   to	  distinguish	  between	  cell	  phenotypes	   is	  essential	   to	   identifying	  neurons	  
and	   astrocytes	   enabling	   us	   to	   gain	   a	   better	   understanding	   of	   their	   interactions	   and	  
functions.	   All	   rats	   were	   exercised	   and	   while	   many	   studies	   explore	   the	   effects	   of	  
exercise	   on	   neurogenesis/mitotic	   activity	   (Bayod	   et	   al.,	   2014;	   Castilla-­‐Ortega	   et	   al.,	  
2014,	   Fuss	   et	   al.,	   2014;	   Gregoire	   et	   al.,	   2014)	   relatively	   few	   explore	   phenotypic	  
expression	   of	   the	   newly	   generated	   cells	   or	   the	   influence	   of	   exercise	   on	   phenotype	  
expression	   (Mateus-­‐Pinheiro	  et	  al.,	   2013;	   Speisman	  et	  al.,	   2013;	   Steiner	  et	  al.,	   2004;	  
van	   Praag	   et	   al.,	   2002).	   This	   study	   assessed	   exercised	   rodents	   and	   compared	   the	  
phenotype	   expression	   between	   all	   labelled	   cells	   using	   molecular	   markers	   GFAP	   for	  
astrocytes,	  NeuN	  for	  mature	  neurons	  and	  DCX	  for	   immature	  neurons.	  Ki-­‐67	  was	  also	  
utilized	  as	  an	  additional	   stain	   in	  order	   to	  detect	  pulses	  of	  mitotic	   activity.	  We	   found	  
(Figure	  13	  and	  Figure	  15)	  no	  detectable	  differences	  between	  cell	  phenotypes	  in	  any	  of	  
the	  explored	  injection	  times	  i.e.	  PND	  60,	  PND	  96	  or	  PND	  74	  (Figure	  18)	  which	  is	  further	  
discussed	  below.	  	  
	  
Our	  findings	  using	  the	  GFAP	  stain	  (Figure	  13,	  Figure	  18)	  are	  different	  to	  those	  seen	  in	  
the	  literature	  but	  agree	  with	  a	  study	  that	  explored	  neurogenesis	  in	  non-­‐exercised	  mice	  
(Steiner	  et	  al.,	  2004).	  When	  mice	  injected	  with	  BrdU	  (4	  hours	  prior	  to	  perfusion)	  there	  
was	  no	  difference	  between	  GFAP-­‐labelled	  cells	  and	  neurons	  (20	  BrdU-­‐labelled	  cells	  per	  
dentate	   gyrus)	   (Steiner	   et	   al.,	   2004).	   A	   study	   conducted	   by	   Mateus	   Pinheiro	   et	   al.,	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(2013)	  compared	  the	  phenotypes	  in	  male	  Wistar	  non-­‐exercised	  controls	  and	  exercised	  
rats.	  This	  was	  conducted	  after	  neurogenesis	  was	  pharmacologically	  blocked	  and	  then	  
unblocked.	  The	  study	  found	  a	  lower	  number	  of	  BrdU/GFAP	  cells	  	  (3	  x	  10-­‐3	  cells	  per	  100	  
µm	  dentate	  gyrus)	  than	  BrdU/NeuN	  cells	  (7	  x	  10-­‐3	  per	  100	  µm	  dentate	  gyrus)	  (Mateus-­‐
Pinheiro	   et	   al.,	   2013).	   Thus	   despite	   agreeing	   with	   findings	   in	   non-­‐exercised	   mice	   it	  
would	  appear	  further	  research	  is	  needed	  in	  exercised	  rats.	  
	  
Another	   study	  by	  van	  Praag	  et	  al.	   (2002)	  examined	  neuronal	  phenotype	   in	  exercised	  
mice	   injected	   with	   the	  mitotic	  marker,	   green	   fluorescent	   protein	   (GFP).	   These	  mice	  
were	  housed	  in	  cages	  with	  running	  wheels	  for	  4	  weeks	  and	  brains	  processed	  48	  hours	  
after	  injection.	  This	  is	  closer	  in	  time	  frame	  to	  the	  current	  study	  that	  exercised	  rats	  for	  
approximately	  3	  weeks	  and	  injected	  them	  2	  weeks	  prior	  to	  perfusion.	  It	  was	  found	  that	  
50	  %	  of	  the	  cells	  were	  unidentifiable.	  There	  were	  no	  mature	  neurons	  labelled,	  63	  %	  of	  
the	  260	  GFP-­‐labelled	  cells	   (163	  cells)	  were	   immature	  neurons	  and	  4.6	  %	  (11.96	  cells)	  
were	   GFAP	   labelled.	   These	   results	   suggest	   that	   exercise	   up-­‐regulated	   the	   neuronal	  
phenotype	   specifically.	   However,	   these	   are	   mice	   injected	   with	   the	   GFAP	   transgene,	  
which	  may	  alter	  gene	  expression	  and	  phenotype	  (van	  Praag	  et	  al.,	  2002).	  This	  may	  in	  
part	   be	   due	   to	   the	   increase	   in	   anti-­‐inflammatory	   cytokine,	   IL-­‐1,	   released	   from	  
astrocytes,	  which	  promotes	  neuronal	  activity	  (Pusic	  et	  al.,	  2014)	  and	  possibly	  astrocyte	  
activity	  too.	  This	  reasoning	  does	  not	  explain	  the	  increase	  seen	  in	  GFAP-­‐labelled	  cells	  in	  
exercised	   non-­‐mutant	   mice	   by	   Steiner	   et	   al.	   (2004).	   Thus	   this	   finding	   could	   be	   a	  
reflective	  only	  of	  those	  cells	  that	  were	  identified	  in	  the	  van	  Praag	  Study	  (noting	  that	  50	  
%	  were	  unidentifiable),	  which	  disagrees	  with	  the	  findings	  of	  this	  study	  that	   found	  no	  
differences.	  
	  
In	  exercised	  rats	  Speisman	  et	  al.	   (2013)	  found	  that	  conditioned	  running	  for	  18	  weeks	  
(rats	   housed	   with	   running-­‐wheels	   and	   rewarded	   with	   food	   pellets)	   resulted	   in	   the	  
major	  phenotype	  being	  neuronal.	  It	  was	  shown	  that	  there	  were	  more	  BrdU/NeuN	  (70%	  
of	   2300	  BrdU-­‐positive	   cells	   in	   the	  whole	  dentate	   gyrus)	   relative	   to	  BrdU/DCX	   (5%	  of	  
2300	   BrdU-­‐positive	   cells	   in	   the	   whole	   dentate	   gyrus)	   and	   BrdU/GFAP	   (10%	   of	   2300	  
BrdU-­‐positive	   cells	   in	   the	   whole	   dentate	   gyrus)	   positive	   cells.	   These	   results	   were	  
obtained	  3	  weeks	  after	  injections	  possibly	  explaining	  the	  increase	  in	  mature	  neuronal	  
phenotype,	  as	  neurons	  take	  up	  to	  21	  days	  to	  mature.	  Therefore	  it	  should	  be	  noted	  that	  
our	  study	  might	  have	  required	  earlier	  injection	  time	  points	  to	  detect	  mature	  neuronal	  
differences.	   Perhaps	   more	   injections	   at	   an	   earlier	   time	   point	   would	   render	   higher	  




Pooled	  EdU/DCX+EdU/NeuN	  cell	  survival	  was	  higher	  in	  PND	  60	  injected	  and	  exercised	  rats	  
than	  PND	  96	  injected	  rats	  
	  
After	   just	   less	   than	   three	   weeks	   of	   exercise,	   there	   were	   significantly	   more	   labelled	  
neurons	  detected	  by	  injecting	  EdU	  on	  PND	  60	  than	  4	  hours	  prior	  to	  perfusion	  on	  PND	  
96	  (Figure	  16).	   In	  an	  attempt	  to	  detect	  differences	   in	  neurogenesis,	  optimal	   injection	  
time	  point	  and	  identify	  phenotypes	  of	  mitotically	  active	  cells	  the	  NeuN	  and	  DCX	  data	  
	   58	  
were	   pooled.	   The	   total	   and	   average	   number	   of	   EdU/NeuN	   +	   EdU/DCX	   showed	   that	  
significantly	   more	   cells	   expressed	   the	   EdU	   marker	   2	   weeks	   after	   injection	   of	   EdU	  
(Figure	   16).	   	   This	   finding	   is	   in	   agreement	   with	   Steiner	   et	   al.	   (2004)	   who	   pooled	  
BrdU/NeuN-­‐	   and	   BrdU/DCX-­‐labelled	   cells	   and	   found	   that	   injections	   4	   hours	   prior	   to	  
perfusion	   rendered	  significantly	   lower	  cell	   counts	   than	  perfusions	  1	  week	  after	  BrdU	  
injections	  (10	  cells	  after	  4	  h	  vs.	  150	  after	  3	  days).	  There	  is	  no	  exact	  replication	  of	  this	  in	  
the	  literature,	  but	  it	  suggests	  that	  a	  larger	  sample	  size	  could	  possibly	  reveal	  differences	  
in	  phenotype	  or	  injection	  time	  points	  may	  be	  an	  influential	  factor.	  
	  
	  
In	  summary,	  the	  pilot	  study	  was	  able	  to	  successfully	  confirm	  the	  use	  of	  EdU	  to	  detect	  
mitotically	  active	  cells	  in	  the	  DG	  of	  rats.	  EdU	  was	  further	  d	  with	  co-­‐labels	  GFAP,	  NeuN,	  
DCX	  and	  Ki-­‐67	  for	  the	  detection	  of	  phentotypical	  differences.	  There	  were	  no	  detectible	  
effects	   shown	   of	   exercise	   and	   analysis	   of	   cell	   phenotypes	   separately	   did	   not	   reveal	  
differences	   in	   neurogenesis.	   By	   combining	  DCX-­‐	   and	  NeuN-­‐labelled	   cells	   it	   appeared	  
that	  EdU	  injections	  at	  PND	  60,	  14	  days	  before	  perfusion,	  rendered	  better	  labelling	  than	  
pulse	   injections	   on	   PND	   74,	   4	   hours	   prior	   to	   perfusion.	   The	   mitotic	   marker,	   Ki-­‐67,	  
appeared	   to	   be	   a	   better	   pulse-­‐label	   of	   proliferating	   cells	   at	   the	   end	   of	   20	   days	   of	  
running	  (Figure	  19).	  	  
	  
	  
4.2)	  Experiment:	  Measuring	  cell	  survival	  and	  neurogenesis	  using	  EdU	  
	  
After	  characterisation	  of	  EdU,	   it	  was	  found	  that	  EdU	  would	  be	  effective	   in	  measuring	  
cell	   survival	   and	   Ki-­‐67	  was	   used	   as	   a	   pulse	   to	  measure	   neurogenesis	   at	   the	   time	   of	  
sacrifice	   after	   20	  days	  being	  housed	  with	   running	  wheels.	   Therefore	  using	   the	  novel	  
tool	   we	   measured	   neurogenesis	   to	   determine	   two	   objectives.	   Firstly	   we	   were	  
interested	   in	   determining	   whether	   MS	   blocks	   the	   effect	   of	   exercise	   on	   cell	   genesis	  
and/or	   survival	   in	   the	   hippocampus	   and/or	   prevents	   these	   proliferating	   cells	   from	  
becoming	  mature	   neurons	   or	   glia.	   Secondly	  we	  hoped	   to	   determine	  whether	   or	   not	  
voluntary	  exercise	  affected	  cell	  genesis	  and	  survival.	  
	  
Weight	  was	  increased	  in	  MS	  rats	  
	  
Weights	   were	   captured	   on	   the	   day	   of	   injection	   for	   each	   rat	   (PND	   60)	   in	   order	   to	  
determine	   a	   behavioral	   measure	   of	   food	   consumption	   (Figure	   20).	   In	   our	   cohort	   of	  
rats,	   the	  MS+NR	   rats	  weighed	  more	   than	   the	  NMS+R	   rats	  on	  PND	  60.	  This	   finding	   is	  
similar	   to	   findings	  by	  Hamilton	  et	   al.	   (2010)	  who	   found	   the	  weights	   of	   age	  matched	  
sham-­‐injected	  male	  Long	  Evans	  rats	  to	  be	  approximately	  374.2g	  in	  MS	  and	  354.2g	  NMS	  
on	   PND	   72.	   This	   confirmed	   our	   rats	   were	   in	   the	   correct	   weight	   range.	   Exercise	   and	  
weight	  have	  been	  linked	  and	  when	  wheel	  running	  was	  introduced	  to	  rats	  it	  was	  found	  
to	   increase	  weight	  (Noble	  et	  al.,	  2014)	  and	  MS	  has	  been	  shown	  to	  decrease	  (Huot	  et	  
al.,	   2001)	   weight	   or	   have	   no	   effect	   	   (Lee	   et	   al.,	   2013).	   MS	   rats	   had	   significantly	  
increased	   weights	   compared	   to	   NMS	   rats.	   It	   is	   possible	   that	   MS	   altered	   the	  
biochemistry	  of	  the	  brains	  of	  rats	   linked	  to	  an	   increase	   in	  weight	  gain	  (Daniels	  et	  al.,	  
2011)	  or	  possibly	  MS	  rats	  consumed	  more	  rat	  chow	  on	  a	  daily	  basis.	  	  




Distance	  Run	  by	  rats	  was	  lower	  in	  MS	  rats	  
	  
Voluntary	  wheel	  running	  is	  a	  measure	  of	  exercise	  in	  rodents	  and	  increases	  over	  time	  as	  
it	   is	   considered	   rewarding	   as	   shown	   by	   conditioned	   place	   preference	   (CPP)	   testing	  
(Greenwood	   et	   al.,	   2011).	   It	   was	   necessary	   to	   ensure	   that	   all	   animals	   ran	   similar	  
distances	  to	  confirm	  that	  the	  level	  of	  exercise	  was	  homologous	  between	  MS	  and	  NMS	  
groups.	  However,	  the	  Wilcoxon	  matched-­‐pairs	  signed	  rank	  test	  showed	  that	  medians	  
were	   different	   between	   the	   20	   days	   of	   running	   between	   MS	   and	   NMS	   rat	   groups	  
(Figure	  21).	  Our	  findings	  are	  similar	  to	  Greenwood	  et	  al.,	  2011	  who	  used	  Fischer	  rats	  
and	  found	  that	  they	  ran	  0.5	  km/day	  -­‐	  2.5	  km/day	  over	  39	  days.	  We	  saw	  an	  effect	  of	  MS	  
on	  running	  distance	  with	  MS	  having	  lower	  daily	  medians	  than	  NMS.	  	  Stress	  is	  reported	  
to	   decrease	   running	   distance	   and	   non-­‐stressed-­‐run	  mice	   ran	   significantly	  more	   than	  
previously	  stressed	  and	  run	  mice	  (Castilla-­‐Ortega	  et	  al.,	  2014).	  This	  may	  be	  considered	  
plausible	  in	  understanding	  the	  behavioral	  effects	  MS	  has	  on	  the	  rats.	  
	  
The	  Survival	  of	  NeuN,	  GFAP	  and	  DCX	  labelled	  cells	  was	  not	  affected	  by	  MS	  
	  
After	  establishing	  that	  both	  MS	  and	  NMS	  ran	  sufficient	  daily-­‐distances	  the	  number	  of	  
surviving	   neurons	   (EdU/NeuN),	   immature	   neurons	   (EdU/DCX)	   and	   astrocytes	  
(EdU/GFAP)	   were	   compared	   between	   groups.	   There	   was	   no	   detectable	   effect	   on	  
neuronal	  survival	  in	  MS	  or	  voluntary	  exercise	  groups	  (Figure	  22	  and	  Figure	  25).	  	  
	  
The	  effect	  of	  MS	  and	  exercise	  on	  EdU-­‐labelled	  neuronal	  survival	  was	  explored	  (Figure	  
22a).	   There	   were	   no	   significant	   differences	   on	   any	   of	   the	   treatment	   groups	   in	   the	  
dorsal	  or	  the	  ventral	  hippocampus.	  This	  study	  found	  no	  effect	  of	  MS	  stress	  on	  mature	  
neurons	  contrasting	  with	  present	   literature.	  Stress	  has	  been	  shown	  to	  decrease	   later	  
neuronal	  survival	  in	  rats.	  Temporarily	  blocking	  neurogenesis	  in	  rats	  has	  shown	  to	  later	  
alter	   the	   level	   of	   neurogenesis	   once	   the	   block	   is	   removed,	   the	   BrdU/NeuN	   labelled	  
cells	   in	   the	   dentate	   gyrus	   of	   adult	   Wistar	   rats	   have	   been	   decreased	   in	   rats	   that	  
experienced	   stress	   (Mateus-­‐Pinheiro	   et	   al.,	   2013).	   Unpredictable	   chronic	  mild	   stress	  
treatments	  also	  alters	  mature	  neuronal	  number	  Lajud	  et	  al.	  (2012)	  found	  that	  fifteen-­‐
day-­‐old	  MS	   Sprague	  Dawley	   rats	   had	   a	   decrease	   in	   BrdU/NeuN	   labelled	   cells	   (which	  
localized	   with	   DCX).	   MS	   specifically,	   reportedly	   decreases	   the	   number	   of	   mature	  
surviving	  neurons	  in	  rats.	  It	  was	  shown	  that	  35	  %	  of	  the	  BrdU	  cells	  were	  NeuN	  with	  an	  
estimate	  of	  700	  BrdU/NeuN	  cells	  in	  MS	  rats	  (Lajud	  et	  al.,	  2012).	  This	  study’s	  results	  are	  
possibly	  due	  to	  the	  dosage	  of	  the	  EdU	  being	  insufficient	  to	  detect	  differences	  between	  
groups.	  Alternatively	  the	  sample	  size	  	  (n=4/5	  depending	  on	  stain)	  was	  relatively	  small	  
to	   identify	   group	   differences	   between	   the	   NMS	   and	   MS	   groups.	   Upon	   pooling	   the	  
dorsal	  and	  ventral	  hippocampi	  we	  still	   found	  no	  significant	  differences	  using	  a	  Mann	  
Whitney	  U	  test	   (n=10/9)	  so	   it	   is	  more	   likely	  that	  the	  dosage	  50mg/kg	  was	  too	   low	   in	  
adult	   rats.	   The	   novel	   EdU	   marker	   did	   not	   label	   sufficient	   cells	   for	   significant	  
quantification	  of	  differences	  at	  this	  dosage.	  It	  should	  be	  noted	  this	  factor	  might	  have	  
influenced	  all	  EdU	  results.	  
	   60	  
	  
	  
This	  study	  also	  examined	  astrogliogenesis	  using	  the	  marker	  GFAP.	  Similar	  to	  the	  finding	  
above,	   there	   was	   no	   detectable	   difference	   between	   the	   surviving	   EdU/GFAP	   cells	  
present	  (Figure	  22b).	  Our	  findings	  in	  astrocytes	  agrees	  with	  an	  earlier	  study	  by	  Mirescu	  
et	  al.	   (2004)	   that	  showed	  astrocyte	  counts	  were	  not	  different	  between	  MS	  and	  NMS	  
rats.	  	  Despite	  not	  being	  significantly	  different	  the	  astrocyte	  number	  was	  low	  relative	  to	  
neurons	   (7%	   of	   approximately	   3000	   BrdU	   labelled	   cells	   thus	   210	   GFAP	   per	   DG).	  
However,	   chronic	   stress	   in	   adult	   rats	   reduced	   the	   number	   of	   microglia	   (including	  
astrocytes)	  expressed	  in	  the	  DG	  with	  90	  cells	  per	  mm2	  DG	  labelled	  in	  CUS	  rodents	  and	  
120	   cells	   per	   mm2	   DG	   in	   controls.	   Thus	   adult	   stress	   has	   been	   shown	   to	   decrease	  
microglia	  (Kriesel	  et	  al.,	  2013).	  Mateus-­‐Pinheiro	  et	  al.,	  (2013)	  found	  pharmacologically	  
arresting	  mitotic	  activity	  decreased	  astrocytes	  3	  fold	  (with	  3	  x	  10-­‐3	  per	  100	  µm	  DG	  in	  
controls	   and	   1	   x	   10-­‐3	   per	   100	   µm	   DG).	   Similarly	   stress	   is	   thought	   to	   decrease	   the	  
number	   of	   surviving	   astrocytes.	   Kriesel	   et	   al.	   (2013)	   found	   a	   causal	   relationship	  
between	   stress	   and	   a	   decrease	   in	   microglia	   (including	   astrocytes),	   and	   linked	  
neurogenesis	  to	  depressive-­‐like	  behavior.	  There	  was	  also	  decrease	  in	  markers	  for	  glial	  
activity.	  Stressors	  such	  as	  chronic	  stress	  and	  forced	  exercise	  decrease	  astrogliogenesis	  
possibly	  due	  to	  exposure	  to	  glucocorticoids	  (Roman	  et	  al.,	  2005;	  Mandyam	  et	  al.,	  2007;	  
Nune	   et	   al.,	   2011).	   Therefore	   it	   is	   likely	   MS	   effects	   astrocytes	   similarly	   to	   neurons	  
decreasing	   number.	   This	   study	   was	   unable	   to	   detect	   any	   changes	   due	   to	   afore	  
mentioned	  reasons.	  
	  
There	  was	  no	  significant	  difference	  found	  between	  treatment	  groups	  co-­‐labelled	  with	  
EdU/DCX	   (Figure	   25).	   This	   marker	   combination	   compares	   the	   number	   of	   surviving	  
immature	   neurons	   (Shruster	   et	   al.,	   2012;	   Monje	   et	   al.,	   2003).	   There	   were	   no	  
detectable	   differences	   seen	   between	   immature	   neurons.	   These	   findings	   agree	   with	  
Hulshof	   et	   al.,	   2011.	   The	   study	   reported	   that	   there	   was	   no	   difference	   in	   neuronal	  
differentiation	   between	   MS	  Wistar	   rats	   relative	   to	   NMS	   controls	   labelled	   with	   DCX	  	  
(approximately	  2000	  cells	  per	  dorsal	  hippocampus	  and	  2500	  per	  ventral).	  Our	  findings	  
and	   those	   of	  Hulshof	  et	   al.	   (2011)	   are	   not	   in	   agreement	  with	   the	   current	   literature,	  
which	  have	  reported	  a	  decrease	  of	  neuronal	  differentiation	  and	  immature	  neurons	  in	  
rodents	  treated	  with	  early	  developmental	  stress	  and	  specifically	  MS.	  A	  study	  by	  Zhao	  
et	  al.	  (2014)	  used	  maternal	  Sleep	  Deprivation	  (a	  pre-­‐natal	  developmental	  stressor)	  and	  
measured	  45000	  BrdU/DCX	  cells	  per	  DG	  and	  sleep	  controls	  vs.	  3000	  BrdU/DCX	  cells	  in	  
pups	  born	  to	  sleep	  deprived	  dams.	  The	  above	  mentioned	  study	  by	  Lajud	  et	  al.	  (2012)	  
also	   showed	   that	  MS	   stress	   decreased	   the	  number	   of	   BrdU/DCX	   labelled	   neurons	   in	  
the	  dentate	  gyrus	  of	  PND	  15	  Sprague	  Dawley	  rats	   (9600	  BrdU/DCX	  cells/DG	  vs.	  3300	  
BrdU/DCX	   /DG).	  Mirescue	   et	   al.	   (2004)	   found	   a	   decrease	   in	   immature	   neuronal	   DG	  
cells	   in	  MS	  rats.	   	  BrdU/Tuj1	  (a	  marker	  for	   immature	  neurons)	  positive	  cells	  showed	  a	  
decrease	  in	  BrdU	  cells	  labelled	  a	  week	  after	  200mg/kg	  BrdU	  injections	  (4000	  in	  MS	  vs.	  
6000	  NMS	  controls).	  Thus	  pre-­‐natal	  stress	  and	  early	  post-­‐natal	  stress	  are	  consistently	  
reported	  to	  decrease	  immature	  neuron	  number	  in	  rodents.	  
	  
Variability	   in	   results	   among	   studies	   could	   possibly	   be	   due	   to	   animal	   age,	   strain	   and	  
different	   MS	   methods.	   It	   has	   been	   suggested	   that	   immature	   neurons	   influence	  
behavior	   as	   they	   have	   been	   shown	   to	   extend	   dendrites	   as	   soon	   as	   one	   week	   after	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differentiation	   (Cameron	   &	   McKay,	   2001)	   and	   are	   able	   to	   establish	   new	   functional	  
connections	   within	   four	   weeks	   in	   mice	   (Kee	   et	   al.,	   2007),	   establish	   LTP	   at	   a	   lower	  
thresholds	  than	  mature	  neurons	  (Ge,	  et	  al.,	  2007)	  and	  have	  been	  linked	  to	  behavioral	  
changes	  in	  mice	  (Sanatrelli	  et	  al.,	  2003).	  Thus	  presumably	  they	  are	  more	  susceptible	  to	  
MS	   stress.	   	   Despite	   this	   the	   effect	   of	   MS	   on	   neuronal	   differentiation	   has	   not	   been	  
widely	  explored	  within	  the	  literature	  and	  as	  such	  our	  study	  indicates	  that	  MS	  alone	  is	  
not	  sufficient	  to	  alter	  neuronal	  differentiation.	  
	  
Voluntary	  running	  no	  detectable	  effect	  on	  Edu	  Labelled	  cells	  
	  
The	   voluntary	   running	   also	   had	   no	   detectable	   effect	   in	   any	   of	   the	   EdU	   labelled	  
treatment	   groups	   (Mature	   neurons,	   astrocytes	   or	   immature	   neurons	   (Figure	   22	   and	  
Figure	  25).	  This	   finding	  does	  not	  support	  current	   literature	   in	  both	  mice	  and	  rats.	   	   In	  
mice	  Rhodes	  et	  al.	  (2003)	  permitted	  voluntary	  wheel	  running.	  They	  found	  runners	  had	  
800	  BrdU	  positive	  cells	  and	  non-­‐wheel	   runners	  had	  200	  BrdU	  positive	  cells.	  The	  97%	  
BrdU	   cells	   in	   runners	   were	   neuronal	   and	   88%	   in	   non-­‐runners.	   As	   little	   as	   7	   days	   of	  
wheel	   running	   in	   mice	   was	   shown	   to	   up-­‐regulate	   the	   number	   of	   surviving	   neurons	  
labelled	  with	  NeuN	   (Rhodes	  et	  al.,	  2003).	   	  A	   study	  by	  van	  Praag	  et	  al.,	  2005	  showed	  
that	  3	  month	  old	  mice	  that	  had	  been	  housed	  with	  running	  wheels	  for	  45	  days	  had	  81.3	  
%	   BrdU/NeuN	   	   	   labelled	   cells	   (2355	   cells	   counted	   of	   which	   1914	   were	   NeuN	   co-­‐
labelled)	  relative	  to	  the	  49.9	  %	  BrdU/NeuN	  cells	  (613	  cells	  counted	  of	  which	  300	  NeuN	  
cells)	  non-­‐runners.	  Thus	  exercise	   is	  shown	  to	  up-­‐regulate	  mature	  neuronal	  survival	   in	  
mice.	  Stress	  combined	  with	  exercise	  reportedly	  also	  influences	  neuronal	  survival.	  The	  
marker	  BrdU/CB	  (Calbindin	  a	  marker	  for	  mature	  neurons)	  showed	  that	  restraint	  stress	  
combined	  with	  voluntary	  exercise	  generated	  150	  neurons	  in	  the	  DG	  and	  approximately	  
50	  in	  purely	  exercised	  mice	  relative	  to	  approximately	  10	  neurons	  in	  controls	  (Castilla-­‐
Ortega	  et	  al.,	  2014).	  This	  was	  24	  days	  after	  injections	  were	  administered.	  
	  
In	  rats	  Speisman	  et	  al.	  (2013)	  showed	  that	  there	  was	  no	  difference	  in	  mature	  neuron	  
numbers	   between	   voluntary	   runners	   and	   non-­‐runners.	   Their	   study	   reported	   1610	  
BrdU/NeuN	  cells	  for	  runners	  (70%	  of	  1600)	  and	  1120	  for	  non-­‐runner	  controls	  (70%	  of	  
2300)	  (Speisman	  et	  al.,	  2013).	  A	  study	  by	  Roman	  et	  al.	  (2008)	  used	  forced	  activity	  on	  
adult	   Wistar	   rats	   and	   found	   that	   it	   did	   not	   significantly	   affect	   BrdU	   labelled	   cells	  
relative	   to	   sedentary	  controls.	  After	  8	  days	  of	   forced	   locomotor	  activity	   in	  a	   rotating	  
barrel	   780	   cells	   (22.2%	  of	   4200	   cells)	  were	  neuronal	   in	   runners	   and	  958	  BrdU/NeuN	  
cells	  (13.5	  %	  of	  6000	  cells)	  in	  controls.	  The	  effect	  of	  forced	  exercise	  may	  be	  the	  reason	  
for	   this	   finding,	   unlike	   the	   current	   study	   that	   explored	   voluntary	   exercise.	   There	   are	  
studies	   that	   have	   explored	   the	   neuro-­‐protective	   effects	   of	   exercise	   in	   MS	   rats	   and	  
found	  voluntary	  wheel	   running	   reduced	  proteins	   involved	   in	  apoptosis	   in	   the	  ventral	  
hippocampus	  (Daniels	  et	  al.,	  2011)	   it	  has	  also	  been	  shown	  than	  6	  weeks	  of	  voluntary	  
wheel-­‐running	  increases	  levels	  of	  BDNF	  in	  the	  rodent	  brain	  (Marais	  et	  al.,	  2009).	  Thus	  
exercise	  alters	  the	  biochemistry	  of	  the	  brain	  possibly	  influencing	  neuronal	  survival	  and	  
genesis	   in	   MS	   rats,	   although	   further	   research	   is	   needed.	   	   It	   has	   been	   shown	   that	  
running	  up-­‐regulates	  the	  markers	  of	  neurogenesis	  for	  longer	  periods	  of	  time	  and	  thus	  
an	  increasing	  neurogenesis	  due	  to	  a	  decrease	  in	  plasma	  corticosterone	  (Gregorie	  et	  al.,	  
2014).	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There	  was	  also	  no	  detectable	  effect	  of	   voluntary	  exercise	  on	  astrogliogenesis,	  which	  
agrees	  with	  the	  findings	  of	  van	  Praag	  et	  al.,	  2005	  who	  also	  found	  that	  exercise	  had	  no	  
affect	  on	  astrogliogenesis	  with	  (non-­‐runners	  48	  BrdU/GFAP	  cells	  in	  the	  DG	  and	  35,25	  in	  
mice	  runners)	  a	  similar	  finding	  was	  confirmed	  by	  Rhodes	  et	  al.	  (2003).	  	  This	  is	  further	  
supported	   in	   rats	   by	   a	   study	   by	   Speisman	   et	   al.	   (2013)	   reporting	   that	   found	   no	  
difference	   between	   conditioned	   runners	   and	   non	   runners	   labelled	   with	   BrdU/GFAP	  
and	   10%	  of	   all	   BrdU	   cells	  were	   labelled	  with	  GFAP	   (160	   cells	   in	   controls	   and	   240	   in	  
runners	  per	  DG).	  	  
	  
A	   decrease	   in	   stress-­‐induced	   hormones	   is	   thought	   to	   modulate	   neurogenesis	   and	  
neuronal	   differentiation.	   Contrasting	   to	   this	   hormones	   such	   as	   glucocorticoids	   are	  
released	   during	   exercise	   stress,	   and	   have	   been	   shown	   to	   activate	   receptors	   in	  
hippocampal	  slices	   that	  cause	  progenitor	  cells	   to	  become	  astrocytes	   in	   tissue	  culture	  
(Anacker	  et	  al.,	  2013).	  Thus	  the	  relationship	  and	  molecular	  mechanisms	  linking	  stress,	  
exercise	   and	  astrogliogenesis	   remains	  unclear.	   This	   contradicts	   findings	   that	   exercise	  
induced	  an	  increase	  in	  neurogenesis	   is	   linked	  to	  BDNF	  levels,	  which	  do	  not	  appear	  to	  
affect	   astrogliogenesis	   significantly	   (Rhodes	   et	   al.,	   2003).	   Forced	   exercise	   and	   other	  
forms	  of	  stress	  decrease	  astrocytic	  proliferation	  (Roman	  et	  al.,	  2005).	  
	  
We	  did	  not	   see	  an	  effect	  of	   exercise	  on	  any	  of	   the	   treatment	  group	  double	   labelled	  
with	  DCX/EdU.	  The	  exercised	  rats	  had	  a	  wider	  range	  of	  data	  points	  than	  non-­‐runners.	  
This	   could	   be	   because	   EdU	   has	   also	   been	   found	   to	   alter	   metabolic	   activity	   and	  
decrease	   cellular	   proliferation	   (Neef	   &	   Luedtke,	   2011)	   and	   possibly	   early	   neuronal	  
differentiation.	  However,	  our	  finding	  agrees	  with	  a	  study	  using	  BrdU	  by	  Gregorie	  et	  al.,	  
2014	   that	   found	   three	  weeks	   of	   running	   had	   no	   effect	   on	   the	   number	   of	  DCX/BrdU	  
labelled	  cells	  in	  the	  dorsal	  hippocampus	  of	  mice.	  This	  disagrees	  with	  Castilla-­‐Ortega	  et	  
al.,	  2014	  who	  found	  that	  23	  days	  of	  voluntary	  wheel	  running	  was	  sufficient	  to	  induce	  
significant	  up-­‐regulation	  of	  DCX/BrdU	  labelled	  cells	  (approximately	  100	  present	  in	  the	  
DG	  after	  24	  days)	  and	  also	  reversed	  the	  effects	  of	  chronic	  restraint	  stress	  normalizing	  




Correlation	  Analysis	   found	   a	   relationship	   between	  Neurons	   (EdU/NeuN)	   and	  Astrocytes	  
(EdU/GFAP)	  
	  
To	  further	  assess	  the	  relationship	  between	  neurons	  and	  astrocytes	  the	  data	  from	  the	  
two	  stains	  were	  pooled.	  We	  compared	  the	  survival	  of	  the	  two	  phenotypes	  (EdU/GFAP	  
vs.	   EdU/NeuN).	   The	   EdU/NeuN	   co-­‐labelled	   cells	   from	   all	   groups	   were	   pooled	   and	  
EdU/GFAP	   co-­‐labelled	   cells	   were	   pooled	   separately	   and	   compared	   using	   a	   Mann	  
Whitney	  U	   test.	  This	  was	  permissible	  as	   there	  was	  no	  significant	  difference	  between	  
the	   treatment	   groups	   (Figure	  24).	   	   There	  was	   also	  no	   significant	   difference	  between	  
the	   total	   number	  of	   co-­‐labelled	  EdU/GFAP	   cells	   and	  EdU/NeuN	  cells	   in	   the	  dorsal	  or	  
ventral	  hippocampi	  (Figure	  23).	  Our	  findings	  are	  in	  agreement	  with	  Roman	  et	  al.,	  2005.	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Using	  double	   labelled	  BrdU/NeuN/GFAP	  cells	   they	  reported	  no	  significant	  differences	  
between	   BrdU/NeuN	   and	   BrdU/GFAP	   labelled	   cells	   in	   exercised	   or	   non-­‐exercised	   or	  
rats	   stressed	   with	   sleep	   deprivation.	   Mateus-­‐Pinheiro	   et	   al.,	   2013	   also	   reported	   no	  
significant	  difference	  in	  basal	  BrdU/GFAP	  labelled	  cells	  relative	  to	  BrdU/NeuN	  labelled	  
cells.	  Despite	  this	  finding	  of	  no	  difference	  between	  neurons	  and	  astrocytes	  survival	  a	  
correlation	  was	  performed	  to	  determine	  if	  there	  was	  a	  link	  between	  the	  neurons	  and	  
astrocytes	   (Figure	   24).	   Upon	   pooling	   the	   data	   from	   all	   treatment	   groups	   our	   study	  
revealed	   no	   significant	   correlation	   between	   neurons	   and	   astrocytes	   in	   the	   dorsal	  
hippocampus	  but	  there	  was	  a	  significant	  correlation	  between	  neurons	  and	  astrocytes	  
in	  the	  ventral	  hippocampus	  (Figure24b).	  
	  
There	   are	   no	   other	   studies	   (to	   our	   knowledge)	   that	   have	   used	   EdU/NeuN	   and	  
EdU/GFAP	  to	  identify	  a	  correlation	  between	  the	  two	  cell	  types.	  Haggeman	  et	  al.,	  2013	  
found	  that	  mutant	  mice	  unable	  to	  express	  GFAP	  had	  a	  significant	  decrease	  in	  mature	  
neurons	  cells	  (20	  NeuN	  in	  mutants	  vs.	  100	  labelled	  cells	  in	  controls).	  The	  reduction	  in	  
GFAP	   was	   correlated	   with	   the	   depletion	   in	   neurons	   in	   mutant	   mice.	   Correlation	  
analysis	  was	  not	  conducted	  with	  GFAP	  but	  analysis	  of	  EdU/NeuN	  and	  EdU/S100β	  were	  
conducted	  and	  compared.	  The	  correlation	  between	  astrocytes	  and	  neurons	  has	  been	  
attributed	  to	  astrocytes	  playing	  a	  direct	  role	  in	  promoting	  neurogenesis	  (Haggeman	  et	  
al.,	  2014).	  Astrocytes	  strengthening	  synapses	  in	  the	  hippocampus	  is	  possibly	  the	  most	  
likely	   reason	   for	   the	   correlation	   between	   the	   two	   neuronal	   cell	   types	   proliferation.	  
Astrocytes	   increase	   synaptic	   strength	   and	   increase	   synaptic	   transmission,	   neuronal	  
activity	   (Kirby	   et	   al	   2013)	   and	   in	   turn	   enhance	   neuroplasticity	   (Nagler	   et	   al.,	   2001;	  
Ullian	  et	  al.,	  2001).	  Disruption	  in	  microglial	  signaling	  can	  result	  in	  perturbations	  in	  the	  
regulation	  of	  neuronal	  excitability	  and	  activity,	  which	  is	  essential	  to	  the	  integration	  of	  
newly	  generated	  neurons	  (Pusic	  et	  al.,	  2014).	  A	  decrease	  in	  astrocytes	  has	  been	  linked	  
to	   depressive	   behavior	   (Kriesel	   et	   al.,	   2014).	   This	   is	   hypothesized	   to	   occur	   due	   to	   a	  
down-­‐regulation	   in	   neurogenesis.	   This	   was	   shown	   by	   pharmacological	   stimulation	  
reversing	   these	   behavioral	   changes	   and	   up	   regulating	   BrdU-­‐labelled	   cells.	   This	  
correlation	  may	  also	  only	  occur	   in	   the	  ventral	  hippocampus	  as	   it	   regulates	   the	  stress	  
response	   and	   anxiety-­‐like	   behavior	   (Bannerman	   et	   al.,	   2004)	   as	   this	   system	   is	  
particularly	  vulnerable	  to	  stress.	  
	  
Neuronal	  proliferation	  (Ki-­‐67/DCX)	  was	  reduced	  in	  MS	  rats	  	  
	  
The	  marker,	  Ki-­‐67	  was	  used	  as	  a	  mitotic	  pulse	  measurement	  of	  proliferation	  and	  the	  
DCX	  co-­‐label	  was	  used	  to	  distinguish	  how	  many	  of	  those	  cells	  were	  committing	  to	  the	  
neuronal	  lineage	  (Figure	  26).	  It	  was	  used	  to	  measure	  the	  number	  of	  mitotically	  active	  
neuroblasts	   that	  were	  present	  at	   the	  time	  of	  perfusion.	  This	  was	   in	  conjunction	  with	  
the	  EdU	  marker	  that	  measured	  survival	   from	  injection	  time	  point	  until	  perfusion.	  We	  
found	   that	   there	   were	   significantly	   fewer	   Ki-­‐67/DCX	   positive	   cells	   in	   MS	   +	   R	   rats	  
relative	  to	  NMS	  +	  R	  rats	  in	  both	  the	  dorsal	  and	  ventral	  dentate	  gyrus	  (Figure	  26).	  	  
	  	  
Many	   studies	   report	   that	  MS	   (Mirescue	   et	   al.,	   2004;	   Lelsie	   et	   al.,	   2011;	   Lajud	   et	   al	  
2012)	   and	   Maternal	   Deprivation	   (MD)	   	   (Oomen	   et	   al.,	   2010)	   decrease	   cellular	  
proliferation	  in	  the	  DG	  of	  rats	  and	  mice	  alike.	  	  As	  previously	  discussed	  MS	  and	  MD	  are	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thought	   to	   decrease	   neurogenesis,	   and	   four	  weeks	   after	   pharmacologically	   arresting	  
neurogenesis	  in	  Wistar	  rats	  there	  was	  still	  lower	  number	  of	  proliferating	  Ki-­‐67	  positive	  
cells	  in	  the	  DG	  relative	  to	  controls	  (Mateus-­‐Pinheiro	  et	  al.,	  2013).	  Not	  all	  studies	  agree	  
with	  this	  finding	  and	  Suri	  et	  al.	  (2013)	  found	  no	  effect	  of	  MS	  in	  Sprague	  Dawley	  rats	  on	  
cellular	   proliferation	   (700	   -­‐	   800	   BrdU	   positive	   cells	   in	   the	   sub-­‐granular	   zone	   and	  
granule	   cell	   layers	   of	   both	   groups	   with	   approximately	   130	   DCX	   positive	   cells	   in	  MS	  
rats).	   Despite	   the	   variability	   in	   the	   literature	   this	   study	   did	   find	  MS+R	   rats	   to	   have	  
lower	  cell	  counts.	  It	  is	  thought	  that	  an	  increase	  in	  plasma	  corticosterone	  in	  MS	  rats	  is	  
responsible	   for	   the	   reduction	   in	   neuronal	   proliferation	   (Lajud	   et	   al.,	   2012).	   This	   is	  
linked	   to	   immature	   neurons	   being	   sensitive	   to	   the	   increased	   presence	   of	  
glucocorticoids	  such	  as	  corticosterone	  (Mirescu	  et	  al.,	  2004;	  Lupien	  et	  al.,	  2009).	  	  Thus	  
the	  early	  life	  stress	  of	  MS	  causes	  alterations	  in	  the	  functioning	  of	  the	  HPA	  axis,	  which	  
regulates	  stress.	  The	  most	  prominent	  theory	  is	  that	  maternal	  separation	  and	  exercise	  
influence	   levels	   of	   BDNF	   or	   its	   downstream	   targets	   that	   influence	   neurogenesis	   and	  
depressive-­‐like	  behavior.	  Increases	  or	  decreases	  in	  immature	  proliferating	  neurons	  can	  
be	  explained	  via	  an	  increase	  or	  decrease	  in	  BDNF.	  	  	  
	  
Maternal	  separation	  has	  been	  shown	  to	  decrease	  levels	  of	  BDNF	  in	  the	  hippocampus.	  
The	  effects	  of	  a	  reduction	   in	  BDNF	  were	  seen	  to	   last	   for	  several	  weeks	   (Lippmann	  et	  
al.,	  2007)	  and	  exercise	  has	  been	  shown	  to	  increase	  the	  levels	  of	  BDNF	  in	  the	  striatum	  
of	  MS	  rats	  that	  were	  exposed	  to	  chronic	  voluntary	  wheel	  running	  (Marais	  et	  al.,	  2009).	  
This	  adds	  to	  the	  findings	  of	  a	  study	  conducted	  by	  Makena	  et	  al.,	  2012	  who	  found	  that	  
MS	   altered	   the	   effects	   of	   exercise	   and	   rats	   subject	   to	   wheel	   running	   and	   MS	   had	  
significantly	  lower	  levels	  of	  synaptophysin,	  phospho-­‐extracellular	  signal	  related	  kinase	  
(p-­‐ERK)	   in	   the	   hippocampus.	   	   This	   could	   indicate	   that	   MS	   blocks	   the	   effects	   of	  
increased	  BDNF	  via	  acting	  on	  ERK	  that	  stimulates	  neurotrophic	   factors	  and	  enhances	  
neuronal	   growth	   and	   neurogenesis	   (Hao	   et	   al.,	   2004).	   The	   effect	   of	   maternal	  
deprivation	   also	   alters	   cell	   morphology	   and	   decreases	   the	   number	   of	   proliferating	  
neurons	  (Oomen	  et	  al.,	  2010).	  Immature	  granule	  neurons	  are	  thought	  to	  be	  involved	  in	  
anxiety	   regulation	   the	   decrease	   in	   neurons	   and	   are	   required	   for	   several	   behavioral	  
functions	  (Mirescu	  et	  al.,	  2004)	  
	  
	  
BDNF	  may	  not	  be	  the	  only	  factor	  influencing	  early	  neurogenesis.	  One	  MS	  study	  found	  
elevated	  BDNF	  in	  the	  hippocampus	  resulted	  in	  no	  increase	  in	  neurogenesis	  (Greisen	  et	  
al.	   2005)	   and	  a	   study	  by	  Yau	  et	  al.,	   2014	   found	   increased	  neurogenesis	   linked	   to	   an	  
increase	  in	  synaptophysin	  and	  it	  receptor	  PSD95	  and	  not	  BDNF.	  Thus	  it	  is	  possible	  the	  
changes	  seen	  are	  not	  solely	  BDNF	  dependent.	  The	  activation	  of	  Erk	  via	  phosphorylation	  
was	  shown	  to	  enhance	  survival	  and	  neurogenesis	  as	  shown	  via	  BrdU/NeuN	  co-­‐labelling	  
of	  neurons	  in	  the	  hippocampus	  of	  male	  rats	  (Hao	  et	  al.,	  2004).	  Therefore	  our	  findings	  
support	   the	   possibility	   of	   MS	   influencing	   Erk	   signaling	   and	   possibly	   exacerbating	   a	  
reduction	  in	  neuronal	  proliferation	  caused	  by	  voluntary	  wheel	  running.	  
	  
Exercise	  significantly	  affects	  cell	  proliferation	  (Ki-­‐67/DCX)	  in	  the	  Dorsal	  Hippocampus	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In	  the	  dorsal	  hippocampus	  the	  NMS+R	  rats	  Ki-­‐67/DCX	  counts	  are	  higher	  than	  NMS+NR	  
(Figure	  26).	  Our	  results	  show	  that	  exercise	  specifically	  influences	  neuronal	  proliferation	  
and	   differentiation	   at	   the	   earliest	   stages	   of	   cell	   differentiation.	   These	   results	   agree	  
with	   previous	   literature	   (Castilla-­‐Ortega	   et	   al.,	   2014;	   Nobel	   et	   al.,	   2014)	   that	   states	  
voluntary	   exercise	   in	   rodents	   has	   increases	   neurogenesis.	   Our	   results	   are	   similar	   to	  
those	  seen	  in	  forced-­‐run	  mice	  for	  23	  days	  170	  BrdU/DCX	  positive	  cells	  and	  non-­‐run	  had	  
70	  BrdU/DCX	  positive	  cells	  as	  estimated	  for	  the	  entire	  dentate	  gyrus	  (as	  multiplied	  by	  8	  
due	   to	   sampling)	   and	   an	   increase	   in	   PCNA-­‐labelled	   proliferating	   cells	   relative	   to	  
controls	   (Castilla-­‐Ortega	   et	   al.,	   2014).	   However,	   forced	   locomotor	   activity	   has	   also	  
been	   shown	   to	   decrease	   cell	   proliferation	   in	   mice	   (Roman	   et	   al.,	   2005).	   In	   male	  
Sprague	   Dawley	   rats	   forced	   wheel	   running	   for	   3	   weeks	   also	   resulted	   in	   1400	   DCX	  
positive	  cells	   in	   the	  dentate	  gyrus	  with	  controls	  having	  9000	  DCX	  positive	  cells	   (Jiang	  
Feng	  et	  al.,	  2014).	  The	  effects	  of	  exercise	  are	  not	  always	  homogenous	  depending	  on	  
the	  kind	  of	  exercise	  (Roman	  et	  al.,	  2005).	  	  
	  
Voluntary	  exercise	  has	   specifically	   shown	   to	   increases	  neurogenesis	   in	   rats	   (Nobel	  et	  
al.,	   2014).	   	   Voluntary	   wheel	   running	   in	   Sprague	   Dawley	   rats	   increases	   cellular	  
proliferation	   in	  CA3	   region	  of	   the	  hippocampus	   (Nobel	  et	  al.,	   2014)	   and	   the	  DG.	   	  As	  
previously	  mentioned	  the	  dentate	  gyrus	  has	  been	  better	  explored	  as	  it	  functions	  have	  
been	  linked	  to	  anxiety	  and	  depressive-­‐like	  behaviors	  relevant	  to	  this	  study	  (Matheus-­‐
Pinero	   et	   al.,	   2014).	   Voluntary	  wheel	   running	   in	   adult	   rats	   (for	   11	  weeks)	   has	   been	  
shown	   to	   increase	   neuronal	   differentiation	   (16000	   DCX	   cells/DG	   vs.	   13000	   DCX	  
cells/DG	   with	   no	   mitotic	   marker)	   	   (Winocur	   et	   al.,	   2014).	   	   This	   is	   supported	   by	  
Speisman	  et	  al.	  (2013)	  who	  also	  reported	  an	  increase	  in	  BrdU/DCX	  labelled	  cells	  in	  the	  
DG	   of	   run	   rats.	   Twelve	   days	   of	   voluntary	   exercise	   followed	   by	   enrichment	   did	   not	  
increase	  Ki-­‐67	   labelled	  cells	   in	  Male	  Long-­‐Evans	   (approximately	  4800	  positive	  cells	   in	  
the	  DG)	  (Hamilton	  et	  al.,	  2014).	  Runners	  administered	  exogenous	  corticosterone	  had	  a	  
higher	   number	   of	   proliferating	   DG	   cells	   relative	   to	   non-­‐runners	   (Yau	   et	   al.,	   2014).	  
Therefore	   even	   with	   stress	   hormones	   present	   running	   increases	   proliferation	   and	  
neuronal	  differentiation.	  Exercise	  increases	  proteins	  in	  signaling	  pathways	  linked	  to	  its	  
release	   such	   as	   Akt,	   ERK,	   CaMKII	   and	   CREB,	   BDNF/TrkB.	   This	   supports	   findings	   that	  
indicate	  exercise	  activates	   the	  BDNF-­‐CreB	  pathways	   that	  enhance	  neuronal	  plasticity	  
(Jian-­‐Feng	  et	  al.,	  2014).	  
	  
	  
Our	  findings	  differ	  to	  the	  above	  studies	  and	  this	  is	  in	  part	  due	  to	  studies	  sampling	  and	  
multiplying	   out	   errors	   in	   counts.	   Estimations	   vary	   based	   on	   brain	   sampling	   are	   not	  
always	  the	  same;	  every	  16th	  section	  (Hamilton	  et	  al.,	  2014)	  and	  8	  sections	  from	  -­‐1.22	  
and	   -­‐2.54	  mm	   from	  bregma	   	   (Castilla-­‐Oretega.	  Et	  al.,	   2014),	   BrdU	  was	  quantified	  on	  
every	  6th	   section	  between	  Bregma	  21.06	  mm	  and	  22.98	  mm	  of	   the	  hippocampus	   (8	  
sections	   total/marker/animal)	   (Gregorie	  et	  al.,	  2014).	  The	  study	  by	   Jiang-­‐Feng	   (2014)	  
does	  not	  specify	  co-­‐ordinates	  and	  states	  every	  6th	  section	  of	  dentate	  gyrus	  was	  used	  
for	   estimations	  with	  10	   sections	   taken	  per	   animal.	   	   Thus	   identifying	   areas	   in	   the	  DG	  
where	  more	  or	   less	   neurogenesis	   occurs	  would	  be	  beneficial	   to	  homing	   in	  on	  which	  
areas	  are	  most	  affected	  and	  for	  homogenous	  comparisons.	  The	  number	  of	   injections	  
and	  dosage	  of	  mitotic	  markers	  varied	  between	  experiments	  also.	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  Dorsal	  and	  Ventral	  hippocampi	  affected	  by	  MS	  	  
	  
Our	   study	  sought	   to	   separately	  analyze	   the	  dorsal	  and	  ventral	  hippocampus	  because	  
they	   have	   shown	   to	   functionally	   differ	   (Bannerman	   et	   al.,	   2004).	   MS	   rats	   had	   a	  
significantly	  reduced	  number	  of	  Ki-­‐67/DCX	  labelled	  immature	  neurons	  relative	  to	  NMS	  
runners	   (MS+R	   vs.	  NMS+R)	   in	   both	   brain	   regions.	  However,	   there	  was	   no	   significant	  
increase	  in	  NMS+R	  relative	  to	  NMS	  +NR	  in	  the	  ventral	  hippocampus.	  
	  
Most	  studies	  have	  focused	  on	  the	  dorsal	  hippocampus,	  but	  a	  paper	  by	  Hulshof	  et	  al.,	  
2011	  explored	  MS	   in	  both	   the	  ventral	  and	  dorsal	  hippocampus	  and	   found	   there	  was	  
only	  a	  decrease	  in	  Ki-­‐67	  measured	  proliferation	  in	  the	  ventral	  hippocampus	  after	  MS+R	  
vs.	  NMS.	  This	  is	  not	  in	  agreement	  with	  our	  findings	  that	  saw	  MS+	  NR	  decrease	  counts	  
in	   both	   dorsal	   and	   ventral	   regions	   in	   run	   rats.	   The	   treatment	   groups	   look	   at	   the	  
combined	  effect	  of	  MS	  and	  exercise	  rather	  than	  MS	  singularly	  which	  may	  account	  for	  
this	  difference.	  	  
	  
	  
Dorsal	  Hippocampus	  affected	  by	  Exercise	  
	  
The	  effect	  of	  exercise	  was	  found	  to	  be	  region	  specific	  in	  this	  study	  and	  was	  also	  able	  to	  
show	  that	  NMS	  +	  R	  had	  a	  higher	  mean	  than	  NMS	  +NR	  in	  the	  dorsal	  hippocampus.	  The	  
findings	   in	   the	   dorsal	   hippocampus	   show	   that	   running	   for	   20	   days	   increases	  
proliferation	  of	  neurons	  only	  on	  the	  dorsal	  hippocampus	  of	  NMS	  rats.	  This	  is	  different	  
from	  Lui	  et	  al.,	  2013	  whose	  research	  showed	  running	  increased	  cellular	  proliferation	  in	  
the	  dorsal	  and	  ventral	  hippocampus.	  This	  study	  however	  was	  conducted	   in	  mice	  and	  
could	  be	  the	  reasons	  for	  the	  difference.	  	  
	  
The	  ventral	  hippocampus	  regulates	  the	  stress	  response	  and	  anxiety-­‐like	  behavior	  while	  
the	   dorsal	   hippocampus	   is	   involved	   in	   spatio-­‐temporal	   memory	   (Bannerman	   et	   al.,	  
2004).	  Makena	  et	  al.	   (2012)	  found	  the	  effects	  of	  voluntary-­‐wheel	  running	  exercise	  to	  
be	   observed	   only	   in	   the	   dorsal	   hippocampus	   of	   MS	   rats	   with	   increases	   in	  
synaptophysin	  and	  p-­‐ERK.	  This	   study	   found	  that	  MS+R	  groups	  had	   lower	  cells	  counts	  
than	  NMS+R	  groups	   in	   both	   ventral	   and	  dorsal	   hippocampus.	   The	   findings	   regarding	  
neurogenesis	  in	  the	  dorsal	  and	  ventral	  hippocampus	  require	  more	  exploration	  before	  




4.3)	  Conclusion	  &	  Future	  considerations	  
	  
Depression	   is	   a	   widespread	   psychiatric	   condition	   disease	   (Marcus	   et	   al.,	   2012)	   for	  
which	   current	   treatments	   have	   variable	   efficacy.	   It	   has	   been	   linked	   to	   adult	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neurogenesis	   in	   humans	   (Eriksson	   et	   al.,	   1998).	   As	   such	   novel	   tools	   to	   study	  
neurogenesis	  are	  needed	  to	  further	  explore	  neurogenesis	  and	  its	  link	  with	  depressive-­‐
like	  behaviors	   (Mateus-­‐Pinheiro	  et	  al.,	   2013).	   The	  MS	   rat	  model	   for	  depression	   is	   an	  
ideal	   model	   in	   which	   to	   do	   so	   as	   it	   has	   been	   firmly	   explored	   in	   terms	   of	   inducing	  
depressive-­‐like	   behavior	   and	   altering	   brain	   biochemistry	   analogous	   to	   human	  
depression.	  
	  
We	   investigated	   the	  effect	   of	  MS	  and	  exercise	   (using	   the	  novel	   EdU	  mitotic	  marker)	  
and	   found	   was	   no	   detectable	   difference	   on	   neuron,	   astrocyte	   or	   immature	   neuron	  
survival.	   The	   study	  did	  however	  propose	   a	   link	  between	  newly	   generated	   astrocytes	  
and	   neurons	   in	   the	   ventral	   hippocampus	   suggesting	   there	   could	   be	   a	   biological	   link	  
between	  the	  two	  phenotypes	  cell	  fates.	  This	  is	  the	  first	  time	  this	  has	  been	  done	  using	  
EdU.	  This	  resulted	  in	  improved	  epitope	  preservation	  and	  tissue	  quality	  for	  quantifying	  
cell	  counts	  more	  accurately	  in	  an	  MS	  model.	  
	  
	  We	   further	   explored	   the	   impact	   of	   MS	   and	   voluntary	   exercise	   on	   neuronal	  
proliferation	   (as	   measured	   by	   pulse	   of	   Ki-­‐67	   and	   DCX).	   MS+R	   groups	   displayed	   a	  
decrease	   in	  the	  number	  of	  proliferating	  cells	   in	  both	  ventral	  and	  dorsal	  hippocampus	  
relative	   to	   NMS+R	   groups.	   This	   suggests	   that	   MS	   possibly	   diminishes	   the	   beneficial	  
effects	  of	  exercise.	  The	  dorsal	  hippocampus	  also	  showed	  an	  increase	  in	  labelled	  cells	  in	  
NMS+R	   relative	   to	   NMS+NR.	   Thus	   exercise	   was	   shown	   to	   increase	   the	   number	   of	  
immature	  neurons	  generated	  in	  the	  DG.	  The	  current	  literature	  suggests	  that,	  BDNF	  is	  a	  
plausible	  link	  as	  it	  has	  been	  linked	  to	  the	  anxiolytic	  effects	  of	  exercise	  in	  the	  MS	  in	  rat	  
model.	   There	   is	   limited	  understanding	   in	   this	   area	  and	   it	  would	  prove	  useful	   further	  
establish	  the	  mechanism	  causing	  the	  decrease	  in	  neuronal	  proliferation.	  
	  
In	   order	   to	   further	   explore	   the	   relationship	   between	   Maternal	   Separation	   and	  
neurogenesis	  it	  is	  necessary	  to	  improve	  quantification	  of	  EdU	  labelled	  cells.	  While	  one	  
50mg/kg	   injection	   in	  rats	  was	  effective	   in	  detecting	  neurogenesis,	  a	  higher	  dosage	  or	  
increase	  in	  the	  number	  of	  injections	  could	  be	  explored	  to	  optimize	  staining	  levels.	  
	  
In	  an	  attempt	  to	  detect	  differences	   in	  neurogenesis	  at	  different	   injection	  time	  points	  
and	  then	  identify	  phenotypes	  of	  mitotically	  active	  cells	  the	  NeuN	  and	  DCX	  data	  were	  
pooled.	   The	   total	   and	   average	   number	   of	   EdU/NeuN	   +	   EdU/DCX	   showed	   that	  
significantly	   more	   cells	   expressed	   the	   EdU	   marker	   2	   weeks	   after	   injection	   of	   EdU	  
(Figure	   26).	   	   This	   finding	   is	   in	   agreement	   with	   Steiner	   et	   al.	   (2004)	   who	   pooled	  
BrdU/NeuN-­‐	   and	   BrdU/DCX-­‐labelled	   cells	   and	   found	   that	   injections	   4	   hours	   prior	   to	  
perfusion	   rendered	  significantly	   lower	  cell	   counts	   than	  perfusions	  1	  week	  after	  BrdU	  
injections	  (10	  cells	  after	  4	  h	  vs.	  150	  after	  3	  days).	  There	  is	  no	  exact	  replication	  of	  this	  in	  
the	  literature,	  but	  it	  suggests	  that	  a	  larger	  sample	  size	  could	  possibly	  reveal	  differences	  
in	  phenotype.	  This	  avenue	  merits	  further	  research.	  
	  
This	  study	  is	  the	  first	  (to	  our	  knowledge)	  to	  effectively	  use	  EdU	  in	  an	  MS	  rat	  model	  for	  
depression	   and	   as	   such	   further	   elucidates	   the	   link	   between	   depression	   and	  
neurogenesis	  and	  exercise.	  It	  provides	  new	  insights	  to	  the	  effect	  of	  stress	  and	  exercise	  
on	  proliferating	  neurons	  in	  the	  adult	  rat	  hippocampus.	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Number of values 60 
  Shapiro-Wilk normality test 
 W 0.7684 
P value < 0.0001 
Passed normality test 
(alpha=0.05)? No 
P value summary **** 
  Sum 388.0
	  
Table Analyzed Day 60 injection exercised (NP) 
  Kruskal-Wallis test 
 P value 0.3020
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 4 
Kruskal-Wallis statistic 3.648 
  Data summary 
 Number of treatments (columns) 4
Number of values (total) 60 
	  
 
GFAP 60 NeuN 60 DCX 60 
Unknown 
60 
Number of values 14 15 15 16 
     Minimum 0.0 0.0 0.0 0.0
25% Percentile 0.0 0.0 0.0 0.0 
Median 8.500 0.0 0.0 1.500 
75% Percentile 20.25 12.00 7.000 7.250 
Maximum 32.00 26.00 29.00 18.00 
     Mean 10.57 6.067 5.467 4.188
Std. Deviation 10.77 7.968 9.523 5.588 
Std. Error of Mean 2.878 2.057 2.459 1.397 
     Lower 95% CI of mean 4.354 1.654 0.1927 1.210
Upper 95% CI of mean 16.79 10.48 10.74 7.165 
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P value < 0.0001 
Passed normality test 
(alpha=0.05)? No 
P value summary **** 
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Table Analyzed Day 96 injection exercised(NP) 
      Kruskal-Wallis test 
   P value 0.4413
  Exact or approximate P value? Gaussian Approximation 
  P value summary ns 
  Do the medians vary signif. (P < 0.05) No 
  Number of groups 4 
  Kruskal-Wallis statistic 2.693 
    Dunn's Multiple Comparison Test Difference in rank sum Significant? P < 0.05? Summary 
GFAP 96 vs NeuN 96 7.717 No ns 
GFAP 96 vs DCX 96 2.475 No ns 
GFAP 96 vs Unknown 96 -0.02564 No ns 
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NeuN 96 vs Unknown 96 -7.742 No ns 
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Shapiro-Wilk normality test 
 W 0.8649
P value 0.0002 
Passed normality test 
(alpha=0.05)? No 
P value summary *** 
 
Table Analyzed EdU average comparison PND60 VS 96 
  Column A PND 60
vs. vs. 
Column B PND 96 
  Mann Whitney test 
 P value < 0.0001
Exact or approximate P value? Exact 
P value summary **** 
Significantly different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
Sum of ranks in column A,B 1362 , 718.0 
Mann-Whitney U 190.0 
  Difference between medians 
 Median of column A 6.667
Median of column B 0.1250 
Difference: Actual 6.542 





GFAP 60 NeuN 60 DCX 60 Unknown 60 
6.666667 9.000000 8.000000 5.000000 
14.333330 8.666667 2.333333 10.666670 
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Shapiro-Wilk normality test 
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W 0.9510 
P value 0.3827 
Passed normality test (alpha=0.05)? Yes 
P value summary Ns 
  	  
Anova	  
Table Analyzed Copy of Day 60 Injection Average redone Oct (NP) 
      ANOVA summary 
     F 1.104
    P value 0.3703 
    P value summary ns 
    Are differences among means statistically significant? (P < 0.05) No 
    R square 0.1120 
          Brown-Forsythe test 
     F (DFn, DFd) 0.2789 (4, 35)
    P value 0.8897 
    P value summary ns 
    Significantly different standard deviations? (P < 0.05) No 
      Bartlett's test 
     Bartlett's statistic (corrected) 1.017 
    P value 0.9071 
    P value summary ns 
    Significantly different standard deviations? (P < 0.05) No 
      ANOVA table SS DF MS F (DFn, DFd) P value 
Treatment (between columns) 87.94 4 21.98 F (4, 35) = 1.104 P = 0.3703 
Residual (within columns) 697.3 35 19.92 
  Total 785.2 39 
      Data summary 
     Number of treatments (columns) 5
    Number of values (total) 40 
      	  
Table Analyzed Copy of Day 60 Injection Average redone Oct (NP) 
  Kruskal-Wallis test 
 P value 0.6032
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 2.734 
  Data summary 
 Number of treatments (columns) 5
Number of values (total) 40 
  	  
ANOVA summary 
     F 1.539
    P value 0.2428 
    P value summary ns 
    Are differences among means statistically significant? (P < 0.05) No 
    R square 0.2240 
      Brown-Forsythe test 
     F (DFn, DFd) 0.2714 (3, 16)
    P value 0.8451 
    P value summary ns 
    Significantly different standard deviations? (P < 0.05) No 
          Bartlett's test 
     Bartlett's statistic (corrected) 0.9739
    P value 0.8076 
    P value summary ns 
    Significantly different standard deviations? (P < 0.05) No 
      ANOVA table SS DF MS F (DFn, DFd) P value 
Treatment (between columns) 87.94 3 29.31 F (3, 16) = 1.539 P = 0.2428 
Residual (within columns) 304.7 16 19.04 
  Total 392.6 19 
      Data summary 
     Number of treatments (columns) 4
    Number of values (total) 20 
    	  
	  
	  
	   80	  
DF MS F (DFn, DFd) P value 










        
Figure 15b 
 
GFAP 96 NeuN 96 DCX 96 Unknown 96 
7.083333 4.333333 0.000000 0.25 
0.000000 0.000000 0.000000 1.20 
15.000000 0.000000 4.666667 5.75 
0.000000 1.666667 1.666667 1.00 
0.000000 0.000000 2.666667 5.25 
    	  
Shapiro-Wilk normality test 
 W 0.7177
P value < 0.0001 
Passed normality test (alpha=0.05)? No 
P value summary **** 
  Sum 50.53
	  
	  
Table Analyzed Copy of Copy of Day 96 Injection Average redone Oct (NP) 
  Kruskal-Wallis test 
 P value 0.7700
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 1.814 
  Data summary 
 Number of treatments (columns) 5
Number of values (total) 40 
  	  
Figure 16a 
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0. 
  	  
	  
Shapiro-Wilk normality test 
 W 0.5442
P value < 0.0001 
Passed normality test (alpha=0.05)? No 
P value summary **** 
	  
Table Analyzed Comparison Totals 2 injections(NP) 
Column A NeuN +DCX 60 
Vs vs 
Column B NeuN+ DCX 96 
  Mann Whitney test 
 P value 0.0198 
Exact or approximate P value? Gaussian Approximation 
P value summary * 
Are medians signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
Sum of ranks in column A,B 1015 , 815 
Mann-Whitney U 319.0 
  	  
	  Figure	  16b	  Averages	  
	  














Shapiro-Wilk normality test 
 W 0.8847
P value 0.0215 
Passed normality test (alpha=0.05)? No 
P value summary * 
	  
Table Analyzed Comparison Totals 2 injections(NP) averages 
Column A NeuN +DCX 60 
vs vs 
Column B NeuN+ DCX 96 
  Mann Whitney test 
 P value 0.0164
Exact or approximate P value? Gaussian Approximation 
P value summary * 
Are medians signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
Sum of ranks in column A,B 137 , 73 
Mann-Whitney U 18.00 









0. 0. 0. 0. 
0. 1. 0. 1. 
0. 0. 0. 0. 
1. 0. 0. 0. 
0. 0. 0. 0. 
6. 1. 0. 4. 
2. 0. 0. 0. 
0. 1. 0. 0. 
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2. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 1. 0. 
0. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 1. 0. 
0. 0. 0. 0. 
0. 0. 
  0. 
    	  
	  
	  
Shapiro-Wilk normality test 
 W 0.3307
P value < 0.0001 
Passed normality test (alpha=0.05)? No 
P value summary **** 
  Sum 21.00
	  
	  
Table Analyzed Day 74 injections non-exercised(NP) 
  Kruskal-Wallis test 
 P value 0.9161
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 0.9577 
  Data summary 
 Number of treatments (columns) 5
Number of values (total) 164 
  	  
	  








0. 0. 0. 1. 
0. 0. 1. 0. 
4. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 0. 0. 
0. 0. 1. 0. 
0. 0. 0. 0. 











  3. 
   1. 
   0. 
   0. 
       	  
Shapiro-Wilk normality test 
 W 0.4366
P value < 0.0001 
Passed normality test (alpha=0.05)? No 
P value summary **** 
  Sum 16.00
	  
Kruskal-Wallis test 
 P value 0.4273
Exact or approximate P value? Approximate 
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P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 3.846 
  Data summary 
 Number of treatments (columns) 5 
Number of values (total) 100 
  	  
Figure	  18a	  




0.00 0.0 0.00 0.0 
0.00 1.0 0.00 1.0 
0.00 0.0 0.00 0.0 
1.00 0.0 0.00 0.0 
0.00 0.0 0.00 0.0 
2.00 0.4 0.20 0.8 
0.00 0.0 0.00 0.0 
0.00 0.0 0.25 0.0 
                                                            Shapiro-Wilk normality test 
 W 0.5037
P value < 0.0001 
Passed normality test 
(alpha=0.05)? No 
P value summary **** 
  Sum 6.650
	  
Kruskal-Wallis test 
 P value 0.9996
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 0.05388 
  Data summary 
 Number of treatments (columns) 5
Number of values (total) 70 
	  
Figure	  18b	  




1.4 0.00 0.25 0.25 
0.4 0.00 0.50 0.00 
0.5 0.25 0.00 0.00 
    	  
Shapiro-Wilk normality test 
 W 0.6755
P value 0.0001 
Passed normality test (alpha=0.05)? No 




 P value 0.2719
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 5.154 
  Data summary 
 Number of treatments (columns) 5


















Shapiro-Wilk normality test 
 W 0.8630
P value 0.0110 
Passed normality test (alpha=0.05)? No 
P value summary * 
	  
	  
Table Analyzed Copy of Weights of treatment groups 
Column A MS 
vs vs 
Column B NMS 
  Mann Whitney test 
 P value 0.0009
Exact or approximate P value? Gaussian Approximation 
P value summary *** 
Are medians signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
Sum of ranks in column A,B 131 , 59 
Mann-Whitney U 4.000 
  	  
	  
	  
	  Figure	  20	  Redone	  weights	  by	  group	  
MS+R MS+NR NMS+R NMS+NR 
310. 352. 315. 315. 
300. 320. 183. 183. 
325. 317. 283. 283. 
350. 340. 291. 291. 
 
340. 256. 256. 
 
               	  
      Shapiro-Wilk normality test 
 W 0.8630
P value 0.0110 
Passed normality test (alpha=0.05)? No 
P value summary * 
	  
                Table Analyzed Weights of treatment groups
  Kruskal-Wallis test 
 P value 0.0046
Exact or approximate P value? Approximate 
P value summary ** 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 4 
Kruskal-Wallis statistic 13.01 
  Data summary 
 Number of treatments (columns) 4
Number of values (total) 19 
	  
Number of families 1 
    Number of comparisons per family 6 
    Alpha 0.05 
      Dunn's multiple comparisons test Mean rank diff. Significant? Summary 
      NMS+NR vs. MS+NR -9.200 No ns
  NMS+NR vs. NMS+R 1.800 No ns 
  NMS+NR vs. MS+R -6.900 No ns 
  MS+NR vs. NMS+R 11.00 Yes * 
  MS+NR vs. MS+R 2.300 No ns 
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NMS+R vs. MS+R -8.700 No ns 
        Test details Mean rank 1 Mean rank 2 Mean rank diff. n1 n2 
      NMS+NR vs. MS+NR 6.600 15.80 -9.200 5 5
NMS+NR vs. NMS+R 6.600 4.800 1.800 5 5 
NMS+NR vs. MS+R 6.600 13.50 -6.900 5 4 
MS+NR vs. NMS+R 15.80 4.800 11.00 5 5 
MS+NR vs. MS+R 15.80 13.50 2.300 5 4 
NMS+R vs. MS+R 4.800 13.50 -8.700 5 4 
	  
	  
	  Figure	  21	  Running	  
	  
DAY 1 DAY 2 DAY 3  DAY 4  DAY 5 DAY 6 DAY 7 DAY 8 DAY 9 DAY10 DAY11 DAY 12 
265. 401. 532. 458. 613. 549. 976. 1275. 1307. 1681. 1467. 1921. 





           	  
DAY 13 DAY 14 DAY 15 DAY 16 DAY 17 DAY 18 DAY 19 DAY 20 
2388. 1957. 1642. 1694. 1956. 2461. 2198. 2341. 
2189. 2084. 1669. 1917. 1788. 2182. 1974. 1862. 
	  
	  
Shapiro-Wilk normality test 
 W 0.9354
P value 0.0242 
Passed normality test (alpha=0.05)? No 






  Friedman test 
 P value 0.0134
Exact or approximate P value? Approximate 
P value summary * 
Are means signif. different? (P < 0.05) Yes 
Number of groups 20 
Friedman statistic 35.14 
  Data summary 
 Number of treatments (columns) 20
Number of subjects (rows) 2 
	  
	  
Number of families 1 
    Number of comparisons per family 190 
    Alpha 0.05 
      Dunn's multiple comparisons test Rank sum diff. Significant? Summary 
      DAY 1 vs. DAY 2 1.000 No ns
  DAY 1 vs. DAY 3  0.0 No ns 
  DAY 1 vs. DAY 4  -1.000 No ns 
  DAY 1 vs. DAY 5 -6.000 No ns 
  DAY 1 vs. DAY 6 -6.000 No ns 
  DAY 1 vs. DAY 7 -10.00 No ns 
  DAY 1 vs. DAY 8 -10.00 No ns 
  DAY 1 vs. DAY 9 -14.00 No ns 
  DAY 1 vs. DAY10 -19.00 No ns 
  DAY 1 vs. DAY11 -24.00 No ns 
  DAY 1 vs. DAY 12 -29.00 No ns 
  DAY 1 vs. DAY 13 -32.00 No ns 
  DAY 1 vs. DAY 14 -27.00 No ns 
  DAY 1 vs. DAY 15 -15.00 No ns 
  DAY 1 vs. DAY 16 -22.00 No ns 
  DAY 1 vs. DAY 17 -21.00 No ns 
  DAY 1 vs. DAY 18 -32.00 No ns 
  DAY 1 vs. DAY 19 -27.00 No ns 
  DAY 1 vs. DAY 20 -26.00 No ns 
  DAY 2 vs. DAY 3  -1.000 No ns 
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DAY 2 vs. DAY 4  -2.000 No ns 
  DAY 2 vs. DAY 5 -7.000 No ns 
  DAY 2 vs. DAY 6 -7.000 No ns 
  DAY 2 vs. DAY 7 -11.00 No ns 
  DAY 2 vs. DAY 8 -11.00 No ns 
  DAY 2 vs. DAY 9 -15.00 No ns 
  DAY 2 vs. DAY10 -20.00 No ns 
  DAY 2 vs. DAY11 -25.00 No ns 
  DAY 2 vs. DAY 12 -30.00 No ns 
  DAY 2 vs. DAY 13 -33.00 No ns 
  DAY 2 vs. DAY 14 -28.00 No ns 
  DAY 2 vs. DAY 15 -16.00 No ns 
  DAY 2 vs. DAY 16 -23.00 No ns 
  DAY 2 vs. DAY 17 -22.00 No ns 
  DAY 2 vs. DAY 18 -33.00 No ns 
  DAY 2 vs. DAY 19 -28.00 No ns 
  DAY 2 vs. DAY 20 -27.00 No ns 
  DAY 3 vs. DAY 4  -1.000 No ns 
  DAY 3 vs. DAY 5 -6.000 No ns 
  DAY 3 vs. DAY 6 -6.000 No ns 
  DAY 3 vs. DAY 7 -10.00 No ns 
  DAY 3 vs. DAY 8 -10.00 No ns 
  DAY 3 vs. DAY 9 -14.00 No ns 
  DAY 3 vs. DAY10 -19.00 No ns 
  DAY 3 vs. DAY11 -24.00 No ns 
  DAY 3 vs. DAY 12 -29.00 No ns 
  DAY 3 vs. DAY 13 -32.00 No ns 
  DAY 3 vs. DAY 14 -27.00 No ns 
  DAY 3 vs. DAY 15 -15.00 No ns 
  DAY 3 vs. DAY 16 -22.00 No ns 
  DAY 3 vs. DAY 17 -21.00 No ns 
  DAY 3 vs. DAY 18 -32.00 No ns 
  DAY 3 vs. DAY 19 -27.00 No ns 
  DAY 3 vs. DAY 20 -26.00 No ns 
  DAY 4 vs. DAY 5 -5.000 No ns 
  DAY 4 vs. DAY 6 -5.000 No ns 
  DAY 4 vs. DAY 7 -9.000 No ns 
  DAY 4 vs. DAY 8 -9.000 No ns 
  DAY 4 vs. DAY 9 -13.00 No ns 
  DAY 4 vs. DAY10 -18.00 No ns 
  DAY 4 vs. DAY11 -23.00 No ns 
  DAY 4 vs. DAY 12 -28.00 No ns 
  DAY 4 vs. DAY 13 -31.00 No ns 
  DAY 4 vs. DAY 14 -26.00 No ns 
  DAY 4 vs. DAY 15 -14.00 No ns 
  DAY 4 vs. DAY 16 -21.00 No ns 
  DAY 4 vs. DAY 17 -20.00 No ns 
  DAY 4 vs. DAY 18 -31.00 No ns 
  DAY 4 vs. DAY 19 -26.00 No ns 
  DAY 4 vs. DAY 20 -25.00 No ns 
  DAY 5 vs. DAY 6 0.0 No ns 
  DAY 5 vs. DAY 7 -4.000 No ns 
  DAY 5 vs. DAY 8 -4.000 No ns 
  DAY 5 vs. DAY 9 -8.000 No ns 
  DAY 5 vs. DAY10 -13.00 No ns 
  DAY 5 vs. DAY11 -18.00 No ns 
  DAY 5 vs. DAY 12 -23.00 No ns 
  DAY 5 vs. DAY 13 -26.00 No ns 
  DAY 5 vs. DAY 14 -21.00 No ns 
  DAY 5 vs. DAY 15 -9.000 No ns 
  DAY 5 vs. DAY 16 -16.00 No ns 
  DAY 5 vs. DAY 17 -15.00 No ns 
  DAY 5 vs. DAY 18 -26.00 No ns 
  DAY 5 vs. DAY 19 -21.00 No ns 
  DAY 5 vs. DAY 20 -20.00 No ns 
  DAY 6 vs. DAY 7 -4.000 No ns 
  DAY 6 vs. DAY 8 -4.000 No ns 
  DAY 6 vs. DAY 9 -8.000 No ns 
  DAY 6 vs. DAY10 -13.00 No ns 
  DAY 6 vs. DAY11 -18.00 No ns 
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DAY 6 vs. DAY 12 -23.00 No ns 
  DAY 6 vs. DAY 13 -26.00 No ns 
  DAY 6 vs. DAY 14 -21.00 No ns 
  DAY 6 vs. DAY 15 -9.000 No ns 
  DAY 6 vs. DAY 16 -16.00 No ns 
  DAY 6 vs. DAY 17 -15.00 No ns 
  DAY 6 vs. DAY 18 -26.00 No ns 
  DAY 6 vs. DAY 19 -21.00 No ns 
  DAY 6 vs. DAY 20 -20.00 No ns 
  DAY 7 vs. DAY 8 0.0 No ns 
  DAY 7 vs. DAY 9 -4.000 No ns 
  DAY 7 vs. DAY10 -9.000 No ns 
  DAY 7 vs. DAY11 -14.00 No ns 
  DAY 7 vs. DAY 12 -19.00 No ns 
  DAY 7 vs. DAY 13 -22.00 No ns 
  DAY 7 vs. DAY 14 -17.00 No ns 
  DAY 7 vs. DAY 15 -5.000 No ns 
  DAY 7 vs. DAY 16 -12.00 No ns 
  DAY 7 vs. DAY 17 -11.00 No ns 
  DAY 7 vs. DAY 18 -22.00 No ns 
  DAY 7 vs. DAY 19 -17.00 No ns 
  DAY 7 vs. DAY 20 -16.00 No ns 
  DAY 8 vs. DAY 9 -4.000 No ns 
  DAY 8 vs. DAY10 -9.000 No ns 
  DAY 8 vs. DAY11 -14.00 No ns 
  DAY 8 vs. DAY 12 -19.00 No ns 
  DAY 8 vs. DAY 13 -22.00 No ns 
  DAY 8 vs. DAY 14 -17.00 No ns 
  DAY 8 vs. DAY 15 -5.000 No ns 
  DAY 8 vs. DAY 16 -12.00 No ns 
  DAY 8 vs. DAY 17 -11.00 No ns 
  DAY 8 vs. DAY 18 -22.00 No ns 
  DAY 8 vs. DAY 19 -17.00 No ns 
  DAY 8 vs. DAY 20 -16.00 No ns 
  DAY 9 vs. DAY10 -5.000 No ns 
  DAY 9 vs. DAY11 -10.00 No ns 
  DAY 9 vs. DAY 12 -15.00 No ns 
  DAY 9 vs. DAY 13 -18.00 No ns 
  DAY 9 vs. DAY 14 -13.00 No ns 
  DAY 9 vs. DAY 15 -1.000 No ns 
  DAY 9 vs. DAY 16 -8.000 No ns 
  DAY 9 vs. DAY 17 -7.000 No ns 
  DAY 9 vs. DAY 18 -18.00 No ns 
  DAY 9 vs. DAY 19 -13.00 No ns 
  DAY 9 vs. DAY 20 -12.00 No ns 
  DAY10 vs. DAY11 -5.000 No ns 
  DAY10 vs. DAY 12 -10.00 No ns 
  DAY10 vs. DAY 13 -13.00 No ns 
  DAY10 vs. DAY 14 -8.000 No ns 
  DAY10 vs. DAY 15 4.000 No ns 
  DAY10 vs. DAY 16 -3.000 No ns 
  DAY10 vs. DAY 17 -2.000 No ns 
  DAY10 vs. DAY 18 -13.00 No ns 
  DAY10 vs. DAY 19 -8.000 No ns 
  DAY10 vs. DAY 20 -7.000 No ns 
  DAY11 vs. DAY 12 -5.000 No ns 
  DAY11 vs. DAY 13 -8.000 No ns 
  DAY11 vs. DAY 14 -3.000 No ns 
  DAY11 vs. DAY 15 9.000 No ns 
  DAY11 vs. DAY 16 2.000 No ns 
  DAY11 vs. DAY 17 3.000 No ns 
  DAY11 vs. DAY 18 -8.000 No ns 
  DAY11 vs. DAY 19 -3.000 No ns 
  DAY11 vs. DAY 20 -2.000 No ns 
  DAY 12 vs. DAY 13 -3.000 No ns 
  DAY 12 vs. DAY 14 2.000 No ns 
  DAY 12 vs. DAY 15 14.00 No ns 
  DAY 12 vs. DAY 16 7.000 No ns 
  DAY 12 vs. DAY 17 8.000 No ns 
  DAY 12 vs. DAY 18 -3.000 No ns 
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DAY 12 vs. DAY 19 2.000 No ns 
  DAY 12 vs. DAY 20 3.000 No ns 
  DAY 13 vs. DAY 14 5.000 No ns 
  DAY 13 vs. DAY 15 17.00 No ns 
  DAY 13 vs. DAY 16 10.00 No ns 
  DAY 13 vs. DAY 17 11.00 No ns 
  DAY 13 vs. DAY 18 0.0 No ns 
  DAY 13 vs. DAY 19 5.000 No ns 
  DAY 13 vs. DAY 20 6.000 No ns 
  DAY 14 vs. DAY 15 12.00 No ns 
  DAY 14 vs. DAY 16 5.000 No ns 
  DAY 14 vs. DAY 17 6.000 No ns 
  DAY 14 vs. DAY 18 -5.000 No ns 
  DAY 14 vs. DAY 19 0.0 No ns 
  DAY 14 vs. DAY 20 1.000 No ns 
  DAY 15 vs. DAY 16 -7.000 No ns 
  DAY 15 vs. DAY 17 -6.000 No ns 
  DAY 15 vs. DAY 18 -17.00 No ns 
  DAY 15 vs. DAY 19 -12.00 No ns 
  DAY 15 vs. DAY 20 -11.00 No ns 
  DAY 16 vs. DAY 17 1.000 No ns 
  DAY 16 vs. DAY 18 -10.00 No ns 
  DAY 16 vs. DAY 19 -5.000 No ns 
  DAY 16 vs. DAY 20 -4.000 No ns 
  DAY 17 vs. DAY 18 -11.00 No ns 
  DAY 17 vs. DAY 19 -6.000 No ns 
  DAY 17 vs. DAY 20 -5.000 No ns 
  DAY 18 vs. DAY 19 5.000 No ns 
  DAY 18 vs. DAY 20 6.000 No ns 
  DAY 19 vs. DAY 20 1.000 No ns 
        Test details Rank sum 1 Rank sum 2 Rank sum diff. n1 n2
      DAY 1 vs. DAY 2 5.000 4.000 1.000 2 2 
DAY 1 vs. DAY 3  5.000 5.000 0.0 2 2 
DAY 1 vs. DAY 4  5.000 6.000 -1.000 2 2 
DAY 1 vs. DAY 5 5.000 11.00 -6.000 2 2 
DAY 1 vs. DAY 6 5.000 11.00 -6.000 2 2 
DAY 1 vs. DAY 7 5.000 15.00 -10.00 2 2 
DAY 1 vs. DAY 8 5.000 15.00 -10.00 2 2 
DAY 1 vs. DAY 9 5.000 19.00 -14.00 2 2 
DAY 1 vs. DAY10 5.000 24.00 -19.00 2 2 
DAY 1 vs. DAY11 5.000 29.00 -24.00 2 2 
DAY 1 vs. DAY 12 5.000 34.00 -29.00 2 2 
DAY 1 vs. DAY 13 5.000 37.00 -32.00 2 2 
DAY 1 vs. DAY 14 5.000 32.00 -27.00 2 2 
DAY 1 vs. DAY 15 5.000 20.00 -15.00 2 2 
DAY 1 vs. DAY 16 5.000 27.00 -22.00 2 2 
DAY 1 vs. DAY 17 5.000 26.00 -21.00 2 2 
DAY 1 vs. DAY 18 5.000 37.00 -32.00 2 2 
DAY 1 vs. DAY 19 5.000 32.00 -27.00 2 2 
DAY 1 vs. DAY 20 5.000 31.00 -26.00 2 2 
DAY 2 vs. DAY 3  4.000 5.000 -1.000 2 2 
DAY 2 vs. DAY 4  4.000 6.000 -2.000 2 2 
DAY 2 vs. DAY 5 4.000 11.00 -7.000 2 2 
DAY 2 vs. DAY 6 4.000 11.00 -7.000 2 2 
DAY 2 vs. DAY 7 4.000 15.00 -11.00 2 2 
DAY 2 vs. DAY 8 4.000 15.00 -11.00 2 2 
DAY 2 vs. DAY 9 4.000 19.00 -15.00 2 2 
DAY 2 vs. DAY10 4.000 24.00 -20.00 2 2 
DAY 2 vs. DAY11 4.000 29.00 -25.00 2 2 
DAY 2 vs. DAY 12 4.000 34.00 -30.00 2 2 
DAY 2 vs. DAY 13 4.000 37.00 -33.00 2 2 
DAY 2 vs. DAY 14 4.000 32.00 -28.00 2 2 
DAY 2 vs. DAY 15 4.000 20.00 -16.00 2 2 
DAY 2 vs. DAY 16 4.000 27.00 -23.00 2 2 
DAY 2 vs. DAY 17 4.000 26.00 -22.00 2 2 
DAY 2 vs. DAY 18 4.000 37.00 -33.00 2 2 
DAY 2 vs. DAY 19 4.000 32.00 -28.00 2 2 
DAY 2 vs. DAY 20 4.000 31.00 -27.00 2 2 
DAY 3 vs. DAY 4  5.000 6.000 -1.000 2 2 
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DAY 3 vs. DAY 5 5.000 11.00 -6.000 2 2 
DAY 3 vs. DAY 6 5.000 11.00 -6.000 2 2 
DAY 3 vs. DAY 7 5.000 15.00 -10.00 2 2 
DAY 3 vs. DAY 8 5.000 15.00 -10.00 2 2 
DAY 3 vs. DAY 9 5.000 19.00 -14.00 2 2 
DAY 3 vs. DAY10 5.000 24.00 -19.00 2 2 
DAY 3 vs. DAY11 5.000 29.00 -24.00 2 2 
DAY 3 vs. DAY 12 5.000 34.00 -29.00 2 2 
DAY 3 vs. DAY 13 5.000 37.00 -32.00 2 2 
DAY 3 vs. DAY 14 5.000 32.00 -27.00 2 2 
DAY 3 vs. DAY 15 5.000 20.00 -15.00 2 2 
DAY 3 vs. DAY 16 5.000 27.00 -22.00 2 2 
DAY 3 vs. DAY 17 5.000 26.00 -21.00 2 2 
DAY 3 vs. DAY 18 5.000 37.00 -32.00 2 2 
DAY 3 vs. DAY 19 5.000 32.00 -27.00 2 2 
DAY 3 vs. DAY 20 5.000 31.00 -26.00 2 2 
DAY 4 vs. DAY 5 6.000 11.00 -5.000 2 2 
DAY 4 vs. DAY 6 6.000 11.00 -5.000 2 2 
DAY 4 vs. DAY 7 6.000 15.00 -9.000 2 2 
DAY 4 vs. DAY 8 6.000 15.00 -9.000 2 2 
DAY 4 vs. DAY 9 6.000 19.00 -13.00 2 2 
DAY 4 vs. DAY10 6.000 24.00 -18.00 2 2 
DAY 4 vs. DAY11 6.000 29.00 -23.00 2 2 
DAY 4 vs. DAY 12 6.000 34.00 -28.00 2 2 
DAY 4 vs. DAY 13 6.000 37.00 -31.00 2 2 
DAY 4 vs. DAY 14 6.000 32.00 -26.00 2 2 
DAY 4 vs. DAY 15 6.000 20.00 -14.00 2 2 
DAY 4 vs. DAY 16 6.000 27.00 -21.00 2 2 
DAY 4 vs. DAY 17 6.000 26.00 -20.00 2 2 
DAY 4 vs. DAY 18 6.000 37.00 -31.00 2 2 
DAY 4 vs. DAY 19 6.000 32.00 -26.00 2 2 
DAY 4 vs. DAY 20 6.000 31.00 -25.00 2 2 
DAY 5 vs. DAY 6 11.00 11.00 0.0 2 2 
DAY 5 vs. DAY 7 11.00 15.00 -4.000 2 2 
DAY 5 vs. DAY 8 11.00 15.00 -4.000 2 2 
DAY 5 vs. DAY 9 11.00 19.00 -8.000 2 2 
DAY 5 vs. DAY10 11.00 24.00 -13.00 2 2 
DAY 5 vs. DAY11 11.00 29.00 -18.00 2 2 
DAY 5 vs. DAY 12 11.00 34.00 -23.00 2 2 
DAY 5 vs. DAY 13 11.00 37.00 -26.00 2 2 
DAY 5 vs. DAY 14 11.00 32.00 -21.00 2 2 
DAY 5 vs. DAY 15 11.00 20.00 -9.000 2 2 
DAY 5 vs. DAY 16 11.00 27.00 -16.00 2 2 
DAY 5 vs. DAY 17 11.00 26.00 -15.00 2 2 
DAY 5 vs. DAY 18 11.00 37.00 -26.00 2 2 
DAY 5 vs. DAY 19 11.00 32.00 -21.00 2 2 
DAY 5 vs. DAY 20 11.00 31.00 -20.00 2 2 
DAY 6 vs. DAY 7 11.00 15.00 -4.000 2 2 
DAY 6 vs. DAY 8 11.00 15.00 -4.000 2 2 
DAY 6 vs. DAY 9 11.00 19.00 -8.000 2 2 
DAY 6 vs. DAY10 11.00 24.00 -13.00 2 2 
DAY 6 vs. DAY11 11.00 29.00 -18.00 2 2 
DAY 6 vs. DAY 12 11.00 34.00 -23.00 2 2 
DAY 6 vs. DAY 13 11.00 37.00 -26.00 2 2 
DAY 6 vs. DAY 14 11.00 32.00 -21.00 2 2 
DAY 6 vs. DAY 15 11.00 20.00 -9.000 2 2 
DAY 6 vs. DAY 16 11.00 27.00 -16.00 2 2 
DAY 6 vs. DAY 17 11.00 26.00 -15.00 2 2 
DAY 6 vs. DAY 18 11.00 37.00 -26.00 2 2 
DAY 6 vs. DAY 19 11.00 32.00 -21.00 2 2 
DAY 6 vs. DAY 20 11.00 31.00 -20.00 2 2 
DAY 7 vs. DAY 8 15.00 15.00 0.0 2 2 
DAY 7 vs. DAY 9 15.00 19.00 -4.000 2 2 
DAY 7 vs. DAY10 15.00 24.00 -9.000 2 2 
DAY 7 vs. DAY11 15.00 29.00 -14.00 2 2 
DAY 7 vs. DAY 12 15.00 34.00 -19.00 2 2 
DAY 7 vs. DAY 13 15.00 37.00 -22.00 2 2 
DAY 7 vs. DAY 14 15.00 32.00 -17.00 2 2 
DAY 7 vs. DAY 15 15.00 20.00 -5.000 2 2 
DAY 7 vs. DAY 16 15.00 27.00 -12.00 2 2 
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DAY 7 vs. DAY 17 15.00 26.00 -11.00 2 2 
DAY 7 vs. DAY 18 15.00 37.00 -22.00 2 2 
DAY 7 vs. DAY 19 15.00 32.00 -17.00 2 2 
DAY 7 vs. DAY 20 15.00 31.00 -16.00 2 2 
DAY 8 vs. DAY 9 15.00 19.00 -4.000 2 2 
DAY 8 vs. DAY10 15.00 24.00 -9.000 2 2 
DAY 8 vs. DAY11 15.00 29.00 -14.00 2 2 
DAY 8 vs. DAY 12 15.00 34.00 -19.00 2 2 
DAY 8 vs. DAY 13 15.00 37.00 -22.00 2 2 
DAY 8 vs. DAY 14 15.00 32.00 -17.00 2 2 
DAY 8 vs. DAY 15 15.00 20.00 -5.000 2 2 
DAY 8 vs. DAY 16 15.00 27.00 -12.00 2 2 
DAY 8 vs. DAY 17 15.00 26.00 -11.00 2 2 
DAY 8 vs. DAY 18 15.00 37.00 -22.00 2 2 
DAY 8 vs. DAY 19 15.00 32.00 -17.00 2 2 
DAY 8 vs. DAY 20 15.00 31.00 -16.00 2 2 
DAY 9 vs. DAY10 19.00 24.00 -5.000 2 2 
DAY 9 vs. DAY11 19.00 29.00 -10.00 2 2 
DAY 9 vs. DAY 12 19.00 34.00 -15.00 2 2 
DAY 9 vs. DAY 13 19.00 37.00 -18.00 2 2 
DAY 9 vs. DAY 14 19.00 32.00 -13.00 2 2 
DAY 9 vs. DAY 15 19.00 20.00 -1.000 2 2 
DAY 9 vs. DAY 16 19.00 27.00 -8.000 2 2 
DAY 9 vs. DAY 17 19.00 26.00 -7.000 2 2 
DAY 9 vs. DAY 18 19.00 37.00 -18.00 2 2 
DAY 9 vs. DAY 19 19.00 32.00 -13.00 2 2 
DAY 9 vs. DAY 20 19.00 31.00 -12.00 2 2 
DAY10 vs. DAY11 24.00 29.00 -5.000 2 2 
DAY10 vs. DAY 12 24.00 34.00 -10.00 2 2 
DAY10 vs. DAY 13 24.00 37.00 -13.00 2 2 
DAY10 vs. DAY 14 24.00 32.00 -8.000 2 2 
DAY10 vs. DAY 15 24.00 20.00 4.000 2 2 
DAY10 vs. DAY 16 24.00 27.00 -3.000 2 2 
DAY10 vs. DAY 17 24.00 26.00 -2.000 2 2 
DAY10 vs. DAY 18 24.00 37.00 -13.00 2 2 
DAY10 vs. DAY 19 24.00 32.00 -8.000 2 2 
DAY10 vs. DAY 20 24.00 31.00 -7.000 2 2 
DAY11 vs. DAY 12 29.00 34.00 -5.000 2 2 
DAY11 vs. DAY 13 29.00 37.00 -8.000 2 2 
DAY11 vs. DAY 14 29.00 32.00 -3.000 2 2 
DAY11 vs. DAY 15 29.00 20.00 9.000 2 2 
DAY11 vs. DAY 16 29.00 27.00 2.000 2 2 
DAY11 vs. DAY 17 29.00 26.00 3.000 2 2 
DAY11 vs. DAY 18 29.00 37.00 -8.000 2 2 
DAY11 vs. DAY 19 29.00 32.00 -3.000 2 2 
DAY11 vs. DAY 20 29.00 31.00 -2.000 2 2 
DAY 12 vs. DAY 13 34.00 37.00 -3.000 2 2 
DAY 12 vs. DAY 14 34.00 32.00 2.000 2 2 
DAY 12 vs. DAY 15 34.00 20.00 14.00 2 2 
DAY 12 vs. DAY 16 34.00 27.00 7.000 2 2 
DAY 12 vs. DAY 17 34.00 26.00 8.000 2 2 
DAY 12 vs. DAY 18 34.00 37.00 -3.000 2 2 
DAY 12 vs. DAY 19 34.00 32.00 2.000 2 2 
DAY 12 vs. DAY 20 34.00 31.00 3.000 2 2 
DAY 13 vs. DAY 14 37.00 32.00 5.000 2 2 
DAY 13 vs. DAY 15 37.00 20.00 17.00 2 2 
DAY 13 vs. DAY 16 37.00 27.00 10.00 2 2 
DAY 13 vs. DAY 17 37.00 26.00 11.00 2 2 
DAY 13 vs. DAY 18 37.00 37.00 0.0 2 2 
DAY 13 vs. DAY 19 37.00 32.00 5.000 2 2 
DAY 13 vs. DAY 20 37.00 31.00 6.000 2 2 
DAY 14 vs. DAY 15 32.00 20.00 12.00 2 2 
DAY 14 vs. DAY 16 32.00 27.00 5.000 2 2 
DAY 14 vs. DAY 17 32.00 26.00 6.000 2 2 
DAY 14 vs. DAY 18 32.00 37.00 -5.000 2 2 
DAY 14 vs. DAY 19 32.00 32.00 0.0 2 2 
DAY 14 vs. DAY 20 32.00 31.00 1.000 2 2 
DAY 15 vs. DAY 16 20.00 27.00 -7.000 2 2 
DAY 15 vs. DAY 17 20.00 26.00 -6.000 2 2 
DAY 15 vs. DAY 18 20.00 37.00 -17.00 2 2 
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DAY 15 vs. DAY 19 20.00 32.00 -12.00 2 2 
DAY 15 vs. DAY 20 20.00 31.00 -11.00 2 2 
DAY 16 vs. DAY 17 27.00 26.00 1.000 2 2 
DAY 16 vs. DAY 18 27.00 37.00 -10.00 2 2 
DAY 16 vs. DAY 19 27.00 32.00 -5.000 2 2 
DAY 16 vs. DAY 20 27.00 31.00 -4.000 2 2 
DAY 17 vs. DAY 18 26.00 37.00 -11.00 2 2 
DAY 17 vs. DAY 19 26.00 32.00 -6.000 2 2 
DAY 17 vs. DAY 20 26.00 31.00 -5.000 2 2 
DAY 18 vs. DAY 19 37.00 32.00 5.000 2 2 
DAY 18 vs. DAY 20 37.00 31.00 6.000 2 2 
DAY 19 vs. DAY 20 32.00 31.00 1.000 2 2 
      	  
Table Analyzed Running stats 
Column A MS+R 
vs vs 
Column B NMS+R 
  Mann Whitney test 
 P value 0.3648
Exact or approximate P value? Gaussian Approximation 
P value summary ns 
Are medians signif. different? (P < 0.05) No 
One- or two-tailed P value? Two-tailed 
Sum of ranks in column A,B 376 , 444 
Mann-Whitney U 166.0 
	  
	  
Figure	  22	  	  	  
	  
**********check	  neurons	  d	  
MS+R MS+NR NMS+R NMS+NR 
0. 40. 39. 20. 
52. 0. 24. 0. 
0. 0. 51. 5. 
0. 55. 44. 0. 
 
0. 37. 
     	  
Shapiro-Wilk normality test 
 W 0.7983
P value 0.0014 
Passed normality test (alpha=0.05)? No 
P value summary ** 
	  
Kruskal-Wallis test 
 P value 0.3327 
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 4.584 
  Data summary 
 Number of treatments (columns) 5
Number of values (total) 36 
  	  
Ventral	  neurons	  
MS+R MS+NR NMS+R NMS+NR 
30. 30. 32. 11. 
25. 36. 0. 13. 
24. 0. 12. 1. 
21. 0. 0. 8. 
 
1. 0. 
   	  
Shapiro-Wilk normality test 
 W 0.8596 
P value 0.0121 
Passed normality test (alpha=0.05)? No 
P value summary * 
	  
Table Analyzed Glia V no restain 
  Kruskal-Wallis test 
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P value 0.4594 
Exact or approximate P value? Approximate 
P value summary ns 
Do the medians vary signif. (P < 0.05) No 
Number of groups 5 
Kruskal-Wallis statistic 3.623 
  Data summary 
 Number of treatments (columns) 5
Number of values (total) 36 
  	  
22b	  
	  
MS+R MS+NR NMS+R NMS+NR 
0. 43. 38. 20. 
62. 0. 8. 0. 
0. 0. 50. 13. 




Shapiro-Wilk normality test 
 W 0.8201
P value 0.0030 
Passed normality test (alpha=0.05)? No 
P value summary ** 
	  
	  
Table Analyzed Glia D no restain 
    Kruskal-Wallis test 
   P value 0.1291
  Exact or approximate P value? Gaussian Approximation 
  P value summary ns 
  Do the medians vary signif. (P < 0.05) No 
  Number of groups 4 
  Kruskal-Wallis statistic 5.665 
    Dunn's Multiple Comparison Test Difference in rank sum Significant? P < 0.05? Summary 
MS+R vs MS+NR -0.3750 No ns 
MS+R vs NMS+R -6.475 No ns 
MS+NR vs NMS+NR 0.5000 No ns 
NMS+R vs NMS+NR 6.600 No ns 
    	  
	  
Ventral	  	  
MS+R MS+NR NMS+R NMS+NR 
30. 30. 32. 11. 
25. 36. 0. 13. 
24. 0. 12. 1. 
21. 0. 0. 8. 
 
1. 0. 
   	  
Shapiro-Wilk normality test 
 W 0.8596
P value 0.0121 
Passed normality test (alpha=0.05)? No 
P value summary * 
	  
Table Analyzed Glia V no restain 
    Kruskal-Wallis test 
   P value 0.3183
  Exact or approximate P value? Gaussian Approximation 
  P value summary ns 
  Do the medians vary signif. (P < 0.05) No 
  Number of groups 4 
  Kruskal-Wallis statistic 3.519 
      Dunn's Multiple Comparison Test Difference in rank sum Significant? P < 0.05? Summary
MS+R vs MS+NR 4.425 No ns 
MS+R vs NMS+R 6.425 No ns 
MS+NR vs NMS+NR 0.5750 No ns 
NMS+R vs NMS+NR -1.425 No ns 
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Figure	  24	  
	  ventral	  correlation	  
	  
Shapiro-Wilk normality test   
W 0.8417 
P value 0.0001 
Passed normality test (alpha=0.05)? No 
P value summary *** 
    
  	  
Number of XY Pairs 18 
Spearman r 0.9006 
95% confidence interval 0.7416 to 0.9638 
P value (two-tailed) P<0.0001 
P value summary *** 
Exact or approximate P value? Gaussian Approximation 
Is the correlation significant? (alpha=0.05) Yes 
	  
dorsal	  
Shapiro-Wilk normality test   
W 0.8203 
P value P<0.0001 
Passed normality test (alpha=0.05)? No 
P value summary *** 
    
Sum 776.0 
	  
Number of XY Pairs 18 
Spearman r 0.1974 
95% confidence interval -0.3105 to 0.6176 
P value (two-tailed) 0.4324 
P value summary ns 
Exact or approximate P value? Gaussian Approximation 





MS+R MS+NR NMS+R NMS+NR 
94. 19. 0. 1. 
3. 0. 57. 86. 
23. 3. 0. 45. 




Shapiro-Wilk normality test 
 W 0.8200
P value 0.0029 
Passed normality test (alpha=0.05)? No 




MS+R MS+NR NMS+R NMS+NR 
65. 7. 5. 7. 
0. 0. 37. 0. 
0. 13. 55. 0. 
0. 0. 9. 0. 
 
29. 0. 3. 
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Shapiro-Wilk normality test 
 W 0.6742 
P value < 0.0001 
Passed normality test (alpha=0.05)? No 
P value summary **** 
	  
	  
Figure	  26	  Ki-­‐67	  dorsal	  
MS+R MS+NR NMS+R NMS+NR 
 0. 82. 103. 31. 
 0. 89. 86. 105. 
 8. 62. 240. 0. 






Shapiro-Wilk normality test 
 W 0.9153
P value 0.1066 
Passed normality test (alpha=0.05)? Yes 




Table Analyzed Ki-67/DCX Dorsal 
      ANOVA summary 
     F 5.054
    P value 0.0140 
    P value summary * 
    Are differences among means statistically significant? (P < 0.05) Yes 
    R square 0.5199 
      Brown-Forsythe test 
     F (DFn, DFd) 0.5691 (3, 14)
    P value 0.6445 
    P value summary ns 
    Significantly different standard deviations? (P < 0.05) No 
      Bartlett's test 
     Bartlett's statistic (corrected) 3.592
    P value 0.3090 
    P value summary ns 
    Significantly different standard deviations? (P < 0.05) No 
      ANOVA table SS DF MS F (DFn, DFd) P value 
Treatment (between columns) 35964 3 11988 F (3, 14) = 5.054 P = 0.0140 
Residual (within columns) 33207 14 2372 
  Total 69171 17 
      Data summary 
     Number of treatments (columns) 4 
    Number of values (total) 18 
      
Number of families 1 
       Number of comparisons per family 6 
       Alpha 0.05 
         Tukey's multiple comparisons test Mean Diff. 95% CI of diff. Significant? Summary 
         MS+R vs. MS+NR -55.00 -155.1 to 45.10 No ns
    MS+R vs. NMS+R -116.2 -211.1 to -21.19 Yes * 
    MS+R vs. NMS+NR -21.75 -116.7 to 73.21 No ns 
    MS+NR vs. NMS+R -61.15 -156.1 to 33.81 No ns 
    MS+NR vs. NMS+NR 33.25 -61.71 to 128.2 No ns 
    NMS+R vs. NMS+NR 94.40 4.872 to 183.9 Yes * 
             Test details Mean 1 Mean 2 Mean Diff. SE of diff. n1 n2 q DF
         MS+R vs. MS+NR 29.25 84.25 -55.00 34.44 4 4 2.259 14 
MS+R vs. NMS+R 29.25 145.4 -116.2 32.67 4 5 5.028 14 
MS+R vs. NMS+NR 29.25 51.00 -21.75 32.67 4 5 0.9415 14 
MS+NR vs. NMS+R 84.25 145.4 -61.15 32.67 4 5 2.647 14 
MS+NR vs. NMS+NR 84.25 51.00 33.25 32.67 4 5 1.439 14 
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MS+R MS+NR NMS+R NMS+NR 
0. 101. 96. 8. 
4. 22. 173. 67. 
13. 7. 98. 0. 





     
 
Shapiro-Wilk normality test 
 W 0.8023
P value 0.0009 
Passed normality test (alpha=0.05)? No 
P value summary *** 
 
  	  
	  
Table Analyzed Ki-67/DCX Ventral 
  Kruskal-Wallis test 
 P value 0.0109
Exact or approximate P value? Approximate 
P value summary * 
Do the medians vary signif. (P < 0.05) Yes 
Number of groups 4 
Kruskal-Wallis statistic 11.17 
  Data summary 
 Number of treatments (columns) 4
Number of values (total) 20 
	  
Number of families 1 
    Number of comparisons per family 6 
    Alpha 0.05 
      Dunn's multiple comparisons test Mean rank diff. Significant? Summary 
      MS+R vs. MS+NR -7.000 No ns 
  MS+R vs. NMS+R -11.70 Yes ** 
  MS+R vs. NMS+NR -6.700 No ns 
  MS+NR vs. NMS+R -4.700 No ns 
  MS+NR vs. NMS+NR 0.3000 No ns 
  NMS+R vs. NMS+NR 5.000 No ns 
        Test details Mean rank 1 Mean rank 2 Mean rank diff. n1 n2
      MS+R vs. MS+NR 4.500 11.50 -7.000 6 4
MS+R vs. NMS+R 4.500 16.20 -11.70 6 5 
MS+R vs. NMS+NR 4.500 11.20 -6.700 6 5 
MS+NR vs. NMS+R 11.50 16.20 -4.700 4 5 
MS+NR vs. NMS+NR 11.50 11.20 0.3000 4 5 

























Top	  this	  up	  to	  1	  Litre	  of	  double	  distilled	  water.	  
	  
BSA	  block	  
20	  ML	  pbs	  
200mg	  BSA	  
0.1 ml	  3	  %	  Triton	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